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ABSTRACT 
 
In this Ph.D. dissertation, the capacity of cultured bovine polymorphonuclear neutrophils 
(PMNs) to passively acquire functional membrane proteins from apoptotic or necrotic 
cells was examined.  The rapid transfer of membrane proteins from a variety of 
syngeneic, allogeneic and xenogeneic donor cells to PMNs was observed. In contrast to 
PMNs from other species, bovine PMNs did not express endogenous major 
histocompatability class II (MHC II) protein, either constitutively or inducibly. The entire 
bovine PMN population was, however, able to acquire detectable levels of surface MHC 
II or cluster of differentiation (CD) 3 protein following PMN co-culture with cells in 
conditions which permitted close contact with dieing cells.  Therefore, it was 
hypothesized that membrane lipids and proteins were acquired by bovine PMN following 
fusion with microparticles (MPs) shed from either apoptotic or necrotic cells.   
 
 It was then determined whether the lifespan of bovine PMNs could be sufficient to 
provide an opportunity for PMNs to interact with T cells. Lymphocyte recruitment to 
sites of inflammation often occurs 3-5 days after the initial PMN recruitment. PMN 
survival would need to span this interval to provide an opportunity for an interaction 
between PMNs and lymphocytes.  Pro-inflammatory cytokines, such as interferon (IFN)-
γ and granulocyte macrophage colony stimulating factor (GM-CSF), and bacterial 
lipopolysaccharide (LPS) were observed to prolong the lifespan of cultured PMNs 
beyond 96 hours. These observations supported the conclusion that it was biologically 
possible for PMNs and T cells to interact at sites of inflammation.  
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Using confocal microscopy, direct evidence was provided for the formation and release 
of MPs from peripheral blood mononuclear cells (PBMCs) and the attachment of these 
MPs to bovine PMNs.   A time-dependent integration of both MP membranes and 
integral membrane proteins into the PMN plasma membrane was also observed. The 
passively acquired membrane lipids and proteins then diffused throughout the PMN 
plasma membrane. Another observation was the formation of MPs which contained 
donor cell cytoplasmic proteins and subsequent transfer this cytoplasmic protein to 
recipient PMNs. These observations raised the possibility that MPs could also transfer 
genetic material. Thus, confocal microscopy provided direct evidence that MPs were one 
mechanism by which bovine PMNs could passively acquire membrane lipids and integral 
membrane proteins. 
 
Finally, the functional consequences of passive acquisition of membrane proteins were 
examined using two different approaches.  A significant increase in green fluorescent 
protein (GFP) transgene expression was observed following PMN infection using the 
GFP expressing bovine adenovirus vector (BAV304).  These PMNs had passively 
acquired membranes from an adenovirus permissive cell line.  This observation provided 
indirect evidence for the passive acquisition of a functional viral receptor protein. Direct 
evidence that PMNs passively acquired functional membrane proteins was provided by 
the observation that the passive transfer of ovine MHC II molecules to bovine PMNs 
enabled these cells to induce antigen-specific proliferation and cytokine expression by 
xenoreactive T cell lines. Despite a reduction in amplitude and duration, T cell responses 
induced by PMNs were qualitatively similar to those observed following activation by the 
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stimulator B cell line. These observations supported the conclusion that PMNs could 
function as antigen presenting cells (APCs) following the passive acquisition of MHC II 
protein.   
 
In conclusion, this research project provided evidence that bovine PMNs have an 
impressive ability to acquire membranes and functional integral membrane proteins from 
dead or dying cells. The implications of this transfer of immunological information are 
discussed within the context of the role which PMNs might play in both innate and 
adaptive immune responses.  
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CHAPTER 1 
LITERATURE REVIEW 
 
1.1 Neutrophils 
1.1.1 Introduction 
Neutrophils, or polymorphonuclear neutrophils (PMNs) are phagocytic cells that 
participate in inflammatory reactions as a first line of defence against bacteria, fungi, 
parasites and viruses 1-3.  The recruitment of polymorphonuclear leukocytes or PMNs to 
an area of tissue injury is one of the primary cell responses during the initiation of host 
defence.  Historically, the neutrophil has been regarded as a terminally differentiated 
effector cell.  The principle role of the neutrophil was thought to be phagocytosis with an 
impressive assortment of preformed antibacterial systems and soluble mediators that 
provide an indiscriminate first line of defence against pathogens and tissue damage.  This 
limited picture of a disposable cell responding blindly to instructions may not provide a 
complete view of PMNs.   
PMNs are formed in the bone marrow at a rate of about 8 million per minute in 
humans, although some reports suggest a turnover rate 10 fold higher 4-6.  Following 
formation in the bone marrow, PMNs migrate to the bloodstream, and about 12 hours 
later move into the tissues.  PMNs have the shortest half-life among leukocytes, with a 
half-life of around 35 hours before they undergo apoptosis, thus limiting their potential to 
participate in long lasting immunological interactions.  PMNs constitute approximately 
60-75% of the blood leukocytes in most carnivores, 50% in horses and 20-30% in healthy 
cattle, sheep and laboratory rodents 7.  
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1.1.2 PMN Recruitment  
 PMNs are the first cell recruited to sites of inflammation for several reasons; 
primarily because of their capacity to rapidly defend the host against invading 
microorganisms, and because they are readily available within circulating blood in high 
numbers.  They exert their anti-microbial activity by three mechanisms that generally 
lead to the destruction of the pathogen:  recognition and phagocytosis of the infectious 
agent, generation of toxic oxygen derivatives through the activation of NADPH oxidase, 
and the release of microbicidal molecules from their specialized lysosomes (called 
azurophil granules) and granules 8.  The various subsets of granules contained within the 
neutrophil constitute an important reservoir not only of antimicrobial proteins, proteases, 
and components of the respiratory burst oxidase, but also of a wide range of membrane-
bound receptors for endothelial adhesion molecules, extracellular matrix proteins, 
bacterial products, and soluble mediators of inflammation.  It is the controlled 
mobilization of these cytoplasmic organelles that permits transformation of the neutrophil 
from a passively circulating cell to a potent effector cell of innate immunity. 
Additionally, the regulated exocytosis of granules enables the neutrophil to deliver its 
arsenal of potentially cytotoxic granule proteins in a targeted manner, thus preventing 
widespread damage to host tissue in most situations.  The contact between PMNs and 
microorganisms occurs frequently in tissues after a lesion or in organs directly exposed to 
the environment, such as the respiratory tract or the digestive mucosa.  Under conditions 
of first contact between PMNs and microorganisms, PMNs are often in contact with 
infectious agents that are not covered by serum opsonins, such as antibodies and 
complement factors.  PMNs, however, express certain non-opsonic receptors such as 
complement receptor 3 (CR3), CD14 9 and all toll-like receptors except TLR3 (in 
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humans) 10,11, which are pattern recognition receptors that are able to recognize molecular 
determinants at the surface of microbes 12.  PMNs offer perhaps the most efficient line of 
defence against invading pathogens.  Their immunological abilities continue to be 
expanded as we learn more about this cell type.  Their crucial role, outlined by the fact 
that no animal can survive for more than a few days without PMNs, may be more diverse 
than previously thought 13.  PMNs are indeed a critical cell to call on as the first line of 
immunological defence.   
Blood borne PMN are found in two main pools:  a circulating pool and a pool 
sequestered in capillaries.  During infection, the numbers of circulating PMN can 
increase 10-fold as they are released from the bone marrow and the sequestered pool.  
Previous studies have demonstrated that, in addition to certain potent chemotactic and 
proadhesive mediators for PMNs such as interleukin (IL)-8 and tumour necrosis factor-α 
(TNF-α), various peptides, polypeptides, fragments of polypeptides and lipids can cause 
the chemotaxis of PMNs. Specifically, formyl methionyl peptides (fMLP), C5a-derived 
from the fifth component of complement, and leukotriene B4 can all serve as potent 
neutrophil chemotactic factors 14.  However, if PMNs are to defend the host against 
microbial invasion, they must first leave the blood stream.  Tissue specific recruitment of 
PMNs is mediated by changes in both the endothelial cells that line blood vessel walls 
and in the PMN following signals generated by inflammation.  Bacterial products such as 
LPS or molecules (such as thrombin or histamine) produced by damaged tissues, cause 
capillary endothelial cells to express a glycoprotein called P-selectin (CD62P).  Normally 
stored in granules, P-selectin moves to the cell surface within minutes after the cells are 
stimulated.  P-selectin then binds to PMN expressed L-selectin (CD62L), triggering a 
rolling action that gradually slows the cells, allowing the second stage of adhesion to 
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occur.  A lipid called platelet-activating factor (PAF), secreted by the endothelial cells, 
activates the rolling PMN which then express CD11a/CD18 or LFA-1.  This is an 
adhesive protein or integrin that binds strongly to an inflamed endothelial glycoprotein 
called intercellular adhesion molecule-1 (ICAM-1; CD54), resulting in a complete PMN 
stop and attachment to the endothelial cell layer.  PMNs are also activated by TNF-α and 
leukotrienes secreted by activated mast cells and secrete small amounts of elastase.  The 
elastases cleave CD43, a protein shown by Woodman et. al. to have a dual role as a 
passive non-specific functional barrier to leukocyte-endothelial adhesion during non-
inflammatory conditions, but during inflammation, CD43 also facilitates emigration of 
leukocytes into tissues 15, allowing an even stronger adhesion.  Following further 
endothelial cell activation by IL-1 or TNF-α, the subsequent expression of E-selectin 
(CD62E) again enhances PMN adhesion.  IL-1 also induces the production of the 
chemokine IL-8 (also designated CXCL8) from endothelial cells which attracts more 
PMNs, while TNF-α stimulates IL-1 secretion from endothelial cells.  TNF-α also 
promotes vasodilation, procoagulant activity, thrombosis, and increases both expression 
of cell adherence proteins and production of chemotactic molecules.  After adhering to 
blood vessel walls, PMNs emigrate into the surrounding tissues by squeezing between the 
endothelial cell layer and the basement layer.  Since PMNs are the most mobile of all the 
blood leukocytes, they are the first cells to arrive at the site of inflammation. 
This is a broad overview of PMN recruitment and function which does not include 
several other proteins which have more specific roles in PMN recruitment, adherence and 
migration.   
 
1.2      Antigen Presentation 
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1.2.1 Introduction 
Antigen processing and presentation pathways are central to the generation of 
adaptive immune responses 16. The immune system needs to recognize target protein 
antigens from pathogens residing in both extracellular and intracellular locations.  The 
crucial immune functions that direct and co-ordinate the delivery of the antigen for 
immune recognition and subsequent generation of T-cell responses have been recognized 
as components of antigen presentation pathways. These functions begin with proteins at 
various subcellular locations in the antigen presenting cell (APC), and end with the 
expression of a peptide-loaded major histocompatability complex (MHC) molecule on 
the APC surface, which can be recognized by T-cells of the appropriate specificity.  This 
process involves intricate proteolytic processing events that generally allow for the 
separation of extracellular and intracellular pathogens into distinct antigen presentation 
pathways.  However, recent evidence shows that this conventional dichotomy in the 
proteolytic processing of endogenous versus exogenous antigen is less restrictive than 
originally thought. The events that constitute the conventional MHC-restricted processing 
pathways are accompanied by interesting deviations that provide opportunities for 
antigens to cross over into their non-conventional processing pathways.   
 
1.2.2 Adaptive Immunity 
The successful establishment of adaptive immunity requires that antigen-specific 
lymphocytes undergo activation, expansion and differentiation. This process is 
determined to a large extent by the interaction between the T-cell and the APC, during 
which antigen-derived peptides in complex with the APC's MHC molecules are presented 
to the T-cell's antigen receptor (TCR) .   17 In order to function as an effective APC, a cell 
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needs to satisfy several criteria, including the capacity to:  a) collect and cleave antigens; 
b) generate antigenic determinants; c) form stable complexes of the peptides with MHC 
class I or class II molecules; and d) express constitutive or inducible co-stimulatory 
molecules. To guide T-cell differentiation to a particular subset or phenotype, APCs also 
need to secrete cytokines, creating a milieu conducive for T-cell differentiation 17-21.  
Virtually any cell expressing MHC molecules is a potential APC. However, APCs are not 
equal in their ability to stimulate T cells. The professional APCs, which include dendritic 
cells (DCs), macrophages and B cells, are better equipped than other cell types to 
maximize T-cell stimulation.  
There has been an enormous amount of research done to determine the roles of 
the proteins involved in the processes mentioned above.  Below is a brief outline of some 
of the major steps necessary in antigen presentation which have been discovered to date.  
 
1.2.3 MHC I Restricted Antigen Presentation  
The MHC I presentation pathway presents antigens from three principal sources:  
1) peptide ligands generated as products of proteolytic degradation in the cytosol; 2) 
peptides generated within the endoplasmic reticulum (ER); and 3) some exogenous 
antigens that can be cross-presented on MHC I.  Cytosolic peptides are first transferred to 
the ER via an ATP-dependent transporter associated with antigen processing (TAP) for 
binding to MHC I 22.  These peptides have already been degraded or cleaved into 
fragments by proteasomes and cytosolic amino peptidases and oligo peptidases.  Once in 
the ER, they join other proteins in the process of translation.  A few additional peptide 
degradation steps are required before an empty MHC I molecule is loaded and 
transported to the cell surface for recognition by cytotoxic T-lymphocytes (CTL).  
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Without going into great detail, suffice to say that there are various criteria that determine 
which proteins will be degraded within the cell to eventually serve as antigenic 
precursors.  These include ‘ageing’ proteins, proteins with amino acid sequences which 
favour their degradation, proteins conjugated with ubiquitin or proteins that experienced 
errors during translation 23.  A high degree of stringency is required for the generation of 
peptides which can bind MHC I proteins as they have a closed binding groove.  Unlike 
other peptide-binding proteins, MHC molecules bind peptide ligands as an integral part 
of their structure, thus making them unstable when peptides are not bound.  This stable 
binding is important to prevent peptide exchanges from occurring at the cell surface 
which would prevent peptide:MHC complexes from being reliable indicators of infection 
24.  Typically, MHC I peptides are octamer/nonamer sequences that have undergone 
distinct proteolytic events to generate exact –COOH and NH2 termini.  The binding of the 
peptide is stabilized at its two ends by contacts between atoms at the two termini, and 
invariant sites in the peptide-binding groove in MHC I molecules.  As MHC molecules 
are highly polymorphic at certain sites along the peptide-binding cleft, this allows for 
broad peptide:MHC binding specificities.  Each different peptide:MHC interaction will 
result in slight variations in conformation for both the peptide and the MHC molecule 
which in turn influence the binding of the T-cell receptor 24.  
Exogenous proteins that enter the cross-presentation pathway have been shown to 
be degraded by proteasomes, and are thought to be dependent on TAP function 22, 
although TAP-independent pathways have also been implicated 25,26.  Although it is 
likely that phagocytosed proteins will eventually enter the ER for processing, interesting 
work has been done to show that ER membranes are an important component of 
phagocytic vesicles which acquire exogenous proteins for cross-presentation and 
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therefore, provides all the machinery necessary to present antigen on MHC I protein in an 
‘ER-independent’ manner (independent to a degree as the ER membranes are still needed 
to fuse with the phagosome) 27.  Finally, both a TAP and ER independent MHC I 
presentation pathway have been identified, whereby proteins targeted to particular 
scavenger receptors are endocytosed and degraded within a proteasome.  They are then 
loaded onto MHC I proteins which have also been endocytosed and dissociated from 
their existing peptide.  The displaced peptide is replaced by the processed exogenous 
peptide 28.  Loaded MHC I proteins are then effectively being ‘recycled’ and used to 
present exogenous peptide.  Many of these processes can also be modulated by the 
presence of certain cytokines that would be present at a site of inflammation. 
 
1.2.4 MHC II Restricted Antigen Presentation  
Following synthesis, MHC II molecules, in conjunction with an invariant chain 
protein, move to cellular exocytic compartments 29.  The invariant chain is cleaved by 
cathepsins, leaving a small peptide (CLIP) which must also be removed before processed 
peptide can bind to MHC II.  The same proteolytic environment (proteosomes and low 
pH) which degrade MHC II destined proteins into peptides are also responsible for the 
removal of CLIP before MHC II/peptide binding can occur.  There are three different 
pathways by which MHC II can be loaded with antigen.  The classical pathway involves 
encountering peptides in the late endosomal-lysosomal compartments to which MHC II-
CLIP has been transported 23.  Recycling of MHC II, similar to that described with MHC 
I, has also been observed, but unlike MHC I molecules, MHC II is more permissive to 
interactions with peptides of ‘non-ideal’ length as they have an open-ended peptide 
binding groove 30.  The third pathway involves presentation of cytosolic antigens, and 
8 
thus adds a new dimension to our understanding of antigen presenting pathways as now 
both MHC I and MHC II antigen presentation have access to both endogenous and 
exogenous antigens.  This pathway has been found to be independent of TAP and the ER, 
but peptide processing involves cytosolic proteases 31,32.  Both the proteasome and 
calpain appear to play important roles in MHC II-restricted endogenous antigen 
presentation.  In order for the processed cytoplasmic antigen to bind with MHC II 
molecules, they were transported into membrane organelles which contain unloaded 
MCH II protein 31.  Following translocation, peptides are further processed by acidic 
proteases within the endosomes, possibly even after binding to MHC II. 
As mentioned previously, the dichotomy of antigen presentation is being reshaped 
into another biological phenomenon with significant redundancy in the classical and non-
classical pathways.  However, there is still a high degree of control within these systems 
and antigen presentation depends on several vital issues such as the form and identity of 
the antigen, intracellular localization, presentation by professional versus non-
professional APC and the immunologic milieu (chemical signalling). 
 
1.2.5 Cross-Presentation 
Cross-presentation involves the uptake and processing of exogenous antigens 
within the major histocompatability complex (MHC) class I pathway. In 1976, Michael 
Bevan first published his observations that two cells with differing major 
histocompatability genes, but which shared the same minor histocompatability genes 
could cross-prime when only one of them was used to immunize a host, which 
recognized both of the major histocompatability proteins as self 33,34.  Although the 
concept of cross-presentation was still in its infancy, scientists quickly realized that the 
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acquisition of exogenous antigen by APCs, and presentation of this antigen by their MHC 
I proteins was the likely explanation for these observations.  More than 25 years ago, 
Gooding and Edwards 35 implicated cross-priming by showing that SV40-transformed 
tumour cells generated SV40-specific CTLs restricted to the MHC haplotype of the host.  
Specifically, injection of allogeneic or even xenogeneic SV40 transformants into a mouse 
could confer subsequent resistance to a challenge with syngeneic SV40 tumour cells.  At 
the time, they were unsure of the specific T-cell subsets generated, but we now know that 
indeed they were observing cross-presentation of SV40 antigen within host APCs on host 
MHC I, inducing host-restricted CD8+ cytotoxic T-cells.  The notion that membranes and 
proteins could be readily exchanged between immune cells was emerging, and the 
consequences were of obvious impact. 
Cross-presentation is primarily performed by dendritic cells (DCs), which are not 
a single cell type but may be divided into several distinct subsets. Those expressing 
CD8α together with CD205, found primarily in the T-cell areas of the spleen and lymph 
nodes, are the major subset responsible for cross-presenting cellular antigens 36. This 
ability is likely to be important for the generation of cytotoxic T-cell immunity to a 
variety of antigens, particularly those associated with viral infection, tumorigenesis, and 
DNA vaccination. At present, it is unclear whether the CD8α-expressing DC subset 
captures antigen directly from target cells or obtains it indirectly from intermediary DCs 
that traffic from peripheral sites 19. 
Most cells have the capacity to present peptides on MHC class I molecules, a 
property that is particularly important for the identification of virus-infected cells by 
CTLs. Detection of virus-infected cells in this manner allows their destruction, thus 
limiting viral replication. To ensure only infected cells are killed, the MHC class I 
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pathway within most cells is restricted to processing endogenously synthesized proteins 
for presentation, excluding exogenously derived proteins. As a consequence, cells 
infected with virus can present viral antigens on their MHC class I molecules and be 
identified for CTL destruction, but bystander cells that merely endocytose viral debris 
cannot process such antigens to form MHC class I-restricted complexes and are therefore 
not targeted.  For a few cell types, particularly DCs, the distinction between endogenous 
and exogenous antigen is not as strict, and MHC class I-restricted presentation of both 
endogenous and exogenous proteins can occur 37. The unusual capacity to process 
exogenous antigens into the MHC class I pathway, referred to as ‘cross-presentation’, 
contradicts the ‘direct’ or ‘classic’ presentation route for endogenously synthesized 
proteins. 
Although the major cell type known to cross-present antigens are the previously 
mentioned subsets of DC 36-38, several other cell types have been reported to cross-
present, including B cells 39, endothelial cells 40, and particularly macrophages 41,42.  
While cross-presentation by B cells and even endothelial cells might need further 
validation, substantial evidence argues that function occurs in both DCs and 
macrophages.  Furthermore, several types of antigens have been reported to be cross-
presented.  These include soluble proteins, immune complexes, intracellular bacteria, 
parasites, and, most importantly, cellular antigens 19,36,41,43.  However, one question for 
which the answer is currently not fully elucidated is how cellular antigens enter the cross-
presentation pathway.  
Recent studies have implicated phagocytosis in cross-presentation 44, but several 
mechanisms have been speculated to lead to antigen capture, including uptake of 
apoptotic cells 45, nibbling of live cellular material 41,46, transfer of heat shock proteins 
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(HSPs) 47, and exosome uptake 48. At present, there is limited in vivo evidence to 
categorically implicate any of these mechanisms. Capture of apoptotic cells by DCs has 
received a great deal of emphasis 49,50, with the likely false conclusion being that 
apoptosis is essential for entry of cellular material into the cross-presentation pathway. It 
is clear that apoptotic material can be cross-presented, as shown by the in vitro cross-
presentation of apoptotic influenza-infected macrophages by human DCs 45. However, it 
is far from certain that apoptosis is essential for access of antigen to the cross-
presentation pathway as evidenced by the sampling of live cellular material by DCs 46.  
Using live-cell imaging techniques, this group demonstrated that DCs (and primarily 
immature DCs) could acquire plasma membrane, and to a lesser extent intracellular 
proteins, from other DCs, macrophages, B-cells and activated T-cells in a cell contact 
dependent manner.  Newly acquired antigens were cross-presented to MHC class I 
restricted T-cells, demonstrating the immunological relevance of such membrane protein 
transfer.  These data are derived from in vitro studies, however, and the role of such a 
mechanism in vivo has yet to be confirmed.  
What is certain regarding the mechanism of cross-presentation is that a 
phagosome to cytosol pathway for the translocation of exogenous peptide exists 51.  
Recent work by Desjardins et. al. supports the hypothesis that phagosomes may have all 
necessary properties to support cross-presentation of exogenous antigens 44,52.  The 
finding that phagocytosis in macrophages proceeds by endoplasmic reticulum (ER) 
recruitment at the cell surface (a process referred to as ER-mediated phagocytosis), 
suggested that antigens from intracellular pathogens could have direct access, within 
phagosomes, to the ER machinery needed for MHC I presentation 53.  Using proteomics 
analyses, Desjardins succeeded in showing the existence within the phagosome of all the 
12 
necessary proteins required for cross-presentation.  These results demonstrated that 
phagosomes were able to process exogenous peptides for MHC class I cross-presentation, 
extending the competence of phagosomes previously shown to be functional only for the 
processing of MHC class II complexes 54.  In addition, this work established that the use 
of ER, an organelle specialized in quality control, to form part of the phagosome 
membrane serves not only to minimize the utilization of the plasma membrane, but also 
confers properties allowing phagosomes to be fully integrated within the immune 
recognition system and play a direct role in cross-presentation. 
 
1.2.6 Co-stimulation 
In addition to MHC-peptide-TCR interaction (signal 1), T lymphocyte stimulation 
is not complete until a second costimulatory signal is received (signal 2).  The 
costimulatory molecules B7.1 (CD80) and B7.2 (CD86) elicit both positive and negative 
costimulatory signals through the CD28 and cytotoxic lymphocyte-associated antigen 4 
(CTLA-4) receptors, respectively 55,56. The repertoire of costimulatory molecules 
continues to grow, revealing a careful orchestration of activities and many possible 
combinations of interactions. Interactions between adhesion molecules, such as leukocyte 
function antigen (LFA)-1 (on T cells) and ICAM-1 (on the APC) amplify the effects of 
the B7 molecules by anchoring the cellular interaction 57. The cytokines IL-2, IL-7 and 
IL-15 are significant players in both the expansion and memory formation of CD8+ T 
cells 58, whereas IL-12 elicits both IFN-  production and T-helper function (Th1) through 
activation of CD4+ T cells 59,60. The complex interaction between an APC and a specific 
T-cell, which underlies T-cell priming and activation, entails the formation of a transient 
structure referred to as the immunological synapse 61.  The required molecular 
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composition of this immunological synapse varies with the state of T-cell development 
(naïve versus memory) and the specific type of T-cell (CD4 vs CD8 vs T-regulatory cell 
vs γδT-cell).  Depending on the type of antigen however, co-stimulation may not be 
necessary.  Some antigens called ‘superantigens’ for example, have been shown to 
require no co-stimulation in generating an immune response to them 62.  The stimulation 
of T-cells with a superantigen, however, is likely to indicate little about a cell’s ability to 
present antigen, but rather the necessity to express MHC II protein.  This is because 
instead of binding in the groove of the MHC molecule, superantigens bind to the outer 
surface of both the MHC II molecules and to several of the different Vβ  gene segments 
of the T-cell receptor 24.  As such, superantigens can stimulate a substantial percentage of 
T-cells (between 2-20% in mice and humans).  This mode of stimulation, however, does 
not prime an adaptive immune response specific for the pathogen, but causes massive 
production of cytokines by CD4 T-cells, which can result in the suppression of the 
adaptive immune response 63,64. 
 
1.2.7 Mixed Lymphocyte Reactions 
 Mixed lymphocyte reactions (MLRs) provide an in vitro system for determining T 
helper (TH) cell proliferation in a cell-mediated response 24. A two-way MLR is induced 
when allogeneic or xenogeneic leukocytes are co-cultured. This co-culture induces both 
T-cell populations to undergo extensive blast formation and cell proliferation during a 
primary stimulation and this response includes the generation of CTLs. Secondary 
stimulation of these alloreactive T-cells induces an extremely rapid and large 
proliferative response. A one-way MLR can be generated by rendering one of the 
stimulator populations unresponsive, often by using mitomycin C or a lethal dose of γ-
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irradiation. The role of TH-cells in a one-way MLR was investigated through the use of 
mAbs to block either MHC II or the TH-cell CD4 protein.  The MLR, and subsequent 
generation of CTLs, was abolished when either CD4, on responder T cells, or MHC II 
proteins, on stimulator cells, were blocked 65. MAb blocking of MLR, combined with the 
observation that depletion of responder APCs had little effect on the MLR, supported the 
conclusion that responder T-cells directly recognized the genetically disparate MHC II 
molecules on the stimulator cells 65,66. Thus, the basic components of an MLR include 
responder TH-cells and allogeneic or xenogeneic stimulator cells which express surface 
MHC II with bound peptide. MLR reactions have also been observed in co-cultures 
which were MHC II compatible but MHC I mismatched.  In these conditions, the primary 
proliferative response was significantly diminished but the induction of a response was 
interpreted as evidence that allogeneic APCs could provide sufficient co-stimulation to 
stimulate CD8+ T-cells in the absence of TH-cells 67. 
An indirect TH-cell stimulation pathway has also been reported whereby 
elimination of stimulator APCs did not result in complete abolishment of the MLR. That 
is, responder APCs were able to acquire stimulator-derived MHC II antigen, and present 
it to responder TH-cells using self-MHC 67,68.  One group reported that this form of 
‘indirect’ stimulation was unable to elicit a primary response, but was only able to 
stimulate primed TH-cells 67. Perhaps this limited T cell stimulation was due to the 
immunogenicity of the cross-presented antigen, or perhaps there was a relatively low 
number of responder T-cells which recognized foreign MHC peptides presented by self-
APCs. The number of T-cells capable of recognizing foreign MHC molecules is thought 
to be between 1 to10% of the CD4 T cell population 24.  
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The MLR reaction, however, seems to be in contradiction to the experiments by 
Doherty and Zinkernagal 69, which illustrated the principles of MHC-restriction of T-
cells.  Their observation that cytotoxic T-cells were restricted in their recognition of virus 
infected cells expressing the same MHC genotype led to the concept of MHC restriction.  
They were fortunate to be investigating MHC I restriction, however, as an MLR involves 
the promiscuous recognition of MHC II/peptide by T-cells and would have given them 
results which argued against the concept of MHC restriction.  It is now thought that such 
alloreactivity as observed in MLRs reflects cross-reactivity of T-cell receptors normally 
specific for a variety of foreign peptides bound by self MHC molecules.  This cross-
reactivity results, in part, because the spectrum of peptides bound by non-self MHC 
molecules on the transplanted tissues differ from those bound by the host’s own MHC 
molecules, and the host’s T-cells are not tolerant to these new peptide:MHC complexes 
65,66. 
 
1.3   A Potential Role for PMNs as Antigen Presenting Cells 
1.3.1  Introduction 
Although the most important roles of PMNs in innate host immune defence are 
likely to be the clearance of immune complexes, the phagocytosis of opsonized particles 
and the release of inflammatory mediators, the past twenty years of PMN research have 
presented the possibility that they are functionally much more diverse than previously 
imagined.  Scientists also now recognize that for each leukocyte population there is a 
diversity of immune functions accompanied with significant redundancy and 
communication capabilities.  That is, a specific immune function may be performed by 
several different cell types, perhaps with slight variations in efficiency or mechanism, but 
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with the outcome remaining the same.  An example of such a redundancy in function is 
with APCs. There are multiple cell types all capable of specifically stimulating T-cells, 
albeit with different efficiencies. Research has also provided evidence that PMNs may 
have the capacity to fulfill all the necessary requirements to be considered APCs. 
 
1.3.2 Antigen Acquisition and Processing 
Tissue damage, by way of injury or infection, is followed by the release of 
vasoactive and chemotactic factors, recruiting PMNs to the site of inflammation.  Being 
active phagocytes and expressing the Fc receptor (FcR) on their surface, PMNs can 
efficiently collect antigens by phagocytosis and FcR-mediated internalization 70,71.  
PMNs can also recognize antigens by Toll-like receptors (TLRs).  These receptors 
recognize microbial components and distinct nucleic acid motifs 72 and at least in 
humans, PMNs are thought to express all TLRs except for TLR3 10,11.  Complement 
receptor 3 has also been implicated in non-opsonic phagocytosis of certain bacteria 8.  
Once inside the phagosome, proteins are degraded by a multitude of proteinase enzymes 
such as proteases and acidic hydrolases. 
An alternative mode of antigen acquisition, particularly for PMNs, may be 
extracellular antigen processing, generating peptides that bind directly to cell surface 
MHC class II molecules on nearby APCs. A recent report demonstrated that IL-8-
stimulated PMNs secreted and activated gelatinase B 73, a matrix metalloproteinase, 
which cleaves type II collagen, leaving the immunodominant peptides intact for binding 
to MHC class II molecules for presentation to T cells.  PMNs were also shown to process 
exogenous bacteria and particulate antigens through an alternate MHC class I processing 
pathway for presentation of peptides to T cells that did not involve ER-Golgi transport or 
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cytosolic processing 74.  By inhibiting ER-Golgi transport and cytosolic processing using 
brefeldin A and proteasome inhibitors, this groups was able to show that antigenic 
processing could occur via vacuolar processing and subsequent secretion of the  
processed antigen which could in turn be presented by other APCs 74.  If PMNs expressed 
MHC II, it is conceivable that they could process and excrete antigen that would in turn 
bind to their own MHC II molecules for presentation to T-cells, although this pathway for 
MHC II dependent antigen presentation has not yet been explored.   
 
1.3.3 MHC II expression  
A requirement for PMNs to play a direct role as antigen presenting cells would be 
the expression of MHC class II protein, necessary for CD4+ T-cell activation.  
Presentation of antigen to CD4+ T-cells is usually associated with professional antigen-
presenting cells, such as dendritic cells, macrophages, and B-cells which constitutively 
express MHC class II.  However, other cell types, such as endothelial cells, T-cells and 
Langerhan cells, have been shown to present antigen to CD4+ T-cells when MHC class II 
expression is induced 75,76. It has now been clearly demonstrated that MHC class II 
expression on PMNs of mice, humans and goats is either inducible or constitutive 77-82.   
This research (Whale et. al., 2005, submitted) has also shown that bovine PMNs acquire 
significant amounts of MHC II protein shed from the membranes of apoptotic or necrotic 
cells, but they do not demonstrate constitutive or inducible expression.  Several 
researchers have shown that in vitro incubation of human PMNs with GM-CSF, IFN-γ, or 
IL-3 results in low-level expression of HLA-DR 81,82.  In addition, significant HLA-DR 
expression has been observed on human PMNs in vivo following administration of either 
GM-CSF or IFN-γ 78,79.  It was determined that a combination of GM-CSF, IFN-γ, and 
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IL-3 was the most effective way of stimulating HLA-DR expression, with GM-CSF 
being the most potent stimulator 79,83.  It was also observed that donor variability existed, 
in that high levels of class II could not be induced on PMNs from all donors 83.  A 
number of potential explanations for these observations exist, ranging from difference in 
ability for cytokines to signal (be it from different numbers of receptors or even the 
presence of class II inhibitors) to the potential that there is an important genetic 
component that may play a role in MHC, cytokine or receptor expression.   
 
1.3.4 Antigen Presentation and Co-stimulation 
The next logical question to address is whether or not MHC II expressing PMNs 
can induce antigen specific T-cell responses, thus confirming their ability to present 
antigen to CD4+ T-cells and directly stimulate an immune response.  A major concern, 
however, is the lack of necessary second signals to activate T-cells, now a generally 
recognized requirement for appropriate T-cell proliferation and differentiation 84-86.  
Inappropriate T-cell activation may also induce apoptosis or anergy 24.  One research 
group found little or no expression of B7-1 and B7-2 on human neutrophil populations, 
regardless of their source or whether they were incubated with GM-CSF and IFN-γ 62.  
As a consequence, PMNs were unable to induce T-cell responses to the tetanus toxoid 
(TT) antigen being tested.  Without appropriate secondary signals, T-cell production of 
IL-2, which leads to T-cell proliferation, is absent.  Despite this lack of secondary signal, 
PMNs were still able to stimulate an antigen specific T-cell population with 
staphylococcal enterotoxin B (SEB) (considered to be a superantigen) 62.  It has been 
previously reported, however, that superantigens can interact with MHC class II and T-
cell receptors in a way that eliminates the need for second signalling molecules to be 
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present on the antigen presenting cell 87.  However, another team found that PMNs 
cultured with autologous serum, IFN-γ and GM-CSF, did indeed express MHC class II, 
CD80 and CD86 at the mRNA and protein level.  These PMNs induced proliferation of 
TT-specific T cells in a MHC class II-restricted manner, albeit an expectedly low 
proliferative response was observed relative to TT-presentation by monocytes 88. It 
should be noted, however, that the possibility exists that contaminating DCs or 
monocytes could affect their RT-PCR detection of mRNA, while the detection of surface 
proteins on PMNs would be unaffected.  Therefore, the possibility remains that the PMNs 
had passively acquired the necessary antigen presenting proteins.  This group did, 
however, address the potential for low numbers of mononuclear APCs in the enriched 
PMN population to affect antigen specific T-cell proliferation.  Their results showed that 
the 1-2% of contaminating monocytes were not a significant contributing factor of T-cell 
proliferation.  Therefore, the failure to induce an anti-TT T-cell response in the 
previously mentioned report could be a result of low levels of expression of co-
stimulatory molecules that deliver the second signal to T cells.   Another study that 
supports the observation that PMNs can present antigen reported that PMNs of patients 
with acute, active Wegener’s granulomatosis, express MHC class II, CD80 and CD86, 
and similarly present antigens to T-cells in an MHC class II-restricted manner 89.   T-cell 
proliferation was induced in both peripheral T-cells as well as antigen specific T-cell 
populations only with autologous PMNs.  There was considerably less stimulation with 
peripheral T-cells, being in line with the low frequency of antigen-specific precursors in 
the periphery, and the total stimulation by PMNs was only about 50% that induced using 
the same number of monocytes.  It was, however, conclusive evidence for antigen 
specific, MHC-restricted T-cell stimulation. 
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Several of the discussed reports suggest that PMNs can express the required 
accessory molecules, such as intracellular adhesion molecule (ICAM)-1 and vascular cell 
adhesion molecule-1, in sufficient amounts to stimulate T-cell activation, even in the 
absence of B7-1 and B7-2.  The significance of ICAM-1 expression is that it is an 
accessory molecule that acts by adhesion to LFA-1 on the T-cell to enhance the 
interaction between the T-cell receptor and the antigen/MHC complex 82.  Fisher et.al. 90 
showed that human PMNs expressing transfected MHC II and ICAM-1 molecules could 
stimulate T-cells at 100-fold lower concentrations of staphylococcal enterotoxin A (SEA) 
bacterial superantigen than with PMNs expressing MHC II alone.  They also showed that 
CD4+ memory cell stimulation was much less dependent on accessory molecule 
expression than naïve T-cell stimulation.  In addition, they were able to stimulate both 
naïve and memory T-cells using plastic adherent ICAM-1 and MHC II transfected PMNs, 
indicating that costimulatory signals mediated to the T-cells through LFA-1 can be 
delivered physically separated from the TCR:MHC II signal 90.  Human peripheral blood 
PMNs have also been shown to constitutively express a B7-1-like molecule that interacts 
with CD28, regulating T-cell function 91.  
 
1.3.5 PMN Cytokine Production 
Until recently, it was generally believed that mature PMNs had limited capacity to 
synthesize de-novo proteins, and played only a passive role in inflammation through 
phagocytosis and the release of preformed cytotoxic compounds 92.  Indeed, recent 
investigations have shown that PMNs can be induced to express a number of genes 
whose products lie at the core of inflammatory and immune responses.  These genes 
include not only the constitutively expressed Fc receptors, complement components 
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(complement receptors 1 and 3; CR1 and CR3), MHC class I, cationic antimicrobial 
peptides and NADPH oxidase proteins, but also a variety of cytokines [including 
interferon (IFN)-α, IL-1, IL-6 and vascular endothelial growth factor] and chemokines 
[including IL-8, TNF-α, growth-related gene product (GRO), α-defensins, macrophage 
inflammatory protein (MIP)-1α and β, interferon-γ-inducible protein of 10kDa (IP10)  
and monokine induced by IFN-γ] 14,93-102.  Because these chemokines are primarily 
chemotactic for PMNs, monocytes, immature dendritic cells and T-cell subsets, a 
potential role for PMNs in orchestrating the sequential recruitment of distinct leukocyte 
types to sites of inflammation is likely to exist.  Such an important immunologic function 
implies that PMNs play a direct role in both cellular and humoral immunity 92.  Table 1 
outlines many of the immunologically relevant proteins expressed by PMNs and provides 
a brief description of their role in regulating pathophysiological processes.   
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 Table 1.1.  A summary of PMN-secreted cytokines and their effects on the T-cell 
response 
PMN-secreted 
cytokines 
Immunological effects on other leukocytes  References 
IL-1 Executes proinflammatory functions and T-cell co-stimulation.  IL-1 might 
favour Th2-type immunity 
95 
IL-6 Polarizes Th responses towards Th2-type immunity 96 
IL-8 Chemoattracts and activates PMNs, promotes extracellular antigen 
processing by inducing gelatinase B release from PMNs.  Also 
chemoattracts T-cells 
14 
IL-10 Suppresses Th1 subset and acts as an anti-inflammatory cytokine 101 
IL-12, IFN-γ Induce Th1-subset bias.  IFN-γ induces MHC II expression on APCs and 
PMNs from some species and activates macrophages 
99 
MIP Chemoattracts and stimulates macrophages, DC and T-cells (Th1) 99 
TGF-β Suppresses inflammatory reactions and induces tissue remodelling 101 
IL-3 Induces MHC II on PMNs in some species 101 
TNF-α Induces MHC II on PMNs in some species, enhances CD86 expression on 
endothelial cells and supports inflammation 
98 
GM-CSF Increases CR3, FcR, MHC I, MHC II and B7 expression, which take part in 
antigen acquisition, antigen presentation and T-cell co-stimulation 
101 
IP-10, MIG, I-
TAC 
Exert angiostatic activities on T-lymphocytes 101 
GRO Chemoattractant and activator of PMNs 99 
α-Defensins Chemoattractant for monocytes and T-cells 100 
 
 
1.3.6 Other Considerations 
Whereas the functional activation of PMNs in response to external stimuli has 
been widely investigated, the modulation of PMN survival is not well known. One major 
problem with accepting that PMNs can act as APCs is the fact that they are thought to be 
too short lived to allow for proper antigen presentation and subsequent T-cell activation.  
Now, mounting evidence supports the idea that the life span of PMNs in vitro can be 
extended 62,83,103, including our own unpublished observations (Chapter 5) where 
approximately 25% of bovine PMN survive longer than 96 hours in appropriate in vitro 
culture conditions (a cytokine milieu that might closely resemble that of an inflammatory 
site).  In one notable study, PMNs in culture were found to rapidly die with a greater than 
50% loss within 48 hours, and nearly 100% after 96 hours 104.  In contrast, PMNs 
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incubated with IL-1β, TNF, GM-CSF, G-CSF, IFN-γ or LPS showed a marked increase 
in survival time, in some cases extending their half-life more than three fold 103.  
Prototypic chemoattractants, such as fMLP, C5a and IL-8 had no affect on PMN 
viability103.  All of the inducers of PMN survival were shown to interfere with the 
physiologic process of apoptosis.  Because mature circulating PMN are terminally 
differentiated, short-lived cells, incapable of proliferation or self-renewal, the regulation 
of PMN survival at sites of inflammation may represent, in addition to recruitment from 
blood, a major mechanism through which functional PMN can be accumulated.  This 
would allow for prolonged PMN function, important for the regulation of host resistance 
and inflammation, and may represent a crucial permissive step to enable a defined set of 
cytokines and microbial products to activate gene expression and alter PMN function.   
A remaining piece of evidence to support a potential role for PMNs as APCs is 
that the immature or precursor form of end-stage PMNs (PMNp) can acquire dendritic 
cell characteristics in the presence of certain cytokines 105.  Dendritic cells are known to 
be the most efficient and effective antigen presenting cell.  By culturing human PMNp in 
the presence of GM-CSF, IL-4 and TNF-α, their maturation program can be drastically 
shifted such that they acquire virtually all the characteristic features of professional 
APCs.  These features include the expression of several additional APC-related surface 
molecules, including the costimulatory molecules B7-1 and B7-2, and accessory 
molecule CD40 105.  Surprisingly the DC-driven PMNp were shown to be at least 10,000 
times more efficient in presenting soluble antigen to autologous T cells when compared 
to freshly isolated autologous monocytes.  Certainly, with better culture conditions, 
mature PMNs might be driven to acquire similar DC characteristics, but since PMNp are 
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regularly seen in inflammatory conditions, they seem to be likely candidates for an 
effective neutrophil source of APCs.   
 
1.4 Apoptosis and Necrosis 
1.4.1 Introduction 
Eukaryotic cell death has been classified into two types: necrosis and apoptosis 
106. Necrosis is considered to be the result of a gross injury to the cells (a pathological 
reaction). This type of cell death is a passive degeneration in which there is a loss of 
integrity of intracellular organelle structures and the cellular plasma membrane. There is 
a lack of control of cellular programs, and intracellular contents are released directly into 
the extracellular fluid. This type of cell death is defined as ‘‘accidental.’’ In contrast to 
necrosis, the initiation and subsequent progression of apoptosis is strictly regulated by a 
cellular genetic program, and has hence been called ‘programmed cell death’ 107. In 
apoptosis, cells do not die passively but rather actively kill themselves. It is a 
physiological process that is followed by the clearance of dead cells via phagocytosis by 
macrophages 108,109. 
The term ‘‘apoptosis’’ was first coined by Kerr et al. 110, who described it as a cell 
death with a ‘‘characteristic morphology of hepatocytes which are dying under 
physiological conditions’’. These morphological changes include a pronounced decrease 
in cell volume, modification of the cytoskeleton resulting in significant membrane 
blebbing, a condensation of the chromatin, and degradation of the DNA into 
oligonucleosomal fragments 111.  Following these morphologic changes, an apoptotic cell 
sheds tiny membrane-bound apoptotic bodies containing intact organelles.  These are 
thought to be quickly phagocytosed such that their intracellular contents are not released 
25 
into the surrounding tissue, and thus avoiding the induction of localized inflammation.  
While ‘‘apoptosis’’ was originally defined morphologically, ‘‘programmed cell death’’ 
comes from a functional definition of cell death that contrasts necrosis (accidental cell 
death). However, apoptosis and programmed cell death have become synonymous 
because the cells dying by programmed cell death usually exhibit the morphological 
characteristics of the originally defined ‘apoptotic’ cells.  
 
1.4.2 Apoptotic Pathways 
There are two major apoptotic pathways that have been well characterized:  the 
mitochondria dependent intrinsic pathway and the death receptor mediated extrinsic 
pathway 107,112. The former pathway is initiated by an internal sensor signal (such as the 
tumour suppresser protein p53), while the latter is triggered by external stimuli (such as 
Fas ligand). A group of cytosolic caspases are involved in initiation, execution, and 
regulatory phases of these pathways. The fundamental components of the intrinsic 
pathway are conserved among eukaryotic species, from invertebrates to mammals 113, 
suggesting that it might be the principal pathway for apoptosis induction.  Finally, both 
intrinsic and extrinsic apoptosis are rapidly induced in the absence of de novo protein 
synthesis, indicating that all of the proapototic components in these pathways are 
preformed inside cells.  Although some viruses were reported to induce apoptosis through 
the extrinsic pathway 114, the major pathway of most virus-induced apoptosis is likely to 
be through the intrinsic pathway. In response to the cellular stresses caused by viral 
infection, activation of p53 or an equivalent protein mediates the initial phase of 
apoptosis. This is followed by the sequential activation of caspases and regulatory 
components of the execution phase. Caspase 3 plays a key role in this phase, inducing 
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apoptotic cell death 115. Alternatively, double stranded RNA-dependent protein kinase 
(PKR) is possibly involved in the induction of apoptosis by some viruses. PKR is an 
interferon-inducible enzyme and is required for the antiviral activities of IFN to become 
effective. During viral infection, PKR is activated and initiates a Fas-associated death 
domain (FADD)-dependent apoptosis cascade 116.  In addition to these two pathways, the 
massive accumulation of protein molecules and abnormal folding in the ER generates 
significant stress (termed ‘‘ER stress’’) on cells, resulting in the induction of a third form 
of apoptosis. Thus, abnormally upregulated synthesis of viral proteins in infected cells 
suggests that this ER stress pathway may also have a role in certain types of virus 
induced apoptosis 116.  
Shortly after defining the morphological characteristics of apoptotic cell death, 
Wyllie et al. 117 reported that apoptosis is accompanied by a fragmentation of 
chromosomal DNA into oligonucleosome-sized DNA. Thus, the classical definition of 
apoptosis has been the cell death in which dying cells exhibit (1) the characteristic 
morphology (the shrinkage of cell volume, the perinuclear condensation of chromatin, 
and the fragmentation of the cell nuclei) and (2) the fragmentation of chromosomal DNA. 
This characteristic fragmentation of chromosomal DNA clearly suggests a massive 
alteration of chromatin structure during the apoptotic process. This alteration would 
accompany hypoacetylation of chromatin components and make high mobility group box 
1 (HMGB1) protein stably associated with chromosomes. HMGB1 protein, a highly 
conserved cellular protein, is known as an abundant nonhistone chromosome-binding 
protein and also as a secreted protein. When released from cells, it can bind with high 
affinity, to the receptor for advanced glycation end products (RAGE) of macrophages and 
powerfully mediates inflammation (a type of ‘‘danger signal’’) 118,119. In apoptosis, the 
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stable association of HMGB1 protein with chromatin can prevent it from being released 
into the extracellular fluid of the dying cells 120. In contrast, disintegration of cellular 
structure in damaged or necrotic cells leads to the passive release of HMGB1 protein and 
the induction of inflammatory responses 120.  In addition, another biologically important 
characteristic of apoptotic cells is the exposure of phosphatidylserine molecules on the 
surface of the dying cells 121. These phospholipid molecules usually appear on the inner 
surface of the plasma membrane but move to the outer surface when apoptosis is induced 
in infected cells.  Phosphatidylserine molecules can function as phagocytic signals for 
macrophages 122.  
 
1.4.3 Apoptotic:Necrotic Cell Ratio 
Although apoptosis has been considered to be a separate process from necrosis, it 
has been observed that under conditions leading to massive apoptosis, considerable 
numbers of necrotic cells were also present 123.  Apparently, virus-triggered proapoptotic 
stimuli can also cause death by necrosis within some of the infected cells. The ratio of 
these two types of cell death is dependent on the physiological status of the cells upon 
infection.  The possibility that these necrotic cells might also be a result of programmed 
cell death has also been proposed following observations that some necrosis is not the 
result of passive cell death but a result of some uncommon type of programmed cell 
death, not involving ordinary apoptotic pathways 124.  Cells may die through a process of 
programmed cell death (death as a specific physiological response) without 
demonstrating the characteristic morphology of apoptosis or vice versa 125. In addition, 
the co-presence of necrotic and apoptotic cells at the site of infection may have 
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physiological significance in vivo, suggesting necrosis is not always the result of 
accidental passive cell death. 
 
1.4.4 Virus Induced Apoptosis 
Although the role of virus-induced apoptosis is considered to be limited as a 
cellular defence mechanism against mammalian virus infection, its effectiveness in 
limiting viral replication in vivo is reflected by the fact that most viruses have acquired 
ways to overcome it, such as through rapid multiplication and expression of anti-
apoptotic genes 123. The accelerated induction of apoptosis by TNF with the resulting 
decrease in viral growth is also representative of the effectiveness of this host defence 
mechanism 126.  Another role of apoptosis in the host defence system is to express a 
phagocytic signal on the surface of infected cells 109. These cells undergo phagocytosis 
with resultant antigen presentation by macrophages to CD4 T lymphocytes. This 
sequence of events is to be considered as the initial steps in the development of acquired 
immunity against pathogenic infection. In addition, the direct interruption of the 
intracellular multiplication and release of the virus occurs as a result of the phagocytosis 
of the virus-infected cells.  It was proposed that the major role of virus induced apoptosis 
in the host defence system is to help phagocytes recognize and digest virus-infected cells, 
leading to the induction of the immunological reactions necessary for the establishment 
of virus specific immunity 127.  
 
1.4.5 Effects of Apoptotic and Necrotic Cells on Macrophages 
Recent studies on the role of apoptosis in the development of acquired immunity, 
although they do not discount the possibility that apoptosis may play a role in the 
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induction of certain kinds of immunity,  revealed that apoptosis elicits a suppressive 
effect on the potential immune activity of phagocytic macrophages 128.  Recognizing the 
critical role of phagocytic clearance of apoptotic cells in the resolution of inflammation 
109, Reddy et.al. hypothesized that macrophages (cells primarily responsible for the 
clearance of apoptotic bodies) must have a selective survival advantage over other cells 
to be able to fulfill this important role.  As inflammation subsides, large numbers of 
recruited cells are competing for a diminishing supply of growth and survival factors, 
resulting in the induction of apoptosis for many of these cells 129.  However, rapid 
clearance of these apoptotic cells is essential in preventing further inflammatory 
problems and yet macrophages are equally susceptible to starvation as other cells 130.  
Reddy et.al. went on to show that macrophages do indeed have a survival advantage 
when there is a deficiency of survival factors that is conferred directly by the uptake of 
apoptotic cells, independent of the source of apoptotic cells or the method of induction of 
apoptosis.  This extended to two distinct macrophage populations; terminally 
differentiated peritoneal macrophages and inactivated proliferating bone marrow derived 
macrophages.  From these observations, they concluded that the role of apoptotic 
clearance as a survival factor may generalize to other phagocytic cells as well.  Moreover, 
they showed that not only was there maintenance of survival, but a parallel inhibition of 
proliferation in the macrophage populations by simultaneously activating the PI-3 kinase 
pathway and inhibiting the ERK1/2 pathways.  It stands to reason that limiting 
proliferation would be a good strategy during a period of deficiency of survival factors.  
Interestingly, a number of microbial products or danger signals which activate the innate 
immune system, such as LPS or bacterial DNA, have also been shown to inhibit 
apoptosis and proliferation of macrophages 128.  Although apoptotic cells and danger 
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signals (including necrotic cells) both activate PI-3 kinase, they have the opposite effects 
on the ERK1/2 pathways.  Perhaps the different signalling events induced by apoptotic 
cells versus necrotic cells (or danger signals) may underlie the divergent outcomes 
generated by antigen presented in the context of one or the other, namely tolerance or 
immunity respectively 83.  Since there are both necrotic and apoptotic cells at sites of 
inflammation, phagocytes are certainly receiving different instructions depending on 
which cell type they phagocytose and will therefore react accordingly.  The induction of 
immunological responses requires the presence of various cytokines in addition to 
antigen presentation by macrophages. Importantly, apoptotic cells do not seem to produce 
cytokines.  In contrast, necrotic cells, which induce deregulated immune reactions, can 
provide the cytokines necessary for the initiation and establishment of virus-specific 
immunity. In this sense, the presence of necrotic cells at the sites where apoptosis is 
prevalent has important physiological significance in vivo. It is possible that the amount 
of necrosis determines the degree of inflammation and the immune reactions that result 
from viral infection. 
 
1.4.6 Other Effects of Apoptosis and Necrosis 
Many cells at sites of inflammation are, or will become either apoptotic or 
necrotic for various reasons.  As both of these forms of cell death have been shown to 
release microparticles (MPs) or small fragments of membranes which contain proteins 
106,131, researchers have increasingly suspected MPs might continue to play an important 
immunological role even after the onset of death.  Of major importance is the fact that the 
induction of apoptosis almost never results in inflammatory injury to surrounding tissues 
132.  This remarkable feature of apoptosis occurs for several reasons. First, the cell 
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membrane of cells undergoing apoptosis remains intact until relatively late in the process 
of cell death 132. Second, apoptotic cells express unique surface markers that permit their 
rapid recognition and ingestion by phagocytes 109. Hence, as long as phagocytic clearance 
of an apoptotic cell occurs before breakdown of its cell membrane, none of its cytosolic 
contents will be released into the extracellular space. In this way, despite the billions of 
cells that die each day by apoptosis, tissues are protected from an otherwise harmful 
exposure to the inflammatory contents of dying cells. Moreover, uptake of apoptotic cells 
actively inhibits the release of proinflammatory mediators such as TNF-α by 
macrophages 133. 
Considering the suppressive role of apoptosis on the immune system as outlined 
above, the presence of necrotic cells at sites of apoptosis is intriguing. Although massive 
necrosis induces extensive inflammatory reactions at the site of infection, it also suggests 
that necrosis might play a biologically important role in the induction of virus-specific 
immunity. The balance of apoptosis and necrosis is essential for the infected animal to 
achieve sufficient immunological protection against the invading pathogens without 
significant immunopathology. To understand the host-pathogen interactions in vivo, 
future studies on the early innate immune responses to viral infection and the significance 
of necrosis and apoptosis in these reactions are required.  There are no reports which 
describe differing PMN function following the uptake of apoptotic versus necrotic cells, 
but PMNs are known to phagocytose both types of dying cells 24. 
 
1.5 Membrane Transfer  
1.5.1 Introduction 
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A growing field of study is emerging around the transfer of membranes between 
leukocytes.  Initially, the main focus of membrane transfer concerned dendritic cells, 
where scientists had coined the term ‘cross-presentation’ for the acquisition, and 
subsequent processing and presentation of exogenous antigens on MHC class I 
molecules.  DCs have also been shown to acquire plasma membrane fragments and 
cytoplasmic proteins from live cells 134. It is theorized that this novel form of antigen 
acquisition provides a mechanism whereby DCs can access antigen in the absence of 
direct infection, and DCs can then present the antigen to T-cells within secondary 
lymphoid tissues.  It appears, however, that more and more situations are being 
recognized where membrane fragments, along with functional proteins, are being 
transferred to a variety of cell types and in many cases this passive transfer of proteins 
results in altered cell biology.  Some scientists have hypothesized that the transfer of 
membrane fragments to leukocytes may serve to either expand and/or regulate an 
immune response 134. 
The preservation of function by passively acquired proteins could have profound 
consequences on the ability of the recipient cells to interact with and regulate other 
immune cells.  Immunologically relevant phenomenon might still be observed even if 
protein function was not maintained.  For example, if non-professional APCs were to 
acquire peptide-loaded MHC II from professional APCs at a site of inflammation, they 
may then have the ability to transport such antigenic information to surrounding lymph-
nodes where soluble antigen might otherwise be excluded 135.  This may provide the 
immune system with a very efficient system for sampling antigens in the periphery and to 
transport the antigen into secondary lymphoid tissues.  With the reported ability of DCs 
134 and B-cells 136,137 to physically remove surface antigen from live cells, the ability for 
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cells to disseminate antigenic information without the same cell being able to present this 
antigen may be functionally relevant.  The dissemination of several other types of protein 
information, by the exchange of membranes and proteins between cells, is also possible.  
For example, the acquisition of adhesion molecules could alter cells’ adherence 
properties, or acquiring cellular receptors could alter the types of molecules able to 
interact with the recipient cell.  Alternatively, cells may acquire all the proteins necessary 
to present antigen, or perhaps they lack some important co-signalling function that would 
render them more likely to play a role in the induction of tolerance or the down-
regulation of an immune response.   
As with most biological systems, there are likely to be several levels of control 
that determine the consequences of membrane transfer.  A simple example of such 
control is seen in macrophages.  If macrophages phagocytose apoptotic cell bodies then 
their potency as APCs is reduced, but following the phagocytosis of necrotic cell bodies, 
their capacity to function as APCs is greatly enhanced 83.  Thus, the type of membrane 
acquired from donor cells can confer distinctly different functions upon the recipient cell.   
It is certain, however, that the growing number of membrane and protein 
exchanges being reported indicates that this phenomenon could be of broad biological 
relevance and worthy of a great deal more research. 
 
1.5.2 Protein Transfer Amongst Leukocytes 
There are several examples of integral membrane protein transfer between 
immune cells.  For example, T-cells have been shown to acquire MHC II/peptide 
complexes from APCs (as well as other molecules) in a process that requires T-cell 
activation 138.  This study also demonstrated intercellular exchange of MHC II/peptide 
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complexes with B-cells, dendritic cells, macrophages and basophils in an activation-
independent manner.  Several publications have investigated this phenomenon and have 
observed that the T-cells which acquire such complexes serve to down-regulate existing 
immune responses by a mechanism associated with the induction of tolerance 138-141.  
There has also been evidence to the contrary, that MHC II expressing T-cells can mediate 
the proliferation of T-cells specific for the same antigen in a secondary culture 142.  
Although this phenomenon is not yet well characterized, the consequences of such 
protein transfer could extend well beyond a transfer of immunological information that 
activates or down-regulates immune responses.   
Natural killer (NK) cells have also been shown to actively capture target cell 
membrane fragments before they deliver their ‘lethal hit’ 143,144.  This phenomenon 
occurs via the immunological synapse and is controlled in an ATP-dependent fashion by 
Src kinase, calcium and PKC, and involves actin rearrangements 144.  Although 
researchers are unsure of all of the consequences of this membrane ‘nibbling’, it is 
thought to be involved in the activation of the NK cell along with an expansion of 
immune recognition.  Tabiasco et. al. have shown that following trans-synaptic 
acquisition of the primary EBV viral receptor protein (CD21), NK cells become 
susceptible to EBV viral infection 145.  Recent electron microscopy of a CD8 T-cell/target 
cell immunological synapse has provided some indication as to how this membrane 
exchange may occur 146.  There was evidence of a physical bridge formed between both 
cells, thus allowing for lateral diffusion of proteins and lipids along the fused membranes, 
without the proteins changing their orientation.  Although it remains unknown how the 
initial membrane fusion between the T-cell and its target occurred, or the mechanism of 
their dissociation, this observation starts to explain the frequent membrane/protein 
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exchanges at the immunological synapse.  Tabiasco’s work effectively demonstrated the 
acquisition of a functional protein by NK cells and this transfer had a significant 
biological impact by rendering NK cells susceptible to EBV infection. 
B-cells are another leukocyte that uses the B-cell receptor (BCR) dependent 
immunological synapse to capture membrane proteins.  Specifically, multiple surface 
immunoglobulins will bind to multivalent binding sites on intact, membrane bound 
polymeric antigens (including membrane anchored proteins) from both APC and non-
APC.  This type of multivalent binding of antigens to the BCR elicits microscopic 
clustering of these bound proteins in the formation of an organized immunological 
synapse and induces B-cell activation.  If there is a high avidity bond between the BCRs 
and the antigen, B-cells can extract membrane-bound antigens from the host cell for 
subsequent processing and presentation to T-cells 136,137.  This emerging form of antigen 
acquisition calls our attention to the unique aspects of molecular interactions in synapses, 
and, amongst other observations, has interesting implications for the cellular trafficking 
of intact antigens and viral particles.   
Continuous and passive synaptic transfers have also been observed in some 
leukemia cell lines 147.  This observed transfer was reported not to involve cytosolic 
molecules or exosomes, but required cell contact.  Intercellular synaptic transfer has 
mostly been described between immunological conjugates comprising an effector cell 
and its target.  This particular study demonstrated that it may also occur between 
autologous cells other than immune cells.  Although no functional consequence was 
studied following such transfer, it was hypothesized that this transfer could facilitate the 
formation of tumour related synapses (between other tumour cells or lymphocytes), or it 
could contribute to intercellular pathways for sustaining activation of these cells.   A 
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study published in 1994, however, showed vesicular shedding from leukocytes resulted in 
the passive acquisition and subsequent functional changes in recipient epithelial tumour 
cells 148.  The vesicles were shown to attach to the plasma membrane of the recipient 
cells, although the authors concluded that complete insertion into the plasma membrane 
was less likely than simple adherence of the vesicles to the surface, as the acquired 
proteins remained in segregated ‘rafts’ rather than diffusing throughout the recipient 
plasma membrane.  Remaining as a protein raft could, however, be a property of such 
protein acquisition, despite membrane fusion.  Specific protein subsets were also 
characteristic of the shed vesicles.  For example, vesicles might carry CD4/CD8 proteins, 
or HLA-DR/CD8 proteins, but not both.  Similarly, not all recipient tumour cells were 
able to acquire all vesicles.  Following co-culture of donor and recipient cells, recipient 
cells exhibiting one, both or neither set of proteins were identified, suggesting that 
acquisition of a given protein required an interaction with vesicles in a receptor mediated 
fashion.  Upon acquisition of the leukocyte proteins, tumour cells exhibited a significant 
increase in adhesion to endothelial cells.  Furthermore, such acquisition was also 
associated with modulation (both increases and decreases) of phosphorylation of many 
recipient proteins.  These results confirmed that surface characteristics of cells are not 
solely dependent on their endogenous plasma membranes, but may be significantly 
altered following passive acquisition of proteins.  These observations lend further support 
to the hypothesis that protein carrying vesicles are biologically important structures. 
 
1.6 Microparticles: 
1.6.1 Introduction 
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Cellular microparticles (MPs), also referred to as microvesicles, are fragments 
shed from the plasma membrane blebs of virtually all cell types when subjected to a 
number of stress conditions, including apoptosis 131.  MPs have also recently been shown 
to be reliable indicators of cellular stimulation, activation or tissue degeneration.  Due to 
the increasing evidence that MPs can interact with neighbouring or even distant cells, 
they have also been identified as true vectors in the transcellular exchange of biologic 
information.   
 
 
 
1.6.2 Microparticle Formation 
Membranes of normal mammalian cells are composed of an asymmetric 
distribution of their aminophospholipids as follows:  phosphatidylserine (PS) and 
phosphatidylethanolamine are mainly sequestered in the inner (cytoplasmic) leaflet, 
whereas sphingomyelin and phosphatidylcholine constitute the majority of the outer 
(exoplasmic) leaflet 149.  When cells are exposed to apoptogenic stimulation, the results 
are a spontaneous collapse of such membrane asymmetry 121 (Figure 1.1).  MP release is 
an integral part of the membrane-remodelling process in which the asymmetric 
distribution of constitutive phospholipids between the two sides of a cell membrane is 
lost.  Since PS has procoagulant qualities, its translocation to the exoplasmic side of cell 
membranes had initially led scientists to hypothesize that the primary role for vascular 
MPs (particularly those from platelets) involves some sort of hemostatic control 150.  
However, PS can also act as a recognition determinant to specifically link activated or 
apoptotic cells to phagocytes 151.  In cultured nucleated cells, the level of MPs released 
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into the supernatant has been shown to correlate with the degree of apoptosis and could 
potentially be used as an in vivo or in vitro indicator of cell death 152.  MPs have been 
shown to be very heterogeneous in size (0.05 - 1µm), protein and lipid composition and 
have also been shown to carry membrane proteins including adhesion protein complexes 
153.   
 
1.6.3 Cellular Interactions with Microparticles 
There is increasing evidence that MPs are detected by cells of various types, and 
often in tissues distant from the site of MP release.  MPs can interact with cells through 
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Figure 1.1   The regulation and physiology of membrane phospholipid asymmetry. This 
model describes how membrane phospholipid asymmetry is generated, maintained, and 
perturbed as a prerequisite to various phosphatidylserine-related pathophysiologies. 
Membrane lipid asymmetry is regulated by the cooperative activities of three 
transporters. The ATP-dependent aminophospholipid-specific translocase, which rapidly 
transports PS and PE from the cell’s outer-to-inner leaflet; the ATP-dependent 
nonspecific lipid floppase, which slowly transports lipids from the cell’s inner-to-outer 
leaflet; and the Ca2+-dependent nonspecific lipid scramblase, which allows lipids to 
move randomly between both leaflets. The model predicts that the translocases are targets 
for Ca2+ that directly regulates the transporter’s activities. The figure shows that elevated 
intracellular Ca2+ induces PS randomization across the cell’s plasma membrane by 
providing a stimulus that positively and negatively regulates scramblase and translocase 
activities, respectively. At physiologic Ca2+ concentrations, PS asymmetry is promoted 
because of an active translocase and floppase but inactive scramblase. Depending on the 
type of cell, elevated intracellular Ca2+ levels can be achieved by cellular activation that 
generally results in the concomitant influx and accumulation of extracellular Ca2+ and by 
its release from intracellular stores. Increased cytosolic Ca2+ can also result in calpain 
activation, which facilitates membrane blebbing and the release of PS-expressing 
procoagulant microvesicles. Exposure of PS at the cell’s outer leaflet. The appearance of 
PS at the cell’s outer leaflet promotes coagulation and thrombosis by providing a 
catalytic surface for the assembly of the prothrombinase and tenase (not shown) 
complexes and marks the cell as a pathologic target for elimination by phagocytes. 
Recognition of the PS-expressing targets can occur by both antibody-dependent and 
direct receptor-mediated pathways 121. 
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 protein surface receptors and in turn, transfer new proteins after membrane fusion 148.  
For example, it has been shown that the chemokine receptor CCR5, which acts as a co-
receptor for human immunodeficiency virus (HIV), can be passively acquired by non-
CCR5 expressing cells when they fuse with CCR5 containing MPs.  Such acquisition 
confers subsequent susceptibility to HIV infection 154.  Of significance was the 
observation of substantial transfer of CCR5 from PBMCs to endothelial cells during 
transendothelial migration which subsequently conferred HIV-1 tropism to CCR5+ 
endothelial cells.  This allows for free passage of blood-borne HIV to tissues via direct 
infection of the endothelial cell layer.  Mack et. al. also reported that the transfer of 
CCR5 to monocytes, but not T-cells, was substantially reduced when monocytes were 
treated with cytochalasin D, an inhibitor of actin polymerization and phagocytosis.  This 
could indicate that the incorporation of CCR5 containing MPs into monocytes involves 
an active process, whereas with T-cells, MPs were passively adsorbed to the cell 
membrane.  Additionally, newly acquired CCR5 was internalized in monocytes following 
cytokine treatment.  This observation could support the concept of a functional 
integration of CCR5 into the membranes of monocytes, or alternatively, a cellular process 
with the purpose of actively eliminating such newly acquired proteins from the surface of 
monocytes.   With T-cells however, as CCR5 acquisition seems to be a passive process, 
they may lack certain control mechanisms as proposed for monocytes.   The binding of 
MPs to different cell types can result in either integration into the recipient cell plasma 
membrane or merely adhesion to the plasma membrane.  Different mechanisms of MP 
integration into host cell membranes may involve passive membrane fusion, endocytosis 
or phagocytosis, depending on the recipient cell type and its state of activation.  Whether 
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or not MP proteins incorporate into the recipient cell membrane in the correct orientation, 
or at all, has obvious implications for the functional consequences of protein acquisition.   
Other examples of MP-related protein transfer are the transfer of arachidonic acid from 
platelet-derived MPs to other platelets and endothelial cells 155, and in 1986 is was 
reported that adherence of platelet-derived microparticles to monocytes was found to be 
responsible for ‘false-positive’ results in flow cytometry 156.  That is, in an attempt to 
detect monocyte derived glycoprotein IIb/IIIa (GP IIb/IIIa) expression using pulse-
labelling with 35S-methionine, researchers could only isolate unlabeled protein in the 
presence of significant numbers of platelets despite a positive flow cytometry analysis for 
GP IIb/IIIa surface expression on monocytes.  Coupled with the fact that anti-GP IIb/IIIa 
antibodies failed to bind to isolated monocytes but bound to platelets, the researchers 
concluded that some sort of platelet contamination was responsible for the detection of 
GP IIb/IIIa on monocytes and implicated microparticles as the source of contamination. 
  Platelet MPs have also been shown to mediate leukocyte-leukocyte interactions 
157.  This phenomenon may be able to assist in the transfer MPs between blood 
leukocytes, allowing cells of the immune system to preserve relevant immunological 
information, such as processed pathogen associated antigenic information, even after the 
onset of death.  
 
1.6.4 Transfer of Genetic Information by Microparticles 
There is also precedence for the transfer of genetic information through MPs.  
Tumour cell derived MPs have been shown to induce in vivo tumour formation through 
oncogene transfer to non-tumorigenic cells 158. The same group also demonstrated that 
whole chromosomes or fragments thereof are horizontally transferred to neighbouring 
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cells by MPs generated from apoptotic cells.  This observed gene transfer, however, may 
have implications beyond tumour progression.  Horizontal transfer of genes has been 
reported in bacteria and fungi, playing an important role in the generation of antibiotic 
resistance and environmental adaptation 159,160.  Holmgren et.al. had also previously 
shown transfer of Epstein-Barr virus (EBV)-DNA along with genomic DNA to the 
nucleus of phagocytosing cells following the uptake of apoptotic cell blebs 161.  In this 
study, fluorescence in situ hybridization was used to show that up to 15% of 
phagocytosing cells had acquired EBV-DNA and subsequently expressed EBV-encoded 
genes at the protein and mRNA levels.  It was also shown that HIV-DNA is transferred in 
a similar fashion to cells that are resistant to HIV infection, indicating a novel pathway of 
receptor-independent transfer of HIV 162.  The transfer of drug resistance genes has also 
been proposed to occur via uptake of apoptotic bodies 163. 
All of the above mentioned observations lend credibility to the hypothesis that 
MPs carrying surface proteins, including MHC Class II, that are released from apoptotic 
leucocytes can adhere to and fuse with PMNs.  Of greater interest is the MPs capacity to 
transfer proteins which alter cellular phenotypes, therefore modifying the intrinsic 
properties of the recipient cells.  In light of the discovery of DNA transfer between cells 
(and subsequent expression), there remains a distinct possibility of RNA transfer between 
cells as well.   
More investigations are required before it is proven that MP based transcellular 
exchange of biological information is a general characteristic with in vivo relevance.  
What is certain is that scientists should view MPs as functional biologic entities rather 
than simple cell debris. 
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1.7 Exosomes 
1.7.1 Protein Composition of Exosomes 
Exosomes are small membrane vesicles (30-100nm) of endocytic origin that are 
secreted by most cells in culture and are clearly distinct from the MPs that are produced 
by apoptotic cells 164.  Interest in exosomes has intensified after their recent description in 
antigen-presenting cells and the observation that they can stimulate immune responses in 
vivo 165,166.  Proteins contained in exosomes derived from particular cell types have 
shown a high degree of conservation, particularly those from antigen presenting cells 164.  
Dendritic cell exosomes from both mice and humans for example, contained heat shock 
proteins, T-cell stimulation proteins (MHC I, MHC II, CD86), targeting and adhesion 
proteins, membrane fusion proteins and several other proteins of intrinsic interest to 
immune stimulation 164,167.  There is a particular abundance of MHC II in exosomes from 
all cells that express MHC II, as one example of exosomes from certain cell lineages 
containing distinct protein signatures.   The protein composition of exosomes is even 
more limited when we consider that they do not contain any proteins of nuclear, 
mitochondrial, endoplasmic-reticulum or Golgi-apparatus origin.  All of the exosomal 
proteins that have been identified are found within the cytosol, in the membrane of the 
endocytic compartments or at the plasma membrane 164.  Exosomes are not simply 
fragments of the plasma membrane, however, as they lack some abundant cell-surface 
proteins such as Fc receptors in DC-derived exosomes 167 or CD28, CD40L and CD45 in 
T-cell derived exosomes 168.  Finally, because exosomes form by inward budding from an 
endosomal membrane, they contain cytosol and expose the extracellular domain of 
transmembrane proteins (Figure 1.2).  Much like with MPs, they also have a higher level 
of PS on the outer exosomal surface, supporting the hypothesis that all such vesicles 
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generated by reverse-budding (as with exosomes and microparticles) require a common 
cytosolic machinery 167.  In lieu of such findings, exosomes are now being considered a 
bona fide secreted sub-cellular compartment, and the current working hypothesis is that 
they have some, as yet unknown, physiological function, rather than primarily an 
alternative way of eliminating unwanted, non-degradable proteins. Perhaps, like 
exosomes, MPs might also selectively carry certain proteins more so than others, and can 
therefore conceivably transfer only a specific subset of proteins to a recipient cell.  
 
1.7.2 Exosome Function 
If such exchange of membrane, protein and cytosol occurs between exosomes (or other 
secreted membrane vesicles) and recipient cells in vivo, it could provide an organism with 
a mechanism of acquiring protein information and the resulting functional consequences 
that might otherwise be unachievable.  Such vesicles could bear combinations of ligands 
to properly engage cell-surface receptors, similar to what happens when two cells 
interact, but without the need for direct cell-cell contact.  Exosomes might simply bind to 
target cell membranes, endowing them with new surface molecules and, amongst other 
effects, could change the recipient cells’ adhesion properties.  Alternatively, exosomes 
might fuse with target cells thereby exchanging membrane proteins and cytosol between 
two cell types.  Whatever sort of ‘intercellular exchange’ takes place, it is reasonable to 
assume that such a process would be strictly regulated, as with all other forms of 
intercellular communication.  There are now numerous in vitro studies published which 
have examined the function of exosomes produced by APCs.  In a few studies, exosomes 
have been shown to specifically stimulate T-cells 166,169, although with 50-100x less 
efficiency than viable APCs.  Other experiments demonstrated tumour rejection 
45 
following immunization with exosomes produced from DCs pulsed with tumour antigens 
165.  The potential remains, however, that such acquisition of antigen by DCs could 
induce either T-cell priming or tolerance.  There is evidence of small vesicles produced in 
rat epithelial cells (named ‘tolerosomes’ as they were not properly characterized as 
exosomes) that have induced some degree of antigen-specific tolerance 170.  Therefore, 
the proposed role for exosomes in the immune system, with regards to the kind of 
immunological response they might induce, could depend on their cellular origin, the 
target cells that they encounter, and the immunological context of such interactions 
(inflammatory vs non-inflammatory environment).  If a pathogen is taken up in the 
periphery by immature or maturing DCs (and possibly other APCs or leukocytes as well), 
they could secrete peptide-MHC complexes via exosomes endowing recipient APCs with 
the ability to stimulate specific T-cells to the newly acquired antigen.  Alternatively, they 
could exchange exosomes after migration to the draining lymph nodes, thereby 
amplifying the magnitude of an antigen specific immune response due to the increased 
number of APCs expressing a particular antigen.  In the absence of inflammation, such 
exchange could contribute to the induction of tolerance in the periphery 164.  There are 
also preliminary reports of antigen-independent effects of exosomes, primarily cell 
activation leading to cytokine production 171 or immunosuppressive effects 172.   
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Figure 1.2  Orientation of various budding events occurring in a cell.   a | Normal 
budding events. The transport of cargo proteins between intracellular compartments 
occurs by means of vesicles budding off a compartment and travelling through the 
cytosol towards another compartment (transport vesicles), or towards the cell surface 
(secretion). These vesicles contain proteins from the lumen of the donor compartment, 
and expose at their surface the cytosolic part of the transmembrane proteins that they 
carry. For the endocytosis of cell-surface receptors (clathrin-coated vesicles), vesicles 
that have the same membrane orientation form. b | Reverse budding events. Budding 
events in which the vesicle that forms contains cytosol and exposes the extracellular or 
lumenal domain of receptors can occur also. This is the case at the plasma membrane 
during virus budding, the secretion of milk-fat globules or the shedding of membrane 
vesicles, or during the formation of the internal vesicles of multivesicular endosomes 164.    
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 In spite of the above mentioned studies, the physiological relevance of exosomes 
remains questionable.  Although the experiments mentioned above were all carried out in 
vitro,  there is also good evidence that exosomes are produced in vivo 173, and that they 
transfer MHC II protein to follicular dendritic cells which do not synthesize endogenous 
MHC II 174.  Much remains to be studied regarding this interesting phenomenon of 
membrane, protein and antigen sharing amongst leukocytes, to uncover the physiological 
role of this new form of cell-cell communication.  
 
1.8 Membrane Fusion: 
1.8.1  Introduction 
A critical factor in the organization of phospholipid bilayers is the necessity of 
maintaining membrane integrity so as to prevent promiscuous membrane fusion. 
Conversely, the controlled fusion of intracellular membranes is essential for basic cellular 
functions, and the temporally and spatially regulated fusion of intercellular membranes is 
required for the formation of multicellular organisms.  Little is known, however, about 
the molecular mechanisms involved in the fusion of multivesicular compartments or 
secretory lysosomes with the plasma membrane.   
 
1.8.2 The Role of SNARE Proteins 
Intracellular vesicle fusion that occurs in the secretory and endocytic pathways 
depends on a similar α-helical bundle structure as used by enveloped viruses during 
fusion with cell membranes 175.  In some cell types, fusion of endocytic compartments 
with the plasma membrane have been shown to be constitutive, whereas in other cell 
types fusion only occurs after activation in a Ca2+-dependent manner 176.  After 
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recognition of vesicle and target membranes by the Rab guanosine triphosphatases and 
their effectors, most intracellular fusion events are determined by specific protein 
machinery which includes soluble factors (N-ethylmaleimide-sensitive factor, NSF, and 
soluble NSF-attachment protein, SNAP) and membrane complexes (such as SNAP-
attachment protein receptor, SNARE) 177,178.  Both membranes that are involved in the 
fusion event need to bear specific SNAREs (known as vesicle-anchored or v-SNARE and 
target-anchored or t-SNARE), which are selectively localized to nearly all cellular 
compartments comprised of lipid membranes 179.  Particular v- and t-SNAREs are 
thought to dictate the specificity of intracellular membrane-fusion events, despite the fact 
that significant promiscuity of SNARE interactions has also been observed 177.  Prior to 
the SNARE interaction, there is an initial step that involves tethering molecules distinct 
from SNAREs 177.   Next, the v- and t-SNAREs bind each other in a pairwise, cognate 
fashion and interact to form a bundle of α-helices (the SNAREpin) that brings apposing 
membranes together and promotes their fusion 179(Figure 1.3).  SNARE proteins must 
reside in opposite membranes for fusion to occur, but their pairing is spontaneous as 
assembly is favoured energetically.  As such, cells and vesicles can bind together at 4oC, 
mediated by SNARE proteins, and remain as unfused intermediates until cells are 
brought to physiological temperatures where the fusion process can be completed 179.   
One important level of control then lies in the assembly of v-t-SNARE complexes 
and the kinetics of this process is further controlled by regulatory proteins such as 
members of the Rab GTPase family 180.  By modulating the rate of SNARE complex 
assembly at local sites either directly or indirectly, regulatory proteins can potentially add 
pairing specificity to different cellular compartments.  Interestingly, it has been proposed 
that SNARES are themselves the minimal machinery needed for membrane fusion to 
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occur 179.  That is, they are both necessary and sufficient for membrane pairing and for 
lipid bilayer fusion.  In addition, SNAREs are necessary as core transport machinery 
accounting for correct vesicle targeting to the principal cellular compartments.  Other 
proteins found to be involved, such as SNAPs and NSF, are not essential for fusion after 
SNARE complexes pair between membranes, rather, their central role in these cases 
appears to be to separate v- from t-SNAREs after a round of fusion to allow for the next 
round 179.  They are generally regarded as necessary, however, in intracellular membrane 
fusion.   
As our knowledge of membrane fusion progresses, scientists will endeavour to 
identify the many proteins and signalling pathways involved in regulating this process.  
Although the presently identified proteins are critical for membrane fusion and 
trafficking, it is probably that completely different membrane fusion mechanisms will be 
identified as a greater variety of cells are used for these investigations. 
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 Figure 1.3.  Contrasting viral fusion and SNARE mediated vesicle fusion.  Cellular 
SNAREpins and Viral Hairpins v-t SNAREpins are complexes of cognate v-SNAREs (in 
green, in the transport vesicle above) and t-SNAREs (in red, in the planar target 
membrane below) bridging two membranes. Analogous t-t SNAREpins may also be 
possible. Membrane anchors are highlighted in yellow. The core of certain viral fusion 
proteins (at left, in orange) is diagrammed in a simplified fashion. The membrane anchor 
of the fusion protein (in yellow) is inserted into the viral membrane, represented by the 
spherical lipid bilayer. The fusion peptide (textured yellow) is inserted into the planar 
target membrane below. Viral fusion proteins generally consist of continuous 
polypeptides (indicated conceptually by the blue polypeptide loop), within which 
oppositely oriented (i.e., antiparallel) helical hairpin-like structures assemble in a helical 
bundle and are proposed to link up the two membranes for fusion 181-183. A SNAREpin 
(whose precise internal structure is not yet known) consists of a 13–14 nm long helix-rich 
core rod of 2 nm width, which most likely contains the membrane-proximal helices of 
VAMP and syntaxin oriented parallel to each other 184,185.  In contrast to viral hairpins, 
cellular SNAREpins are formed from separate polypeptides that reside in different 
membranes before fusion. It is likely that multiple copies of viral hairpins or SNAREpins 
are needed to trigger fusion, and these are likely arranged in a ring-like structure at a 
contact point along the lines illustrated. The striking similarity between SNAREpins and 
viral hairpins suggests that extracellular and lumenally oriented viral fusion proteins, as 
well as intracellular membrane fusion proteins, all employ a fundamentally similar 
mechanism to coalesce lipid bilayers 179.   
 
 
 
CHAPTER 2 
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THE RESEARCH OBJECTIVES AND HYPOTHESES 
 
Within the last decade, it has become apparent that at least some cells have a 
remarkable capacity to function as donor or recipient cells for the exchange of membrane 
fragments and associated integral membrane proteins.  The mechanisms of both donating 
and acquiring membranes and proteins can differ, and depends on the types of donor and 
recipient cells involved.  Although the reasons and mechanisms for such transfer are 
poorly understood thus far, the potential exists for significant functional consequences in 
recipient cells.   
The role of PMNs in adaptive immunity has also gained attention in recent years.  
Reports that PMN survival is prolonged following exposure to certain signals, the early 
recruitment of PMNs to sites of inflammation and their ability to migrate from blood to 
tissue and back to blood, and reports that PMNs can either endogenously express or 
passively acquire immunologically relevant proteins have lead to speculation that PMNs 
may play a role in both innate and adaptive immunity. Furthermore, PMNs may also be 
excellent candidates for disseminating immunological information throughout the body.   
It was hypothesized that bovine PMNs could passively acquire functional proteins 
upon fusion with microparticles shed from apoptotic and necrotic cells.  Enriched 
populations of bovine PMNs were used to evaluate the ability of this cell population to 
acquire a variety of integral membrane proteins and membrane fragments, with a 
particular emphasis on the transfer of MHC Class II protein from B-cells to PMNs.   
 
The research objectives were divided into four main areas of investigation listed below 
along with the relevant hypotheses: 
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1) In Chapter 3, the hypothesis that PMN survival could be prolonged when 
cultured with immunologically relevant concentrations of certain cytokines 
and bacterial molecules was tested.  PMN adherence to plastic was also 
monitored as an indication of PMN activation.  Evidence for prolonged PMN 
survival in vitro could translate to the formation of relevant immunological 
interactions between PMNs and the later recruited lymphocytes to sites of 
inflammation in vivo.   This would also allow for extended observation of 
PMN function  in vitro. 
2) A series of studies were designed to differentiate between possible 
endogenous expression versus passive acquisition of MHC II on bovine PMNs 
and to test the hypothesis that bovine PMNs passively acquired proteins and 
membrane fragments upon fusion with microparticles shed from apoptotic and 
necrotic cells. Based on these studies, a hypothetical model was proposed for 
PMN passive acquisition of membrane lipids and protein (Chapter 5). 
3) Confocal microscopy was used to obtain direct evidence for PMN passive 
acquisition of membrane proteins and to analyse the mechanism by which 
PMNs acquired these membrane proteins. These analyses substantiated the 
hypothesis and the model proposed in Objective #2 (Chapter 6). 
4) To test the hypothesis that functional proteins were acquired by bovine PMNs, 
two independent methods were designed to investigate the functional 
consequences of passive membrane protein acquisition by PMNs. The first 
method investigated the change in GFP-transgene expression following PMN 
acquisition of membranes from a BAdV-3 permissive cell line and the 
subsequent infection with the BAV304 vector constructed in Chapter 4.  The 
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second set of analyses focused on the immunological consequences of passive 
acquisition of MHC II and the potential for PMNs to then function as APCs 
(Chapter 6). 
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 CHAPTER 3 
 
BOVINE POLYMORPHONUCLEAR NEUTROPHIL ACTIVATION 
AND SURVIVAL IN CULTURE  
 
 
3.1 Introduction 
It is generally accepted that the half-life of immature PMNs is only a few hours 
after leaving the bone marrow, and perhaps up to a few days for mature PMNs 7.  In vitro, 
PMNs rapidly die, with changes characteristic of cells undergoing apoptosis 104,186.   
The brief lifespan of PMNs may be an important factor in limiting the potential role that 
PMNs might play in the propagation of an adaptive immune response.  If, however, 
PMNs could survive for at least a few days, significant numbers of PMNs might co-exist 
with T-cells which have been recruited to a site of inflammation 4-5 days after pathogen 
infection.  Alternatively, PMNs might interact with T-cells or professional APCs in the 
draining lymph nodes, where an extended period of survival would potentiate greater 
opportunity and range of interaction and subsequent immunological impact.  It has been 
falsely reported that once PMNs have been recruited into the tissues, they do not return to 
the blood 103.   Several earlier studies provide evidence that PMNs are present in the 
afferent lymph, and have therefore exited the tissues to return to the secondary lymphoid 
organs 187,188 where they could possibly play a role in the control of the adaptive immune 
response.  In addition, PMNs detected in efferent lymph must have originated from 
inflamed tissues and are destined to return to the blood 189,190.  
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 The activation of PMNs in response to external stimuli has been widely 
investigated, but the modulation of PMN survival has not been well studied.  There is 
however, mounting evidence that PMNs can be induced to survive for longer periods of 
time than previously believed 104,191.  For example, mature human PMNs incubated with 
various cytokines or bacterial products were shown to have a significantly longer half-life 
than non-treated PMNs.  Specifically, IL-1 treated PMNs showed an increase in half-life 
from 35 hours to 115 hours.  LPS treated PMNs were 95% viable at 72 hours of culture 
versus 14% viability for untreated PMNs. Mature circulating PMNs are terminally 
differentiated, short-lived cells, which lack the capacity to proliferate.  Thus, regulation 
of PMN survival time at sites of inflammation may represent another mechanism by 
which PMNs could participate in the regulation of an adaptive immune response.   
 The aim of the present investigation was to test the hypothesis that PMN survival 
could be prolonged when cultured with immunologically relevant concentrations of 
certain cytokines and bacterial molecules by analyzing the effect of cytokines (GM-CSF 
and IFN-γ) and bacterial molecules (LPS and synthetic CpG-ODN, a synthetic analogue 
of bacterial DNA), known to be involved in the regulation of inflammatory reactions, on 
PMN survival.  These cytokines were selected based on previous reports which suggest 
that both IFN-γ and GM-CSF are important pro-inflammatory cytokines to which bovine 
PMNs are known to respond 192,193.  LPS and CpG-ODN were selected as important 
representatives of bacterial molecules which induce innate immune responses in PMNs 
through TLRs.  There is evidence that PMNs express both TLR4 (LPS receptor) and 
TLR9 (CpG-ODN receptor) and should therefore respond to these bacterial products 10,11.  
The lifespan of bovine PMNs in vitro was analysed by quantifying the number of viable 
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cells at various culture time points.  Viable cells were deemed to be those which excluded 
trypan blue dye and cells were counted directly with a haemocytometer.  Similarly, using 
attachment to plastic as a sign of PMN activation, adherent cells were counted following 
culture with the same compounds. 
 
3.2 Materials and Methods 
3.2.1 Culture Media and Reagents 
All cell cultures were maintained in AIM-V Serum Free Lymphocyte Medium 
(Gibco BRL, Burlington, ON) containing 20% (v/v) heat inactivated fetal bovine serum 
(FBS; Gibco BRL) and 50 µM 2-mercaptoethanol (2-ME; Biorad; Mississauga, ON), and 
unless otherwise indicated, cultures were incubated at 37oC in a humidified atmosphere 
with 5% CO2.  Recombinant bovine Granulocyte-Macrophage Colony Stimulating Factor 
(GM-CSF) was from Genentech Inc. (San Francisco, CA), lipopolysaccharide purified 
from E. coli bacteria (LPS) was from Sigma-Aldrich (Oakville, ON) and recombinant 
bovine interferon-gamma (IFN-γ) from Ciba-Geigy (Basel, Switzerland).  Synthetic CpG-
ODN 2007 (QIAGEN, GmbH, Hilden, Germany) has been shown to have biological 
activity with cultured bovine leukocytes and the sequence and activity of this ODN has 
been previously described 194. 
 
3.2.2 Purification of Blood Leukocytes 
Bovine PMNs were isolated as previously described (Chapter 5)   
 
3.2.3 Determining PMN Viability 
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Bovine PMNs isolated from blood collected from 5 animals (10 x 106 cells/well) 
were cultured in 6-well plates (Corning Inc., NY, USA) with different concentrations of 
FBS (2%, 10% or 20%), CpG-ODN (1µg/ml), GM-CSF (0.01ng/ml), LPS (50ng/ml), 
IFN-γ (1ng/ml) or combinations thereof (LPS + GM-CSF, LPS + IFN-γ, GM-CSF + IFN-
γ and LPS + GM-CSF + IFN-γ) in a final volume of 6ml.  All cultures containing the 
cytokines, LPS or ODN also contained 20% FBS.  Cells were incubated for 24h, 48h, 
72h, or 96h periods before being collected and counted.  Each well was rinsed 3x with 2 
ml calcium and magnesium-free phosphate buffered saline (PBSA; 137mM NaCl, 2.7mM 
KCl, 8.1mM Na2HPO4, 1.5mM KH2PO4, pH 7.3) to remove all non-adherent PMNs 
before adding 2ml of PBSA containing 0.1% ethylenediaminetetraacetic acid (EDTA, 
Sigma-Aldrich) for 2 minutes to remove the remaining adherent PMNs with vigorous 
pipetting. Viable and non-viable cells, as determined by trypan blue dye exclusion and 
inclusion respectively, were then counted using a microscope and haemocytometer, and 
the percentage of viable cells was determined by comparison to the total cell number.  
The relevant data was collected by comparing cell counts from a larger number of 
animals rather than performing several replicate treatments with fewer animals.  
 
3.2.4 Measuring PMN Activation 
Bovine PMNs (20 x 103 cells/well) were incubated in each well of polypropylene 
plastic 8-chamber slides (Sigma-Aldrich) with Aim-V/20% FBS either alone or with 
CpG-ODN 2007 (1µg/ml), GM-CSF (0.01ng/ml), LPS (50ng/ml), IFN-γ (1ng/ml) or 
combinations thereof (LPS + GM-CSF, LPS + IFN-γ, GM-CSF + IFN-γ and LPS + GM-
CSF + IFN-γ) in a final volume of 300µl.  After the 24h culture period, the chambers 
were removed, and the slides were submerged 3x in PBSA to remove any non-adherent 
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cells.  The slides were allowed to air-dry before staining with DifQuick (Baxter 
Scientific, Miami, FL) and examined at 400x magnification under a microscope.  Plastic-
adherent PMNs were counted and recorded.  One replicate per treatment for each of 4 
animals was counted. 
 
3.2.5 Statistical Analysis 
All data presented were non-parametric in their distribution and comparisons 
between treatment groups were performed with Kruskal-Wallis analysis, using  a Dunn’s 
post-test (GraphPad Prism, CA, USA).  P values less than 0.05 were considered 
significant. 
 
3.3 Results 
3.3.1 PMN Viability in in vitro Culture 
In order to consider bovine PMNs as a cell type with the potential to contribute to 
the induction of adaptive immune responses, they must survive long enough such that 
they have an opportunity to interact with lymphocytes recruited to sites of inflammation 
or the draining lymph node.  The in vitro viability of purified bovine PMNs was analysed 
following culture with various serum concentrations along with the addition of 
recombinant bovine cytokines (GM-CSF and IFN-γ) and bacterial products (LPS, 
synthetic CpG-ODN 2007).  Although all cultures began with 100% PMN viability, in 
the condition containing the typical culture media supplemented with 2% FBS, PMN 
viability declined rapidly with greater than 60% cell death over a 24 hour period (Figure 
3.1A) and almost 100% cell death by 48hr (Figure 3.1B).  Media supplemented with 20% 
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FBS on the other hand maintained significantly higher PMN viability as compared with 
media containing 2% FBS (Figure 3.1A-D).  Of particular interest was the ability of LPS 
combined with either GM-CSF or IFN-γ (or both) to maintain nearly 30% viability 
during a 96 hour culture period (Figure 3.1D).  In contrast, CpG-ODN 2007 did not 
prolong PMN survival either alone (Figure 3.1A-D) or in combination with other 
cytokines (data not shown).   These experiments demonstrated that bovine PMN viability 
can be maintained for a prolonged periods (compared with media supplemented with 2% 
FBS) when cultured with media + 20% FBS or stimulated with combinations of LPS, 
IFN-γ and GM-CSF.   
 
3.3.2 PMN Activation 
The relationship between neutrophil survival and activation was also investigated 
by analysing the induction of neutrophil adherence to plastic within a 24 hour culture 
period.  Following PMN culture with various combinations of cytokines and bacterial 
products (outlined above), there was a significant increase in cell adherence to plastic 
culture slides (Figure 3.2).  Increased cell adherence was interpreted as a sign of 
neutrophil activation 24.  Consistent with the results for the prolongation of PMN 
viability, the combination of LPS and pro-inflammatory cytokines induced the greatest 
increase in adherent cell number.  This experiment demonstrates that culturing PMNs 
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Figure 3.1.  PMN viability during different culture conditions.  10 x 106 bovine 
PMNs from 5 different animals were cultured for (A) 24h, (B) 48h, (C) 72h, or (D) 96h 
with different FBS concentrations as follows; 2% (media 2%), 10% (media 10%) or 20% 
(media 20%).  All remaining cultures were completed using 20% FBS with the addition 
of the following stimulants; 1µg/ml CpG-ODN 2007 (CpG-ODN), 50ng/ml LPS (LPS), 
0.01ng/ml GM-CSF (GM-CSF), 1ng/ml IFN-γ (IFN-γ), or combinations (using the same 
concentrations) as follows;  LPS + GM-CSF (LPS+GM-CSF), LPS + IFN-γ (LPS+IFN-
γ), GM-CSF + IFN-γ (GM-CSF+IFN-γ), or LPS + GM-CSF + IFN-γ (LPS+GM+IFN).  
Viable PMNs were collected and counted by trypan blue exclusion at the end of each 
culture period. 
*Significant difference between indicated culture groups (P<0.05), and ** (P<0.01). 
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with combinations of LPS, IFN-γ and GM-CSF can significantly alter PMN adherence to 
plastic (as an indication of cell activation) and this response correlated with an increase in 
PMN lifespan. 
3.4 Discussion 
For PMNs to play a role in the induction of an adaptive immune response, they 
must be able to interact with T-cells at both the appropriate tissue site and within the time 
frame required for induction of T cell responses. There are several conceivable means by 
which PMNs could contribute to the induction and maintenance of an adaptive immune 
response, only some of which would necessitate prolonged PMN survival.  For example, 
if PMNs are indeed capable of presenting antigen to T-cells, they could stimulate a 
secondary immune response in effector T-cells within minutes of a cognate interaction 24.  
By comparison, if PMNs are to present antigen to naïve T-cells, they might need to 
survive for several days before T-cells are recruited to the site of inflammation or the 
draining lymph node.  Alternatively, PMNs might perform a simple role in the 
dissemination of immunological information by transporting antigen to secondary 
lymphoid tissues, where other APCs could acquire and present this antigen.  Finally, 
PMN contribution to the induction of an adaptive immune response might be very 
indirect through the secretion of  immune modulating cytokines.  Whatever their role, a 
longer period of PMN survival and activation would certainly enhance their opportunity 
to make a more significant impact on immune responses.   
This group of experiments was performed to determine if there were biologically 
relevant conditions that could both prolong neutrophil survival while simultaneously 
inducing a state of activation such as would be expected before the production of 
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immunologically relevant proteins and cytokines.  PMNs are known to be the leukocyte 
population with the shortest half-life of approximately 35 hours 7. Their brief lifespan  
would appear to limit their capacity to interact with lymphocytes which may require 
several days before recruitment to sites of inflammation 24.  However, here we have 
effectively demonstrated that PMN survival can be prolonged (>96 hrs) if stimulated by 
the appropriate cytokines and pathogen-associated molecular pattern molecules which 
may be present at sites of inflammation.  Simply increasing the concentration of FBS in 
the culture medium, from a typical cell culture level of 2% to 20%, increased PMN 
viability during a 24 hour culture period by over 40% (Figure 3.1A).  Any further 
increase in FBS levels had little additional effect on PMN viability over time (data not 
shown).  Of further interest was the increased level of viability when PMNs were 
cultured with low concentrations of cytokines, in particular GM-CSF alone or a 
combination of LPS with either GM-CSF or IFN-γ.  The concentrations of cytokine and 
LPS used to stimulate the PMNs were titrated such that we observed a significant 
increase in PMN half-life and viability, with a minimum effective concentration of each 
stimulant.  Lower concentrations of all of the stimulants used still increased PMN 
viability, but not to the same degree as the data presented.  Furthermore, the cytokine 
concentrations used in these experiments were well within the range detected in tissues at 
sites of inflammation 195-199. 
We encountered a difficulty with certain PMN collections at the 24hr time point.  
Specifically, many PMNs remained adhered to the surface of their culture plates, 
particularly with the LPS + IFN-γ treatment.  Our attempts to remove such adherent cells 
with PBSA + 0.1% EDTA or even trypsin were successful at removing most of the 
adherent cells from all conditions not containing IFN-γ, but between 5-15% of the total 
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PMN population remained adhered in the 24hr cultures containing IFN-γ. Thus, the 
values reported for these conditions represent an under-estimate of PMN viability. 
As cell activation is often characterized by the increased expression of surface 
adhesion proteins 24, the number of plastic-adherent PMNs following culture with the 
same stimulants used in the PMN viability experiment was measured.  The 24 hour 
culture period was chosen since little difference was observed in cell viability at this time 
point within the culture conditions being compared.  There was a remarkable correlation 
between prolonged PMN half-life and their adherence to plastic.  The technique of 
counting all cells attached to the chamber-slide helped to assure that cells which had 
clumped together, or conversely, miscounted cells by not selecting representative areas of 
the culture chamber were not being missed.  In fact, clumping of adherent cells and 
clustering of cells along the outside edge of the culture chamber was observed.  Another 
advantage of manually counting the adherent cells following DifQuick staining was that 
differentiating between PMNs, eosinophils and contaminating monocytes was possible.  
Although the contaminating monocytes represented a very small percentage, typically 
less than 1-4%, the number of eosinophils varied between 5-20% of the total population. 
The inhibition of human PMN apoptosis has been investigated in vivo for the first 12-24 
hours after the induction of an inflammatory response 200,201.  Previous data has indicated 
that a defined set of signals involved in inflammation promote survival of human PMNs, 
and that this effect is mediated by interfering with the genetic program leading to cell 
death. Prolongation of survival, important for the regulation of host resistance and 
inflammation, may represent a crucial permissive step for a defined set of cytokines 
and microbial products that activate gene expression and function in PMNs.  It was 
difficult, however, to interpret these studies due to the rapid recruitment of PMNs to sites 
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of inflammation.  In this investigation, we confirmed that the lifespan of bovine PMNs 
can be significantly prolonged when stimulated with cytokines and bacterial products 
which may be present at sites of inflammation.  These observations have significant 
implications for the potential of PMNs to eliminate invading pathogens and regulate or 
propagate adaptive immune responses.  Our understanding of the role played by PMNs in 
immune responses is far from complete, and this data challenges previous concepts 
regarding the brief time-frame during which PMNs were though to contribute to the 
inflammatory process.   
67 
 
 
CHAPTER 4 
 
 
 
PRODUCTION OF BOVINE ADENOVIRUS TYPE-3 VECTOR 
EXPRESSING GREEN FLUORESCENT PROTEIN 
 
 
 
 
4.1 Introduction 
 
Bovine adenoviruses (BAdVs) belong to the Mastadenovirus genus of 
Adenoviridae family. Currently, the accepted 10 serotypes of BAdVs are divided into two 
subgroups on the basis of the differences in their biological and serological properties 202. 
Serotypes 1, 2, 3, and 9 belong to subgroup I and grow relatively well in established 
bovine cell lines. BAdV type 3 (BAdV-3) has been extensively studied with the goal of 
developing it as an expression vector.  Replication-defective, recombinant adenoviral 
vectors are widely used for in vivo gene transfer because of the ability of these vectors to 
enter many different target cells and efficiently express transgenes 203. 
This laboratory has developed a recombinant bovine adenovirus vector with the 
gene coding green fluorescent protein (GFP) inserted in the E3 region.  This vector 
(BAV304) was constructed such that its reporter gene can be used to trace BAdV-3 
infection through transgene expression in host cells.  The GFP fluoresces a bright green 
colour when exposed to UV light and facilitates a rapid quantification of both virus 
infection and transgene expression.  Thus, it is possible to use flow cytometry to analyze 
the phenotype of cells that are infected by BAdV-3 through expression of the GFP 
transgene.   
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The purpose of this study was to use BAV304 in order to determine if the level of 
BAdV-3 infection in bovine PMNs would change after PMNs had passively acquired 
membrane and associated integral membrane protein from a BAdV-3 permissive cell line 
(293-cells).  It was hypothesized that increased BAdV-3 infection of PMNs, detectable as 
increased GFP expression, would be observed following PMN passive acquisition of  
viral receptor protein from 293-cell membranes. 
 
4.2 Materials and Methods 
4.2.1 BAdV-3 Culture 
The WBR-1 strain of BAdV-3 was cultivated in Madin-Darby bovine kidney 
(MDBK) and VIDO R2 cells. VIDO R2 is a transformed fetal bovine retina cell (FBRC) 
line expressing the E1 proteins of human adenovirus type-5. The cells were grown in 
Eagle’s minimum essential medium supplemented with 5% fetal bovine serum. 
 
4.2.2 Construction of Plasmid pFBAV304 
The recombinant plasmid vectors were constructed by standard procedures 204 
using restriction enzymes and other DNA-modifying enzymes as directed by the 
manufacturers.  Specifically, the green fluorescent protein (GFP) gene under the control 
of the cytomegalovirus (CMV) immediate-early promoter and bovine growth hormone 
poly(A) signal was removed from the  pQBI 25 plasmid (Quantum Biotechnologies) by 
BglII and DraIII digestions followed by blunt ending with T4 DNA polymerase. This 
fragment was first cloned into the SrfI site of the E3 transfer vector pBAV-301 (plasmid 
constructed by ligating the 7,635-bp KpnI-SspI fragment from pFBAV302 to KpnI-NotI 
[T4 treated]-digested plasmid PpolyIIsn14) in the same orientation as the E3 transcription 
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unit to generate pBAV301.gfp. A KpnI-SwaI fragment encompassing the modified E3 
region was isolated from pBAV301.gfp and recombined with SrfI-digested pFBAV.302 
DNA 205 in E. coli BJ5183, creating plasmid pFBAV304. 
 
4.2.3 Isolation of Recombinant BAdV-3 
VIDO R2 cell monolayers in 60-mm-diameter dishes were transfected with 5 to 
10 µg of PacI-digested pFBAV304 recombinant plasmid DNA by using Lipofectin 
(Gibco/BRL). After incubation at 37°C, the transfected cells showing cytopathic effects 
were collected and freeze-thawed twice, and the recombinant viruses were plaque 
purified on VIDO R2 cells. 
 
4.2.4 Western Blot Analysis of GFP 
Extracts of mock- or virus-infected cells were resolved (5 µg per lane) by sodium 
dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis (PAGE) and transferred to a 
nitrocellulose membrane (Bio-Rad). Nonspecific binding sites on the membrane were 
blocked with 1% bovine serum-albumin before incubation of the blots with GFP protein-
specific polyclonal antibodies (Clontech). The membranes were washed and exposed to 
anti-mouse or anti-rat immunoglobulin G conjugated to horseradish peroxidase or 
alkaline phosphatase and developed by using a horseradish peroxidase or alkaline 
phosphatase color development kit (Bio-Rad). 
 
4.3 Results 
4.3.1 Construction of Replication-Competent BAdV-3 Expressing GFP 
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Plasmid pFBAV304 DNA (Figure 4.1) was digested with PacI and transfected 
into VIDO R2 cells to isolate recombinant virus BAV304. BAV304 was amplified in 
MDBK cells, and viral DNA was extracted from the infected cells. The viral DNA was 
analyzed by agarose gel electrophoresis after digestion with restriction enzyme BamHI. 
We observed a 2.3-kb DNA fragment in the BAV304 genome (Figure 4.2A, lane 3) 
which was absent in the BAV3.E3d genome (Figure 4.2A, lane 2). This suggested that 
the BAV304 genome contained the GFP gene, a possibility confirmed by Southern blot 
analysis (Figure 4.2B, lane 3). A similar 2.3-kb DNA fragment was also observed in the 
pFBAV304 genome (Figure 4.2A, lane 4) but not in pFBAV302 (lane 5). This suggests 
that pFBAV304 contained a GFP gene, a possibility confirmed by Southern blot analysis 
(Figure 4.2B, lane 5). 
To examine the expression of GFP, recombinant BAV304-infected cell lysates 
were analyzed by Western blotting using GFP-specific polyclonal antibodies (Clontech). 
The anti-GFP antibodies identified a band of 28 kDa in recombinant BAV304-infected 
cells (Figure 4.3, lanes 1 to 3). No such band was observed in mock (lane 4)- or wild-type 
BAdV-3 (lane 5)-infected cells. In BAV304-infected cells, GFP was detected from 12 to 
36 h postinfection (lanes 1 to 3). 
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Figure 4.1. Strategy used for the generation of recombinant BAV304 vector. The 
GFP plasmid was constructed as described in the text. Origins of DNA sequences:  
plasmid DNA, thin line; BAdV-3 genomic DNA, hollow box; inverted terminal repeats, 
filled box. The plasmid maps are not drawn to scale. 
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Figure 4.2.  Analysis of recombinant BAV304 genome. (A) The DNAs were extracted 
from BAdV-3 (lane 1), BAV3.E3d (lane 2), BAV304 (lane 3), pFBAV304 (lane 4), and 
pFBAV302 (lane 5) digested with BamHI and analyzed by ethidium bromide staining of 
an agarose gel. (B) The fragments shown in panel A were transferred to a Nytran 
membrane and probed with a α-32P-labeled GFP gene. Lane M, 1 Kb Plus DNA Ladder 
(Gibco/BRL) used for sizing the DNA fragments. 
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Figure 4.3.  Western blot analysis of GFP expression. Proteins from mock (lane 4)-
infected, BAdV-3-infected (lane 5), or BAV304-infected MDBK cells harvested at 12 
(lane 1), 24 (lane 2), and 36 (lane 3) h postinfection were separated by SDS-PAGE (10% 
gel) under reducing conditions and transferred to nitrocellulose.  The separated proteins 
were probed in Western blots by GFP-specific polyclonal antiserum. Molecular masses 
(lane M) are indicated in kilodaltons. 
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4.4 Discussion 
 
The BAV304 vectors were produced in a bovine kidney cell line (MDBK) and 
purified using a standard adenovirus purification technique.  Purification was deemed 
necessary in order to eliminate the possibility that soluble GFP protein might be 
phagocytosed by PMNs.  Soluble protein could give a false positive reading for transgene 
expression in PMNs.  Infectious BAdV-3 titre was markedly reduced during the 
purification process.  Therefore, establishing an accurate virus titration method was of 
major importance.  This was achieved by counting the number of fluorescing plaques that 
BAV304 formed on an MDBK monolayer.  This is an accurate technique since each 
plaque is distinct at high viral dilutions, and plaques can be counted as early as 2-3 days 
after infection.  An accurate titre, or at least a reliably consistent titration method is 
important for establishing the multiplicity of infection (MOI) number.  For this reason, all 
the vectors used throughout our experiments were first produced and then a standardized 
pool of virus was used throughout subsequent experiments.  
As GFP expression in cells is easily detected using flow cytometry, the BAV304 
construct was an effective tool for determining the tropism of BAdV-3 for specific cell 
populations.  Our intended use for this vector was to determine whether PMNs were able 
to passively acquire a functional BAdV-3 receptor.   
 
 
75 
 
CHAPTER 5 
 
BOVINE POLYMORPHONUCLEAR CELLS PASSIVELY ACQUIRE 
MEMBRANES AND INTEGRAL MEMBRANE PROTEINS FROM APOPTOTIC 
AND NECROTIC CELLS 
 
 
5.1 Abstract 
 
Leukocytes can acquire membrane fragments and integral membrane proteins 
from dead and dying cells, and in some cases, from live cells.  While investigating the 
possibility that bovine polymorphonuclear cells (PMNs) might present antigen, co-
culture assays confirmed that integral membrane proteins were rapidly and efficiently 
transferred to bovine PMNs from a variety of apoptotic and necrotic cells. 
Specifically, rapid acquisition of such proteins as MHC Class II and CD3 was shown 
from a variety of syngeneic, allogeneic and xenogeneic cell types.  Such acquisition 
occurred within 40 minutes of PMN co-culture with isolated peripheral blood 
mononuclear cells (PBMCs) and was not inhibited at 4oC. The transfer of murine 
MHC II molecules precluded the possibility of endogenous expression. We also 
demonstrated the transfer of fluorescently labelled membrane lipids along with 
integral membrane proteins. Collectively, these observations support the hypothesis 
that membrane protein transfer was mediated by the fusion of membrane fragments or 
microvesicles with the PMN plasma membrane and not by phagocytosis of cell 
fragments. These observations indicate that phenotypic studies of PMNs must 
consider circumstances whereby PMNs may passively acquire membrane proteins 
due to the impressive capacity of PMNs to acquire membrane lipids and a variety of 
integral membrane proteins from dead or dying cells.   
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5.2 Introduction 
 
Historically, PMNs have been regarded as terminally differentiated effector 
cells.  The principle role of the PMN was thought to be phagocytosis with an 
impressive assortment of preformed antibacterial systems and soluble mediators that 
provide a relatively rapid defence against pathogens and tissue damage.  However, 
the role of PMNs within the immune system may be much broader. For example, 
PMN derived cationic peptides can influence cell trafficking and dendritic cell 
activation 206 and PMNs have also been shown to express an impressive assortment of 
proteins and cytokines such as CR1, CR3, FcR, IFN-α, IL-1, IL-3, IL-8 and TNF-α 92.  
These observations provide further evidence that innate and adaptive immune 
responses are closely integrated.   
Until recently, there was no evidence to suggest that PMNs could play a role 
in the induction of an adaptive immune response 92, however, there are several reports 
that PMNs from a variety of species can express MHC Class II proteins and co-
stimulatory molecules (CD80 and CD86) 80,88,207,208.  Co-expression of MHC Class II 
and co-stimulatory molecules would potentially endow PMNs with the capacity to 
influence the adaptive immune system through antigen presentation.  Previous 
investigations with mouse, human and goat PMNs defined conditions where MHC II 
expression was observed following stimulation with IFN-γ, GM-CSF or IL-3 78,79,81,82, 
or in human patients with Wegener’s Granulomatosis 89,209.  In some cases, PMN 
expression of MHC II was reported as constitutive 77,80.  Human PMNs were also 
shown to function as accessory cells for primed T-cell activation with protein 
antigens and super-antigens 62,88,89,210.  Earlier observations, that recombinant bovine 
adenovirus vaccine vectors had a tropism for PMNs, triggered an interest in 
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determining the role of PMNs in the induction of a specific immune response.  Since 
bovine adenoviral vectors can stimulate strong immune reactions 211, the hypothesis 
that bovine PMNs might function as antigen presenting cells (APCs) was tested, 
thereby providing a link between the innate and adaptive branches of the immune 
system.  As there was a growing body of literature to suggest that PMNs from other 
species could assume such a role, we began by investigating the expression of MHC 
Class II, a key protein involved in antigen presentation, on bovine PMNs.  It was 
observed that bovine PMNs expressed detectable levels of MHC Class II on their 
surface only when co-cultured with PBMCs.  This observation suggested that PMNs 
may either up-regulate endogenous MHC II expression or passively acquire MHC II 
protein from other leukocytes. 
Recent observations suggest that cell membrane fragments are readily 
exchanged between certain immune cells 134,138-141.  Although the consequences of 
this event are not fully understood, several interesting theories are emerging to 
explain its significance.  ‘Cross-presentation’, for example, is a term coined for the 
circumstance where a dendritic cell (DC) can acquire antigen from another cell and 
present this antigen on endogenous MHC Class I.  What is especially unique about 
this process is that DCs are able to sample both extracellular membranes and 
intracellular proteins from live cells 134.  Other cell types, such as macrophages, can 
only acquire cytoplasmic membranes from dead or dying cells 134.  T-cells have also 
been shown to acquire membrane proteins from antigen presenting cells in an 
activation dependent manner 138,140. In particular, T-cells can acquire MHC Class II 
proteins and co-stimulatory molecules, which support antigen presentation to other 
primed T-cells 138,140.  Furthermore, some B-cell lines are capable of a continuous 
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uptake of autologous cell membrane and proteins through an immunological synapse 
147.  
The purpose of this study was to investigate if MHC II detected on the surface 
of bovine PMNs was the result of passive acquisition or due to endogenous synthesis 
of MHC II protein. The data presented demonstrate that bovine PMNs have a 
remarkable capacity to passively acquire both plasma membrane lipids and a variety 
of integral membrane proteins from several types of dead or dying cells.   
 
5.3 Materials and Methods 
5.3.1 Culture Media and Reagents 
All cell cultures were maintained in AIM-V Serum Free Lymphocyte Medium 
(Gibco BRL, Burlington, ON) containing 20% (v/v) heat inactivated fetal bovine serum 
(FBS; Gibco BRL) and 50 µM 2-mercaptoethanol (2-ME; Biorad; Mississauga, ON).  
Recombinant human IL-2 was purchased from R&D Systems Inc. (Minneapolis, MN), 
recombinant bovine Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) was 
from Genentech Inc. (San Francisco, CA), lipopolysaccharide (LPS) was from Sigma-
Aldrich (Oakville, ON) and recombinant bovine interferon-gamma (IFN-γ) from Ciba-
Geigy (Basel, Switzerland). 
 
5.3.2 Purification of Cells 
Blood was collected from the jugular vein of male or female Holstein cattle (age > 
12 months) using 0.3% ethylenediaminetetraacetic acid (EDTA, Sigma-Aldrich).  Whole 
blood was centrifuged at 1400 x g, without braking, for 20 minutes to separate the buffy 
coat layer, which was removed at the interface between the red blood cell pellet and the 
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plasma, diluted 1:1 with calcium and magnesium-free phosphate buffered saline (PBSA; 
137mM NaCl, 2.7mM KCl, 8.1mM Na2HPO4, 1.5mM KH2PO4, pH 7.3) and layered onto 
Ficoll-Hypaque (Pharmacia LKB, Biotechnology, Uppsala, Sweden) and centrifuged at 
1400 x g (without braking) for 20 minutes, to obtain a mononuclear cell population.  
After removal of plasma and buffy coat, the top half of the remaining red blood cell/PMN 
(RBC/PMN) fraction was also discarded.  RBCs were lysed by adding 5-10ml of the 
RBC/PMN fraction to 40ml of a lysis solution (distilled water with 0.17M NH4Cl, 10mM 
KHCO3, and 0.11mM EDTA; pH 7.3) followed by three washes with PBSA.  Cells 
prepared by this method were consistently >98% viable as determined by trypan blue dye 
exclusion and contained less than 4% mononuclear cells.  No attempt was made to 
differentiate between PMN and eosinophilic granulocytes, but the latter were usually 
present in low numbers as determined by cell counts using DifQuick (Baxter Scientific, 
Miami, FL) stained cytospins. 
To obtain an enriched population of B-cells, PBMCs were collected, resuspended 
in PBSA at 4×107 cells/ml, and incubated with 1ml of both MM1A (CD3; VMRD, 
Pullman, WA) and DH59B (CD179a; VMRD) sodium azide-free monoclonal antibodies 
(mAb) at 5µg/ml for 30 min on ice.  Cells were then incubated with goat anti-mouse IgG-
coated magnetic beads (Dynabeads® M-450, Dynal, Great Neck, NY) at a bead to target 
cell ratio of 5:1. Bead-bound cells were removed with a magnet as described by the 
manufacturer and the remaining cells were washed in PBSA and resuspended in AIM-V 
medium at 1x107 cells/ml.  
Clone 2 B-cells (a sheep B-cell line) were cultured as a source of B-cells that 
undergo low level apoptosis in culture as previously described 212. 
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An enriched T-cell (CD3 cells) population was obtained by culturing 5×106 
PBMCs in 5ml of Aim-V medium with 5% v/v FBS, 4µg/ml Concanavalin A (Sigma-
Aldrich) and 4ng/ml of human IL-2.  Cells were passaged and the media was replaced 
every 2-3 days.  This culture system produced an activated T-cell population (>99% 
CD3+) which expressed MHC Class II (~ 50% MHC II+). 
Activated PMNs were collected from the mammary gland of heifers following 
injection into each teat canal of 5ml of minimal essential medium (MEM) containing 
1µg/ml LPS (Sigma-Aldrich).  PMNs were collected approximately 16 hours after LPS 
injection by infusing each teat with 10ml of MEM, massaging the mammary gland and 
then expressing the liquid from the teat canal into a sterile bottle.  This procedure was 
repeated with 5ml of MEM.  Cytospins stained with DifQuick (Baxter Scientific, Miami, 
FL) were examined with a microscope and PMN purity was consistently 95-98%.  
Approximately 4 days after stimulation of the mammary gland, large numbers of 
macrophages were recruited to the mammary gland and were collected in the same way 
as for PMN collection to generate an enriched macrophage population 213. 
Transwell separated co-cultures were performed using a 0.4µm transwell plate 
(Corning Costar, Cambridge, MA) in order to eliminate direct cell-cell contact between 
the PMN population (cultured in the bottom well) and the cell population contained in the 
upper chamber.  The transwell system was selected to allow for the exchange of soluble 
products, while eliminating access of intact cells or larger cell fragments to the bottom 
well.  All cell cultures were incubated at 37oC in 5% CO2 and all co-cultures were carried 
out in 6-well plates with 1-3x106 PMNs/well at a 1:3 ratio (PMN: Other cell) with 6ml of 
AIM-V medium (20% FBS) unless otherwise specified.  
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5.3.3 Biotin and fluorescence labelling 
Cells were labelled with PKH 26 Red Fluorescent Cell Linker Kit (Sigma-
Aldrich) according to the manufacturer’s instructions.  Similarly, according to the 
manufacturer’s instructions, viable cells were labelled with EZ-Link Sulfo-NHS-Biotin 
(Pierce, Rockford, IL).  Biotinylation of surface proteins was confirmed by flow 
cytometric analysis of streptavidin-fluorescein isothiocyanate (Southern Biotechnology 
Birmingham, AL) binding. 
 
5.3.4 Induction of apoptosis or necrosis 
Cell lysis was performed by three cycles of snap-freezing in liquid nitrogen and 
thawing in a 37oC water bath (freeze/thaw, 1x107cells/ml).  Cells were then sonicated for 
20 seconds using a microtip vibrating at 20 kHz and amplitude of 40%.(VibraCell ™ 
Sonicator, Betatex Inc.).  To induce apoptosis, cells were gamma-irradiated with 
approximately 11000rads.  To confirm the induction of apoptosis the TUNEL assay 
(Flow TACS ™ In Situ Apoptosis Detection Kit, R&D Systems, Minneapolis, MN) was 
used. 
 
5.3.5 Membrane extraction 
Clone 2 ovine B-cells or bovine B-cells were washed two times in PBSA and 
8x107 cells were resuspended in 2ml of homogenisation buffer (20mM Tris HCl pH 7.5, 
10mM NaCl, 0.1mM MgCl2, 10mM PMSF).  Cells were sonicated for 20s, underlaid 
with 5ml of 40% sucrose (in homogenisation buffer), and centrifuged at 75,000 x g for 1h 
at 4oC.  The white floccular material at the interface between the buffer and sucrose was 
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collected, diluted in PBSA and pelleted at 210,000 x g for 1hr at 4oC.  The pellet was 
resuspended in PBSA and stored at –70oC.  
 
5.3.6 Flow cytometry 
Monoclonal antibodies (mAb) specific for bovine CD3 (Clone MM1A), CD14 
(Clone MM61A), CD21 (Clone Baq15A), CD179a (Clone DH59B) and the DR region of 
bovine MHC II (Clone TH14B) were purchased from VMRD (Pullman, WA).  Rat-anti-
mouse I-A/I-E was purchased from Becton-Dickinson (Missisauga, ON) and FITC 
labelled goat-anti-rat IgG from Caltag Laboratories (Burlington, CA).  Fluorescein 
isothiocyanate (FITC)-conjugated and phycoerythrin (PE)-conjugated, isotype-specific 
goat anti-mouse immunoglobulin (Ig) antibodies were purchased from Southern 
Biotechnology.  The level of specific mAb binding was quantified by subtracting cells 
that reacted with an equivalent concentration of an isotype-matched, irrelevant mAb 
(Cedar Lane Laboratories Ltd., Ontario).  Cells were fixed in 2% paraformaldehyde in 
PBS (same as PBSA with pH of 6.7) and stored in the dark at 4oC until data acquisition 
and analysis was performed with a FACScan flow cytometer using the Cell Quest 
program (Becton Dickinson, Mountain View, CA). 
 
5.3.7 Statistical Analysis 
All of the results presented are non-parametric in their distribution.  In the cases 
where results are paired, the Wilcoxon matched pairs t-test was used.  When individual 
data sets were not paired, then the Mann-Whitney t-test was used.   
 
5.4 Results 
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5.4.1 Detection of MHC Class II on freshly isolated bovine PMNs 
 
Initial investigations explored the possibility that bovine PMNs were able, as 
had been observed in other species, to endogenously express MHC class II proteins.  
Such expression was reported to be either inducible or constitutive. It is interesting to 
note, however, that a previous report suggested that expression of MHC Class I and II 
proteins was significantly reduced following the use of centrifugation to isolate 
caprine PMNs 80.  Consequently, we decided to first determine if the cell isolation 
procedure affected MHC II expression on bovine PMNs.  Fresh whole blood was 
lysed to remove erythrocytes and the PMN population was analysed for MHC class II 
expression using flow cytometry.  There was marked animal to animal variation in the 
percentage of PMNs with a detectable level of MHC II (Range = 7-36%), but PMNs 
from all animals had detectable surface MHC II (Figure 5.1A).  We then investigated 
whether bovine PMNs expressed detectable levels of MHC II following isolation 
using centrifugation speeds of 1400 x g to first separate the mononuclear cells (buffy 
coat) from PMNs. Bovine PMNs isolated following centrifugation of whole blood 
had little detectable surface MHC II protein (Range = 0.1-2.5%).  To determine if the 
time between blood collection and cell isolation might affect the level of MHC II 
expression, we incubated whole blood for 24 hours prior to PMN isolation.  PMNs 
incubated for 24 h in whole blood had significant levels of detectable MHC II 
following isolation by either centrifugation (Range = 3-36%) or whole blood lysis 
(Range = 11-56%) (Figure 5.1A).  In addition, MHC Class II (Range = 0-22%) was 
detected on PMN collected directly from the bovine mammary gland without any 
post-collection manipulation (Figure 5.1A). In all experiments, we did not observe the 
acquisition of MHC II by a specific subset of PMNs but rather a general acquisition 
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of protein by all PMNs as evidenced by a population shift in the FACS profile (Figure 
5.1B).  These observations suggested that both the interval between blood collection 
and bovine PMN isolation, as well as the method used for PMN isolation could 
significantly alter the level of MHC II detected on the cell surface.  The mammary 
gland data also confirmed that MHC II may be present on the surface of PMNs in 
vivo.   
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Figure 5.1.  PMN isolation method alters 
detection of MHC class II protein on the 
surface of bovine PMNs.   (A) Three 
isolation techniques were compared:  
Centrifugation (n=10) - purified PMNs 
were isolated following centrifugation to 
separate mononuclear cells; Lysis (n=10) - 
whole blood lysis to remove erythrocytes 
and leave all leukocytes; and isolation of 
PMNs from the mammary gland following 
LPS injection to induce inflammation and 
recruitment of an enriched PMN 
population (n=6). Data presented are 
values for individual animals (medians 
indicated in each group) with blood 
samples from the same animals used to 
compare each isolation method.  The 
centrifugation and lysis techniques were 
also compared at 0h and 24h after blood 
collection.  There was a significant 
difference in % MHC II labelling for the 
following:  1) centrifugation vs lysis at 0h 
and 24h (P<.001 and .004 respectively), 2) 
centrifugation at 0h vs 24h (P=.002), 3) 
mammary gland vs lysis at 0h (P=.02), 4) 
mammary gland vs centrifugation at 0h 
(P=.008).  There was no significance 
(P>.05) between the two lysis groups.  (B) 
A representative FACS histogram (i) and 
dot plot (ii,iii) of MHC II stained bovine 
PMNs following a 24h co-culture with 
irradiated PBMCs (i - solid line; profile in 
iii) or PMN alone (i - dotted line; profile in 
ii). 
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5.4.2 Induction of MHC II Expression 
Previous investigators reported that MHC II expression could be induced 
when human PMNs were cultured with GM-CSF or IFN-γ 78,79,81,82.  Following 
incubation of purified bovine PMNs with recombinant bovine GM-CSF (1ng/ml), 
IFN-γ (10 or 100 ng/ml), LPS (0.5ug/ml) or a combination of all three, no MHC II 
expression was detected (Figure 5.2A).  Only when PMNs were co-cultured in direct 
contact with PBMCs was surface MHC Class II protein detected on PMNs by flow 
cytometry (Figure 5.2B).   
It has also been reported that a soluble T-cell factor can induce MHC II 
expression on human PMNs 88. To determine if a soluble T-cell factor might induce 
MHC II expression on bovine PMNs, purified PMNs were co-cultured for 24hr with a 
0.4µm transwell membrane separating PBMCs or ConA/IL-2 activated T-cell 
populations.  The transwell membrane facilitates an exchange of secreted soluble 
factors but prevents direct cell-cell contact.  PMNs co-cultured with PBMCs or 
activated T-cells by this method showed no detectable MHC II expression (Figure 
5.2B).  These observations supported the conclusion that direct cell-cell contact was 
required for PMNs to express MHC II molecules on their surface.  
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Figure 5.2.  PMN stimulation does 
not alter surface expression of 
MHC class II protein. (A) 
Following 24h stimulation of PMNs 
with medium alone, various 
cytokines, or a combination of all 
three (I+G+L).  Cytokine 
concentrations were as follows:  IFN-
γ - 100ng/ml, GM-CSF -  1ng/ml, 
LPS - 0.5µg/ml.  Data presented are 
values for individual animals 
(medians indicated in each group) 
with PMNs from each animal (n=8) 
used to compare all culture condition 
There were no significant differences 
in any group when compared to the 
media control (p>.05).  (B) PMNs 
were also co-cultured for 40 minutes 
or 24h in direct contact with PBMCs 
(PBMC 40min, PBMC 24h).  Both of 
these groups were significantly 
different from the media control 
(P<.008).  PMNs were also co-
cultured for 24h with PBMCs 
(PBMC+transwell) or activated T-
cells (T-cell+transwell) and separated 
by a 0.4µm transwell membrane. 
Transwell cultures were not 
significantly different from the media 
control. Data presented are values for 
individual animals with the median 
value indicated for each group.   
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5.4.3 Passive Acquisition of MHC Class II 
Since under defined isolation proceedures no evidence that purified bovine 
PMNs could be induced to express endogenous MHC II was observed, the hypothesis 
that PMNs might passively acquire MHC II was tested.  To test this hypothesis, the 
kinetics of MHC II expression on PMNs following co-culture with PBMCs was first 
examined.  Throughout the co-culture experiments, we used a donor cell:PMN ratio 
of 3:1 as an approximation of the ratio of PBMC:PMN found in bovine blood under 
normal physiological conditions 214.  Detectable levels of MHC Class II DR 
molecules on PMNs within 40 minutes of co-culture at 4oC was observed (Figure 
5.2B).  A parallel experiment was performed at 37 oC and no significant difference in 
MHC II acquisition was observed (data not shown).  This experiment demonstrated 
that MHC II proteins were rapidly acquired by PMNs when exposed to PBMCs and 
the acquisition of MHC Class II molecules at 4oC further supported the hypothesis 
that MHC II molecules were passively acquired by bovine PMNs.  
The final experimental approach used to confirm that bovine PMNs had 
passively acquired MHC II molecules was to analyse the transfer of murine MHC 
class II proteins from murine splenocytes to bovine PMNs.  The monoclonal antibody 
specific for murine MHC II (I-Ad/I-Ed) did not cross-react with bovine MHC II 
(Figure 5.3). Therefore, we were able to demonstrate that following PMN co-culture 
with murine splenocytes the MHC II detected on the surface of bovine PMNs was of 
mouse origin. This provided unequivocal evidence for the passive transfer of MHC II 
(Figure 5.3).  
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Figure 5.3.  Passive transfer of murine MHC class II protein to bovine PMNs 
following a 24h co-culture with murine splenocytes.  The antibody used to detect 
species-specific MHC II and co-culture conditions are indicated beneath the x-axis.  
Comparison within each co-culture group revealed a significant difference (P<.004).  
The data presented are values for individual animals (n = 9) and median value is 
indicated for each group.  
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5.4.4 Characterization of MHC Class II Donor Cell 
 
Investigation of which leukocytes could donate MHC Class II molecules to 
PMNs was examined.  Enriched populations of bovine T-cells (activated to induce 
MHC II expression), B-cells, and monocytes were prepared and each population was 
co-cultured with PMNs.  These experiments revealed that only B-cells efficiently 
transferred MHC Class II protein to the surface of PMNs (Figure 5.4B).  Most B-cells 
(>60%), however, die soon after being isolated and cultured (Figure 5.4A), therefore 
it was hypothesized that apoptotic cell fragments might be the source of MHC II 
molecules passively acquired by PMNs.  To further investigate the mechanism by 
which integral membrane proteins are transferred to PMNs it was determined if the 
physiological state of the donor cell influenced this process.  Passive acquisition of 
MHC Class II by bovine PMNs was analyzed following co-culture with viable or 
necrotic cells and isolated cell membranes (Figure 5.4B).  To confirm that apoptosis 
was required for the efficient transfer of integral membrane molecules, co-cultures of 
bovine PMNs with bovine B-cells and a sheep B-cell line (clone 2 cells) which has a 
low level of apoptosis in culture (data not shown) were compared.  There was no 
detectable transfer of MHC II protein to bovine PMNs following co-culture with 
sheep B-cells unless the B-cells were physically disrupted by repeated freeze/thaw 
and sonication.  Following this B cell treatment, PMN acquisition of ovine MHC 
Class II was equivalent to that observed previously with bovine B-cells (Figure 5.4A).   
Finally, the possibility that the passive acquisition of membrane proteins by 
bovine PMNs might represent a phenomenon which was not restricted to MHC Class 
II proteins was addressed.  The co-culture of purified bovine T-cells and PMNs  
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Figure 5.4.  Identification of MHC II donor cell phenotype. (A)  PBMCs were 
labelled with anti-MHC II, anti-CD3 (T-cells), anti-CD14 (monocytes) and anti-
CD21 (B-cells) specific monoclonal antibodies to monitor changes in cell number 
during a 24h co-culture with PMNs.  A significant reduction in both MHC II+ 
(P<.005) and CD21+ (P<.006) cells was observed.  (B)  PMNs were co-cultured for 
24h with MACS purified bovine cell populations (T-cells = CD3+; monocytes = 
CD14+; B-cells = [PBMCs – (CD3+ + C14+)]).  Viable clone 2 sheep B-cells (Clone 
2), isolated Clone 2 membranes (Cl2-memb), and freeze-thaw and lysed clone 2 B-
cells (Cl2-F/T) were also co-cultured with bovine PMNs for 24h.  Data presented are 
values for individual animals with median values indicated for each group.  
Compared with the media control, significant differences were observed following 
PMN co-culture with PBMCs (P<.003), activated T-cells (P<.03), B-cells (P<.01), 
clone 2 membranes (P<.03), and lysed clone 2 cells (P<.003). 
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resulted in the transfer of detectable CD3 protein on approximately 17.0 % of PMNs. 
Furthermore, gamma-irradiation of bovine T cells to induce apoptosis (confirmed by 
TUNEL assay) resulted in a significant increase in the percentage of PMNs with 
detectable CD3 on their surface (Figure 5.5). The detection of CD3 on the surface of 
PMNs provided further evidence for the passive acquisition of integral membrane 
proteins and suggested that a variety of molecules could be acquired from apoptotic 
cells. 
 
 
5.4.5 Passive Acquisition of Membranes and Integral Membrane Proteins 
Passive acquisition of MHC II and CD3 molecules suggested that PMN 
acquisition of integral membrane proteins might reflect a more general process.  Two 
different labelling techniques were then used to determine if PMNs passively 
acquired both membrane lipids and a broad range of integral membrane proteins. 
Bovine PBMCs were labelled with either the lipophilic PKH-26 dye or surface 
proteins were biotinylated before the PBMCs were co-cultured with PMNs.  The 
transfer of these two labels was then monitored using flow-cytometry (Figure 5.6) 
and analyses supported the conclusion that PMNs passively acquired both plasma 
membrane lipids and integral membrane proteins. 
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Figure 5.5.  Bovine PMNs passively acquire both CD3 and MHC II molecules 
from bovine T cells.  PMNs were co-cultured for 24h with either PBMC, T-cells or 
gamma-irradiated PBMC and T-cells (PBMCs + irr; T-cell + irr) and then stained 
with anti-MHC II or anti-CD3 monoclonal antibodies as indicated.  Data presented 
are values for individual animals (n = 9) and group medians are indicated. All co-
cultures were significantly different from their appropriate media control (P=.004).  
There was also a significant difference in the percentage CD3+ PMNs following co-
culture with non-irradiated versus gamma-irradiated  T-cells (P<.008). 
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Figure 5.6.  Transfer of integral membrane proteins and plasma membrane 
lipids from PBMCs to PMNs.  Flow cytometric detection of MHC II, CD3, Biotin, 
or PKH molecules on bovine PMNs following a 24h co-culture with unlabelled 
PBMCs, biotin labelled PBMCs (Biotin) or PKH-26 (PKH) labelled PBMCs, 
respectively.  Data presented are values for individual animals (n=7) and the median 
value is indicated for each group. There was a significant transfer of MHC II 
(P<.001), CD3 (P<.001), biotin/SA-FITC (P<.002), and PKH-26 (P<.03) when 
compared to the media control. 
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5.5 Discussion 
This study demonstrates for the first time that interactions between bovine 
PMNs and either dead or dying cells can lead to the passive acquisition of plasma 
membrane lipids and a variety of integral membrane proteins. The present 
observations, however, contradict previous reports that human, murine and caprine 
PMNs can endogenously express MHC Class II molecules.  Although the possibility 
that PMNs from other species can express endogenous MHC class II and can, 
therefore, act as accessory cells cannot be discounted, the in vitro data consistently 
supported the conclusion that bovine PMNs did not endogenously express MHC 
Class II (Figure 5.2).  The presence of detectable MHC II molecules on the surface of 
bovine PMNs isolated directly from an inflamed mammary gland was, however, 
observed (Figure 5.1). These observations are consistent with previous reports that 
both human [9-12] and murine [13] PMNs may express MHC II in vivo. Thus, the 
possibility that physiological conditions may exist during which bovine PMNs 
express endogenous MHC II cannot be discounted but our in vitro data consistently 
supported the conclusion that bovine PMNs have an impressive capacity to passively 
acquire a broad range of integral membrane proteins during cell isolation and culture. 
It might therefore, be prudent to re-examine previous reports regarding PMN 
expression of MHC II in vitro to determine if an opportunity existed for the passive 
acquisition of membrane proteins.   
A previous report that human PMNs expressed MHC II molecules did not 
provide sufficient technical detail to determine if passive transfer of MHC II was a 
possibility during cell isolation or culture 81. Culture conditions used in this study, 
however, may have supported the increased expression of MHC II on contaminating 
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mononuclear cells.  Thus, there was no assurance that MHC Class II detected on 
PMNs wasn’t passively acquired from other contaminating cells. Radsak et. al. 88 
used RT-PCR to confirm endogenous MHC Class II expression in PMNs, but the 
presence of even low numbers of either monocytes or DC could have affected PCR 
results.  This group also suggested that a soluble T-cell factor was responsible for the 
induction of MHC II expression on human PMNs.  In contrast, bovine PMNs co-
cultured in the presence of either activated T-cell or PBMCs but separated by a 0.4um 
transwell membrane did not show detectable MHC II expression (Figure 5.2). Thus, 
the present observations consistently supported the conclusion that bovine PMNs had 
passively acquired MHC II molecules and studies with recombinant cytokines were 
consistent with a previous report that IFN-γ could not induce MHC II expression on 
caprine PMNs, another ruminant species 80.   
Of particular importance was the rapid acquisition of MHC II molecules by 
bovine PMNs within 40 minutes and that this acquisition occurred with equal efficiency 
at 4o and 37 oC. Mammalian cell transcription and translation are markedly decreased at 
4oC 215 and this limits metabolically active processes. Reduced membrane fluidity at 4oC 
further restricts the potential for membrane fusion and phagocytosis. Thus, the rapid 
acquisition of surface MHC II protein at 4oC is not consistent with phagocytosis but is 
more consistent with a direct attachment of membrane fragments to the PMN surface. A 
proposed model for such transfer of membrane lipids and integral membrane protein is  
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Figure 5.7.  Microparticle model for the passive transfer of membrane lipids and 
integral membrane proteins to bovine PMNs.  After the induction of apoptosis or 
necrosis, donor cells (D) release microparticles which can contain integral membrane 
proteins (IMP), or lipophilic PKH dye (PKH).  These microparticles adhere to and 
fuse with PMN plasma membranes.  IMPs inserted in the proper orientation in PMNs 
can then be detected using biotin (B). 
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shown in Figure 5.7.  Cells undergoing apoptosis shed membrane fragments as small 
heterogeneously sized microvesicles which can contain integral membrane proteins 131.  
These microvesicles exhibit increased adherent properties 216 and we hypothesize that 
they attach directly to the PMN surface and can then become incorporated into the PMN 
membrane.  
The model proposed for PMN passive acquisition of integral membrane 
proteins is consistent with several critical observations. It was observed, as previously 
reported for caprine PMNs [4] that the method of PMN isolation can alter apparent 
MHC II expression (Figure 5.1A). The absence of detectable MHC II on PMNs 
following centrifugation would be consistent with the removal of loosely attached 
microvesicles or membrane fragments by centrifugal forces.  The observation that 
centrifugation did not reduce surface MHC II on PMNs following incubation of blood 
at 37 oC for 24h may be consistent with either the phagocytic uptake of donor cell 
fragments by PMNs or direct fusion of microparticles with the PMN plasma 
membrane. If phagocytosis was involved in the passive acquisition of integral 
membrane proteins then a mechanism would be required for the efficient recycling of 
proteins from the phagolysosome to the cell surface. The observation that a variety of 
integral membrane proteins, such as CD3 (Figure 5.5) and biotinylated proteins 
(Figure 5.6), were also efficiently transferred to the PMN plasma membrane implies 
that a large number of proteins were recycled from the phagolysosome. MHC II 
molecules, when loaded with peptide, can be recycled to the cell surface but a similar 
process has not been reported for other integral membrane proteins. 
The observation that PKH, a lipophilic fluorescent dye, was transferred from 
donor cells to PMNs (Figure 5.6) provided evidence that donor cell membranes were 
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transferred with integral membrane proteins. This observation is consistent with the 
hypothesis that membrane proteins were transferred to PMNs by either direct cell-cell 
contact or the release of membrane fragments or microparticles from dead or dieing 
cells. Initially, it was observed that B-cells were responsible for the transfer of MHC 
II molecules to PMNs during PBMC co-culture experiments.  Upon further 
investigation, however, a variety of syngeneic and xenogeneic cell types were 
effective donors of membrane lipids and proteins (Figures 5.3-5.6).  There was no 
significant difference in the efficiency with which PMNs acquired MHC Class II 
protein from necrotic and apoptotic cells (Figures 5.3 and 5.4) but there did appear to 
be a relationship between the level of protein expression on a donor cell and the 
efficiency with which the protein was transferred to PMNs. For example, all T-cells 
express CD3 but only a subpopulation express MHC II protein at a relatively lower 
level. A much greater transfer of CD3 (Figure 5.5) than MHC II (Figure 5.4B) from 
bovine T cells to PMN was observed. The apparent lack of specificity in the passive 
transfer of membrane proteins implicates a mechanism that does not rely upon 
specific recognition signals for either protein uptake or insertion into the PMN plasma 
membrane. The binding of microparticles to the PMN surface and the subsequent 
fusion of these microparticles with the plasma membrane could explain this non-
specific process.  
Conditions that enhance the generation of microparticles might then be 
expected to enhance the passive transfer of integral membrane proteins.  Cellular 
microparticles are shed from the plasma membrane of virtually all cell types when 
cells are subjected to a number of stress conditions, including apoptosis [27].  It was 
consistently observed that that the passive transfer of membrane proteins was most 
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efficient when donor cells were either apoptotic or necrotic. Cell survival assays 
indicated that bovine B-cells survived for a very short time in culture, providing a 
likely explanation for their role in MHC II transfer during PMN co-culture with 
PBMCs (Figure 5.4). In contrast, MHC II transfer was limited during PMN co-culture  
with ovine Clone 2 B-cells (Figure 5.4B) but TUNEL analysis revealed a low level of 
spontaneous apoptosis in this B cell line (data not shown).  Finally, a more efficient 
CD3 transfer from bovine T cells to PMNs after T cell apoptosis was induced by 
gamma-irradiation was observed (Figure 5.5). It was also possible to transfer integral 
membrane proteins to PMNs by using the plasma membranes from physically 
disrupted cells (Figure 5.4B). Thus, it may be that microparticles, as well as a variety 
of other cell membrane fragments, can attach to the surface of PMNs. Apoptotic and 
necrotic cells, however, transferred MHC II molecules more efficiently than isolated 
cell membranes. Thus, integration of passively acquired membrane proteins into the 
PMN plasma membrane may be limited by the type of transfer vehicle which carries 
the integral membrane proteins (Figure 5.7).  
The transfer of membrane fragments to immune cells may serve to either 
expand and/or regulate an immune response 217. If PMNs gain antigen presentation 
capabilities when they acquire membrane proteins from dying APCs, then they might 
expand the immune response by presenting antigen to T-cells recruited to sites of 
inflammation. If, however, PMNs lack the appropriate co-signals to effectively 
activate T-cells then the results of PMN antigen presentation may be the elimination 
of self-reactive T-cells, the induction of tolerance, or the down-regulation of an active 
immune response. Alternatively, there is evidence that PMN can regurgitate 
processed antigen for other APCs to present during the induction of a specific 
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immune response 74. Thus, antigenic peptides on passively acquired MHC II 
molecules may be transferred from PMNs to other antigen presenting cells. It is now 
critical to determine if the passive acquisition of a diverse array of integral membrane 
proteins can alter the functional activity of bovine PMNs. We are presently 
characterizing the mechanism by which PMNs passively acquire membrane proteins 
and investigating the functional consequences of this protein transfer. 
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CHAPTER 6 
 
 
THE MECHANISM AND FUNCTIONAL CONSEQUENCES OF 
INTEGRAL MEMBRANE PROTEIN ACQUISITION BY BOVINE 
POLYMORPHONUCLEAR CELLS 
 
 
 
6.1 Abstract 
 
We have previously shown that bovine PMNs have an impressive capacity to 
passively acquire membrane fragments and associated integral membrane proteins from 
apoptotic and necrotic cells.  The present study investigated the mechanism by which this 
integral membrane protein transfer occurs.  We observed with confocal microscopy that 
microparticles (MPs) shed from fluorescently labelled blood leukocytes attached to the 
surface of PMNs.  With time, MPs incorporated into the PMN plasma membrane and 
fluorescently labelled proteins diffused throughout the membrane.  We also observed the 
transfer of cytoplasmic proteins, contained within MPs, from donor cells to PMNs.  The 
functional consequences of PMN passive membrane protein acquisition were also 
investigated.  Passive transfer of membranes from an adenovirus permissive cell line to 
PMNs significantly increased adenovirus infection of PMNs. Furthermore, passive 
transfer of ovine MHC II molecules enabled PMNs to induce xenoreactive T-cell 
proliferation and cytokine expression. In conclusion, the passive transfer of functional 
membrane proteins might have major implications for the immunological role of PMNs 
recruited to sites of inflammation. 
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6.2 Introduction 
Research continues to reveal that leukocytes may perform diverse immune 
functions. This functional diversity at the cellular level creates extensive redundancy and 
a complex communication network within the immune system. The most important role 
of PMNs in innate immunity may be the clearance of immune complexes, phagocytosis 
of opsonized particles, and the release of inflammatory mediators. Recent research has 
revealed, however, the possibility that PMNs are functionally much more diverse than 
previously imagined. For example, when stimulated in an appropriate manner, PMNs 
may be able to acquire the functional characteristics of an antigen presenting cell (APCs) 
208. The present investigation examines the functional potential of bovine PMNs 
following the passive acquisition of integral membrane proteins from necrotic or 
apoptotic cells.   
It was previously demonstrated that bovine PMNs rapidly acquire membrane 
fragments and immunologically relevant integral membrane proteins, such as MHC class 
II and CD3, from cells undergoing apoptosis or necrosis (Whale et.al. 2005, submitted).  
The phenomenon of membrane/protein transfer between cells is not a new finding, with 
several examples of such transfer between immune cells described in the literature 134,138-
141,143,144.  T-cells, for example, can acquire immune complexes and other membrane 
proteins from APCs in a process dependent upon T-cell activation 138.  This exchange of 
membrane proteins was not limited to T-cells but also included the transfer of membrane 
proteins to B-cells, dendritic cells, macrophages and basophils.  Furthermore, passively 
acquired membrane proteins may alter the function of recipient cells since T-cells that 
acquire MHC II/peptide  complexes can either inhibit 138-141  or activate in vitro antigen-
specific T-cells responses142.  Thus, the functional consequences of membrane protein 
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transfer require further investigations, especially since this phenomenon may have 
implications beyond the regulation of immune responses. For example, the passive 
acquisition of an EBV viral receptor protein (CD21) by NK cells can confer susceptibility 
to EBV infection 145.  Thus, integral membrane proteins can retain their function 
following transfer from one cell to another.  
Several mechanisms have been proposed by which protein may be transferred 
between immune cells.  Transfer can involve an intimate interaction between cells at an 
‘immunological synapse’ where tight junctions are formed between adhesion molecules.  
Recent electron microscopy of a CD8 T-cell/target cell immunological synapse revealed  
that a physical bridge formed between the cells to facilitate the lateral diffusion of 
proteins and lipids between fused membranes 146. Dendritic cells use a different 
mechanism to physically sample extracellular or intracellular membrane/protein 
fragments from live cells 134 but other cells have also been shown to  acquire membrane 
proteins from dead or dying cells 134.  Our investigations revealed that bovine PMNs 
acquired membrane proteins from apoptotic or necrotic cells and this transfer appeared to 
require close cell contact. We hypothesized that microparticles (MPs) shed from dying 
cells might mediate membrane protein transfer to PMNs.  MPs, also referred to as 
microvesicles, are fragments shed from the plasma membrane blebs of virtually all cell 
types when cells are submitted to a variety of stress conditions, including apoptosis, and 
when cells are stimulated or activated 131. There is increasing evidence that MPs can 
interact with adjacent and distant cells and may function as vectors for the intercellular 
exchange of biologic information.   
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Mammalian cell membranes are characterized by an asymmetric distribution of 
aminophospholipids with phosphatidylserine (PS) and phosphatidylethanolamine 
sequestered in the inner (cytoplasmic) leaflet and  sphingomyelin and 
phosphatidylcholine sequestered in the outer (exoplasmic) leaflet 149.  When cells are 
exposed to apoptogenic stimulation, there is a collapse of this membrane asymmetry 121 
and MP release is an integral part of the membrane-remodelling process. Since PS has 
procoagulant qualities, its translocation to the exoplasmic side of the cell membrane was 
initially thought to play a role in hemostatic control 150.  However, it has been proposed 
that PS may also function as a recognition determinant to target activated or apoptotic 
cells to phagocytes 151.  This hypothesis is based on the observation that the level of MP 
release into culture supernatants correlates with the degree of cellular apoptosis 152.  MPs, 
which are heterogeneous in size (0.05 - 1µm), protein and lipid composition, may also 
serve to transfer membrane proteins amongst cells. For example, MPs can carry adhesion 
molecule complexes 153 and passive acquisition of these complexes can alter cell 
signalling and adhesion 148.  Furthermore, MP transfer of the chemokine receptor CCR5, 
which acts as a co-receptor for human immunodeficiency virus (HIV), to non-CCR5 
expressing cells confers susceptibility to HIV infection 154.  MPs may also transfer 
genetic information since tumour cell-derived MPs have been used to transfer oncogenes 
and induce tumour formation 158. The diversity of MP functions and the observation that 
they were released from apoptotic cells led us to hypothesize that MPs may serve as the 
vehicle for the transfer of integral membrane proteins between apoptotic cells and bovine 
PMNs.  
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The aim of the present investigation was to elucidate the mechanism of passive 
membrane and protein transfer to bovine PMNs, as well as to determine the functional 
consequences of such protein acquisition.  Using confocal microscopy, we were able to 
visualize MP formation by fluorescently labelled bovine PBMC and monitor MP 
attachment and subsequent fusion with PMNs.  Viral infection and antigen presentation 
studies were used to determine if passively acquired proteins were functional and could 
confer new biological properties to recipient PMNs. 
 
6.3 Material and Methods 
6.3.1 Culture Media and Reagents 
All cell cultures were carried out in AIM-V Serum Free Lymphocyte Medium 
(Gibco-BRL, ON, Canada) containing 20% (v/v) heat-inactivated fetal bovine serum 
(FBS; Gibco-BRL) and 50 µM 2-mercaptoethanol (2-ME; Biorad, ON, Canada). This 
media is referred to as “complete AIM-V medium” unless otherwise stated.   
 
6.3.2 Purification of Blood Leukocytes 
Blood was collected from the jugular vein of male or female Holstein cattle (age > 
12 months) using 0.3% ethylenediaminetetraacetic acid (EDTA, Sigma-Aldrich, ON, 
Canada) as an anticoagulant and PBMCs and PMNs were purified as described 
previously (Chapter 5). Cells isolated by these methods were consistently >98% viable as 
determined by trypan blue dye exclusion and contained less than 4% mononuclear cells.  
No attempt was made to differentiate between PMN and eosinophilic granulocytes, but 
the latter were usually present in low numbers (range = 2-10%). 
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6.3.3 Cell Lines 
An ovine B-cell line (Clone 2; Cl2) was cultured as previously described 212 and 
green fluorescent protein expressing B cells (Cl2-GFP) were generated by using a  
retroviral vector to transduce the GFP gene 218. The 293 cell line (ATCC# CRL-10852) 
was cultured in Dulbeco’s minimal essential medium supplemented with 10% FBS 
(Gibco-BRL) and 293 cells were split 1:4 and passaged every 3-4 days. 
 
6.3.4 Xenoreactive T-cell Populations 
Bovine PBMC (10 x 106) were co-cultured 10:1 with γ-irradiated (11000 rads) 
ovine Cl2 cells in each well of a 6-well plate (Corning Inc., NY, USA).  After 5 days, 
PBMC cultures were split 1:3 into fresh media supplemented with 2ng/ml recombinant 
human IL-2 (R&D Systems Inc., MN, USA).  Cultures were again split 1:3 after 3 days 
and transferred to fresh media with IL-2 added for another 3 day culture.  This 
xenostimulation procedure, with γ-irradiated Cl2 cell stimulation and IL-2 dependent T-
cell expansion, was repeated once more before performing a mixed lymphocyte 
proliferative response (MLR) assay. Following the second xenostimulation, cells in the 
culture were >99% bovine CD3+ T-cells and these cells developed a strong 
lymphoproliferative reaction (LPR) following addition of γ-irradiated Cl2 cells.   
  
6.3.5 Biotin, PKH and Oxidative Burst Fluorescent Labelling 
To track transfer of cellular membranes, cells were labelled with the lipophilic 
PKH 26 Red Fluorescent Cell Linker Kit (Sigma-Aldrich) according to the 
manufacturer’s instructions.  Similarly, to monitor the transfer of proteins, viable cells 
were surface labelled with EZ-Link Sulfo-NHS-Biotin (Pierce, IL, USA) according to the 
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manufacturer’s instructions. Biotinylation of surface proteins was confirmed using flow 
cytometry to analyze streptavidin-fluorescein isothiocyanate (SA-FITC) binding.  The 
compound 2`,7`-dichlorofluorescein-diacetate (DCFH-DA; Sigma-Aldrich) was used to 
fluorescently label PMNs since DCFH-DA specifically reacts with hydrogen peroxide.  
PMNs (1ml @ 1x107cells/ml) were incubated with 0.1 mM DCFH-DA for 20 minutes 
and then washed twice with Ca++Mg+-free PBS. This procedure labelled over 99% of 
PMNs with green fluorescence.  PKH is a lipophilic fluorescent dye that stably inserts 
into the plasma membrane and can be used to visualize the formation and transfer of MPs 
between cells. In contrast, biotin can be used to covalently label the extracellular domains 
of a broad variety of membrane proteins and following this labelling it is possible to 
monitor the transfer of membrane proteins made visible by labelling with SA-FITC.  The 
non-fluorescent, non-polar dye DCFH-DA is able to cross PMN membranes and within 
the cell it is transformed by esterases into a polar molecule which cannot diffuse out of 
the cell.  In the presence of H2O2, this polar DCFH is then converted to DCF, which 
fluoresces green and provides a PMN-specific marker. Bovine PBMCs were labelled with 
PKH-26 or biotin-SA-FITC prior to co-culture with PMNs which were either unlabeled 
or stained with PKH or DCFH-DA.   
 
6.3.6 Transfer of Cell Membranes to Bovine PMNs 
To achieve a rapid and consistent membrane protein transfer from 293-cells and 
Cl2 B-cells to bovine PMNs, the donor cells were lysed before co-culture with PMNs. 
This method of membrane protein transfer also eliminated potential contamination of 
PMNs with other cell populations. Donor cells (1 x 107 cells/ml) were sonicated for 2 x 7 
seconds using a microtip vibrating at 20 kHz and amplitude of 40% (VibraCell ™ 
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Sonicator, Betatex Inc.).  Lysed cells were vigorously pipetted to disperse any clumps, 
before centrifuging for 3 minutes at 216 x g to remove intact cells. Membrane co-cultures 
with bovine PMNs were carried out for 24h with the cell ratio of 1 PMN: 3 ‘lysed cell 
equivalents’. 
 
6.3.7 Construction of Recombinant Bovine Adenovirus BAV304 and Infection of 
Cells 
A recombinant bovine adenovirus type-3 (BAdV-3) vector was constructed which 
contained the GFP gene in the E3 region (BAV304) 219.  BAV304 was added to 293-cell 
cultures, PMNs alone, PMNs co-cultured with lysed 293-cell membranes, or bovine 
PBMCs.  Cultures were incubated for 48h before GFP expression was quantified with a 
flow cytometer.  The detection of GFP expression in PMNs following BAV304 infection 
was restricted to viable PMNs by using propidium iodide (2.5 µg/ml) staining to exclude 
dead cells. 
 
6.3.8 Flow Cytometry 
The monoclonal antibody (mAb) specific for a conserved epitope on the alpha 
chain of the bovine ortholog of HLA-DR (Clone TH14B) was from VMRD (Pullman, 
WA, USA). Fluorescein isothiocyanate (FITC)-conjugated, isotype-specific goat anti-
mouse immunoglobulin (Ig) antibodies were purchased from Southern Biotechnology 
(Birmingham, AL, USA).  The level of specific mAb binding was quantified by 
subtracting the percentage of cells that reacting with an isotype-matched, irrelevant mAb 
(Cedar Lane Laboratories Ltd., Ontario, Canada). The irrelevant mAb was used at the 
same concentration (5µg/ml) as the relevant mAb.  Cells were fixed in 2% 
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paraformaldehyde and stored in the dark at 4oC until data acquisition and was performed 
with a FACS Calibre flow cytometer (Becton Dickinson, CA, USA) and data analysis 
was performed using the Cell Quest program.  This cell labelling and analysis protocol 
was used to confirm that significant amounts of lysed Cl2 cell membranes were acquired 
by bovine PMNs following co-culture.   
 
6.3.9 MLR Assays 
An MLR assay was used to assess responses of a xenoreactive T-cell population 
to Cl2 B-cells and to determine if PMNs could function as APC following passive 
acquisition of MHC II proteins from Cl2 membranes.  Xenoreactive T-cells (5 X 104 
cells/well) were co-cultured with either γ-irradiated Cl2 B-cells (1000 cells/well), γ-
irradiated PBMCs (11000 rads, 5 X 104 cells/well), or PMNs incubated with or without 
Cl2 membrane fragments (5 X 104 cells/well).  Cells were added to triplicate cultures of 
T cells in 96-well plates (Corning Inc.) and cultures were incubated for 90 hours at 37oC 
in a humidified atmosphere with 5% CO2 before the addition of 0.4 µCi/well [methyl-3H] 
thymidine (Amersham Pharmacia Biotech) during the final 6 hours of culture. Cultures 
were harvested onto unifilter glassfiber microplates (Perkin Elmer, Woodbridge Ontario, 
Canada) and incorporation of 3H-thymidine was measured using a microplate 
scintillation and luminescence counter (Top Count, Canberra Packard, ON, Canada).  
Data are expressed as a stimulation index (SI = cpm with Cl2 B-cells or other 
stimuli/cpm for T-cells cultured in medium alone) and all assays were performed with 
xenoreactive T-cell populations generated from 6 animals. 
 
6.3.10 Analysis of T-Cell Cytokine Gene Expression 
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Xenoreactive T-cells (5 x 106/well), specific for ovine Clone 2 B-cells, were 
plated in a 12 well plate (Corning/ VWR CanLab) and incubated for 2h, 4h, 8h or 12h 
with 5 x 105 γ-irradiated Cl2 cells, 1 x 106 syngeneic PMNs, or 1 x 106 syngeneic PMNs 
that had been incubated with membranes from 3 x 106 lysed Cl2 cells.  T cell cultures 
were collected at each time point, washed twice with PBSA, and then lysed with 1 ml 
Trizol (Gibco-BRL). Total RNA was extracted as described previously 220. RNA 
concentration and quality were determined spectrophotometrically by measuring 
absorbance at 260 nm and purity was assessed using an Agilent 2100 Bioanalyzer with 
RNA 6000 Nano kits (Agilent Technologies Canada Inc., ON, Canada). The quality of 
total RNA was assessed by comparing the ratio of the area under the ribosomal peaks for 
28S and 18S. Quantitative Real-Time PCR (qRT-PCR) was conducted using 
SuperScript™ III Platinum® Two-Step qRT-PCR Kit with SYBR® Green (Invitrogen) on 
the Bio-Rad iCycler (Bio-Rad Laboratories Ltd., Mississauga, ON, Canada) as indicated 
in manufacturer’s protocol.  Primers for sense and anti-sense strands of selected genes 
(Table 6.1) were designed using Clone Manager 7 (Scientific & Educational Software, 
600 Cary, NC., USA) and PCR products were sequenced to confirm the specificity of the 
primers (data not shown). The qRT-PCR analysis for each cytokine was performed in 
triplicate using RNA isolated from three T-cell populations and Ct-values were 
normalized with respect to actin Ct-values. A Melt Curve was performed to ensure that 
any product detected by the iCycler was specific to the desired amplicon. The data is 
reported as ∆Ct-values which represents the number of PCR cycles required to detect 
fluorescence for a gene of interest subtracted from the number of PCR cycles required to 
detect fluorescence from the actin transcript within the same sample. 
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Table 6.1:  Primers to amplify bovine cytokines 
Bovine 
Gene 
Accession 
Numbera
Primer 
Direction 
Primer Sequence 
(5’-3’) 
IL-2 AF535144 Forward TCCTGCATCCTCTACAAGTG 
  Reverse AGACATCCTGGGCTTGAAAC 
IL-4 TC269418 Forward ACGCTGAACATCCTCACAAC 
  Reverse CGCCTAAGCTCAATTCCAAC 
IL-10 NM174088 Forward GCTGTATCCACTTGCCAACC 
  Reverse CCAGGTAACCCTTAAAGTCATCC 
TNFα AF011926 Forward GGCGGAGTGTAGGAAGTATC 
  Reverse CATCTGGAGGAAGCGGTAG 
IFN-γ M29867 Forward CCTCCTTGGGACCTGATCATAACAC 
  Reverse CCAAAAGCCCACAGAGCAGTAAAG 
a(www.ncbi.nlm.nih.gov) 
 
 
6.3.11 Confocal Laser Scanning Microscopy (CLSM) 
CLSM analyses were performed with an MRC 1024 confocal laser scanning 
microscope (Bio-Rad, Hemel Hempstead, UK) attached to a Microphot SA microscope 
equipped with an oil immersion 60x 1.4 numerical aperture plan apochromat lens (Nikon, 
Japan), and a 10x eyepiece lense.  High magnification pictures were taken using the same 
lens with a 3x zoom. For each condition, 20 µl of cell co-cultures were placed on a glass 
slide with a glass coverslip before mounting the slide on the viewing stage. 
 
6.4 Results 
6.4.1 PBMC Microparticle Formation and Adherence to PMNs 
To test the hypothesis that MPs were shed from PBMCs and then attached to and 
subsequently fused with PMN membranes, confocal microscopy was used to analyze 
interactions between these two cell populations.  It was known from previous findings 
that PMNs could acquire membrane fragments and protein from isolated bovine PBMCs 
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very rapidly (within 40 minutes) and this acquisition could occur at 4oC (Whale et.al. 
2005, submitted). Using a combination of staining techniques to identify donor and 
recipient cells, the formation and release of MPs from bovine PBMCs (Figure 6.1A), and 
subsequent attachment of MPs to the surface of PMNs was observed (Figure 6.1B).  
Figure 6.1C shows a PKH labelled PMN (red) in close proximity to a biotinylated and 
SA-FITC labelled PBMC (green) and a much smaller MP (green). These observations 
support the conclusion that MPs are shed from bovine PBMCs and that MPs can mediate 
the transfer of both membranes and integral membrane proteins from PBMCs to PMNs. 
Direct cell-cell contact may also play a role in this process (Figure 6.1C).  
 
 
 
6.4.2 Fusion of MPs with PMN Membranes 
To understand the process of passive membrane protein acquisition it is critical to 
determine if MPs integrate into the PMN plasma membranes. If MPs simply attach to the 
PMN surface then it is unlikely that passively acquired proteins would confer new 
cellular functions beyond possible changes in cell adherence properties 153. Co-culture of 
labelled PBMC with PMNs resulted in detectable transfer of MPs to the PMNs surface 
(Figure 6.2A) and lipophilic labelling with PKH revealed diffusion of MP membrane 
throughout the PMN plasma membrane within 20-30 minutes of co-culture (Figure 6.2B). 
To confirm that PMNs were the recipients of MP membrane proteins, this experiment 
was repeated with PMNs labelled with PKH (red) and PBMC surface proteins labelled 
with biotin and SA-FITC (green, Figure 6.2C). It again appeared that acquired membrane 
proteins were diffusing throughout the PMN plasma membrane (yellow). Finally, PMNs 
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were labelled internally with DCFH-DA (green) to facilitate better visualization of PKH-
labelled PBMC membrane (red) diffusion throughout the PMN plasma membrane (Figure 
6.2D). Collectively, these observations support the conclusion that passively acquired 
membranes and membrane proteins integrated into the PMN plasma membrane. Previous 
flow cytometric experiments had suggested PMN passive acquisition of membrane 
proteins from PBMC increased with time (Chapter 5). Confocal microscopy was used to 
examine this process in more detail and to determine if the integration of PBMC 
membranes and integral membrane proteins increased  
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Figure 6.1.  Formation and release of MPs from PBMC and MP attachment to 
bovine PMNs.  (A) MP formation and detachment from PKH dye (red) labelled PBMCs 
was observed with confocal microscopy.  (B) Attachment of a MP shed from a PBMC to 
the surface of an unlabelled PMN.  (C) PBMCs labelled with biotin-SA-FITC (green) 
shed MPs (green) which then attached to the surface of a PKH dye (red) labelled PMN. 
Close cell-to-cell contact between PBMC (green) and PMN (red) was also observed. 
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Figure 6.2.  Integration of passively acquired membranes and membrane proteins 
into the PMN plasma membrane. (A) Attachment of both PBMC (red) and shed MPs 
(red) to the surface of PMNs (no label). (B) Diffusion of lipophilic PKH label (red) 
throughout plasma membrane of PMN (unlabelled).(C) Attachment of PBMC-derived 
MPs containing biotin-SA-FITC labelled membrane proteins (green) to the surface of 
PKH labelled PMNs (red). Yellow fluorescence may reveal integration or mixing of 
PBMC-derived membrane proteins (green) within the PMN plasma membrane (red). (D) 
PMN labelled with DCFH-DA (green cytoplasm) display diffuse surface labelling with 
PKH labelled PBMC membranes (red). 
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over time. Very little membrane attachment was detected following a brief co-culture 
(Figure 6.3A) but membrane attachment did increase with time (Figure 6.3B and C). 
Furthermore, following a 24 h co-culture of PMNs and PBMC there was extensive 
dispersion of labelled PBMC membranes throughout the PMN plasma membrane (Figure 
6.3D). These observations support the conclusion that there is a time-dependent 
integration of passively acquired membranes and integral membrane proteins into the 
PMN plasma membrane. 
  
6.4.3 Transfer of Cytoplasmic Protein to PMNs 
The observation that MPs fused with PMNs raised the possibility that either 
cytoplasmic proteins or genetic material (DNA or RNA) contained within MPs may also 
be transferred to PMNs.  An ovine B-cell line, expressing cytoplasmic GFP (Cl2-GFP), 
was used to determine if detectable levels of cytoplasmic proteins could be transferred by 
MPs to a recipient cell. Following γ-irradiation, Cl2-GFP cells formed (Figure 6.4A) and 
released (Figure 6.4B) MPs which contained detectable levels of GFP. It was difficult to 
identify recipient PMNs with a strong green fluorescent signal following attachment of 
GFP-labelled MPs but individual PMNs were found that contained both discreet and 
diffuse GFP staining (Figure 6.4C).  Discreet foci of green fluorescence may indicate 
endocytosis of GFP containing MPs and diffuse green fluorescence might indicate either 
release of GFP from the endocytic vesicle or a direct release of GFP into the PMN 
cytoplasm following fusion of MPs with PMNs. 
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Figure 6.3.  PMN acquisition of PBMC membranes and integral membrane proteins 
increases with time.  (A) No detectable transfer of PBMC membranes (red) to PMNs 
(green, DCFH-DA label) was observed when co-culture was less than 5 minutes. 
Following co-culture for (B) 20-30 min or (C) 2h, PMNs (red, PKH label) had acquired 
increasing amounts of biotin-labelled protein from PBMCs (green). Following co-culture 
for 24 h (D) extensive integration of PKH-labelled PBMC membranes was observed on 
the surface of DCFH-DA-labelled PMNs (green). 
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Figure 6.4.  MP transfer of cytoplasmic proteins to PMNs.  (A) Generation of MPs 
containing GFP following γ-irradiation of Cl2-GFP cells. (B) Release of MPs containing 
detectable GFP fluorescence from γ-irradiation of Cl2-GFP cells. (C) Binding of MPs 
containing GFP to a PMN (unlabelled) and diffusion of GFP within the cytoplasm of a 
PMN (arrow). 
 
C 
  
20µm 30µm 
20µm 
120 
 
6.4.4 Passively Acquired Proteins Retain Their Function 
Confocal microscopy provided evidence for integration of passively acquired 
proteins within the plasma membrane of PMNs. Therefore, we used two different assays 
to determine if passively acquired proteins altered PMN function.  The first assay was 
based on PMN infection with recombinant BAdV-3 which expressed GFP (BAV304). 
This assay allowed a direct measurement of the number of infected PMNs.  BAV304 
infection of PMNs with an MOI of 1 results in detectable GFP transgene expression in 
approximately 7-15% of cells (Figure 6.5A).  In contrast, 293-cells are more permissive 
to BAdV-3 infection and GFP transgene expression is detectable in all cells at 48h post-
infection (MOI=1, Figure 6.5A).  Although cellular receptors for BAdV attachment have 
not been identified, it is well accepted that viral entry is protein mediated 221.  Therefore, 
PMNs were incubated with and without cell membranes from lysed 293-cells, and then 
compared BAdV-3 infection through GFP-transgene expression.  Co-incubation of PMNs 
with cell membranes from lysed 293-cells increased the number of cells with detectable 
GFP transgene expression by approximately 3-fold (Figure 6.5A). Furthermore, this 
increased frequency of GFP+ PMNs was accompanied by an increased level of GFP 
expression within individual cells (Figure 6.5B). The specificity of 293 membrane 
protein transfer to PMNs was evaluated by co-culturing PMNs with bovine PBMCs using 
conditions known to transfer membrane proteins. Bovine PBMCs are not infected by 
BAV304 (data not shown) and PMN expression of GFP was not significantly altered 
when infected with BAV304 following co-culture with PBMCs (Figure 6.5A). These 
observations support the conclusion that passive transfer of a functional integral 
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Figure 6.5:  Infection of bovine PMNs with recombinant BAdV-3 expressing GFP protein (BAV304).  
(A) GFP expression in PMNs was measured at 48 hours post-infection using flow cytometry. Uninfected 
PMNs were used as the negative control (PMN) and the BAdV-3 permissive cell line (293 cells) was the 
positive control. PMNs were infected directly with BAV304 (PMN + BAdV) or infected following co-
culture of PMNs with either 293 cell membranes ((PMN + 293) + BAdV) or non-permissive leukocytes 
(PMN + PBMC) + BAdV). Data presented are values for PMNs isolated from 4 individual animals 
(bar=median value for each group).  The unpaired, non-parametric Mann-Whitney T-test revealed a 
significantly (P = 0.03) increased percentage of PMNs were infected following incubation  with 293 cell 
membranes ((PMN + 293) + BAdV) when compared to BAV304 infected PMNs alone (PMN + BAdV). 
(B) Representative FACS dot-plot profiles showing GFP expression at 48h post-BAV304 infection of 
PMNs alone (left panel) or bovine PMNs pre-incubated with 293-cell membranes (right panel). 
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membrane protein from 293-cells to bovine PMNs significantly altered the capacity of 
PMN to be infected by BAdV-3. 
A second, more specific method was then used to analyze the functional 
consequences of passive membrane protein acquisition by PMNs.  Xenoreactive bovine 
T-cell populations were generated using the ovine Cl2 B-cell line and these T-cell 
populations were then used to determine if passively acquired ovine MHC II molecules 
could induce antigen-specific T-cell activation.  The transfer of membranes from lysed 
Cl2 B-cells to either syngeneic or allogeneic PMNs induced an equivalent antigen-
specific proliferative response by the xenoreactive T-cell line (Figure 6.6A). The current 
model for an MLR is that alloreactive T-cells recognize genetically disparate MHC 
molecules with bound peptide in the groove 66.  If this model is correct then the present 
experiments confirm that bovine PMNs which passively acquire MHC II proteins (Figure 
6.6B) can function as APCs for T-cells that have been previously activated by antigen. 
The MLR induced by PMNs was significantly less than that observed with γ-irradiated 
Cl2 B-cells. This may simply be due to the much lower level of passively acquired MHC 
II protein on PMNs (Figure 6.6B) or there may be qualitative differences in antigen 
presentation by PMNs. The passive transfer of co-stimulatory molecules with MHC II 
was not determined but we analyzed T-cell cytokine expression to determine if PMN 
stimulation of T-cells was qualitatively different from the T-cell activation induced by 
Cl2 B-cells. Expression of TH1-type (IFN-γ; TNF) and TH2-type (IL-4; 1L-10) cytokines 
was analyzed and IL-2 expression was also analyzed since this cytokine is important for 
T-cell proliferative responses. Cytokine expression analysis revealed that PMNs, 
following passive acquisition of ovine MHC II, induced 
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Figure 6.6:  Bovine PMNs which passively acquire ovine MHC II induce 
proliferation of xenoreactive T-cells.  (A) Proliferation of a xenoreactive T-cell line was 
measured following co-cultured with  either γ-irradiated Clone 2 B-cells (Clone 2), syngeneic 
PMN incubated with Cl2 membranes (Syn-PMN + CL2memb) or allogeneic PMN incubated with 
Cl2 membranes (Allo-PMN + CL2memb), bovine PMNs alone (PMNs), or syngeneic PBMCs 
(PBMCs).  Data presented are the mean and 1 SD of values from triplicate cultures of a T-cell 
line generated from one animal. Similar results were obtained with Cl2-specific T cell 
populations generated from 5 other animals. (B) A representative FACS profile of MHC II 
expression on bovine PMNs alone (left panel) or following PMN co-culture with membranes 
from lysed Cl2 cells (middle panel). The level of MHC II expression on CL2 B-cells is shown in 
the right panel. 
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T-cell expression of both TH1- and TH2-type cytokines (Figure 6.7). The onset, 
amplitude, and duration of cytokine gene expression varied significantly when PMN 
stimulation was compared to Cl2 B cells.  Furthermore, as expected from MLR results 
(Figure 6.6A), PMNs which passively acquired ovine MHC II induced significantly less 
IL-2 expression than T-cells stimulated with Cl2 B-cells. Thus, PMN stimulation of 
activated, xenoreactive T-cells resulted in quantitative differences in cytokine gene 
expression but expression was significantly increased for all cytokines analyzed.  When 
reading the results reported in Figure 6.7, remember that a lower ∆Ct-value indicates an 
increased level of expression of the gene of interest.  
 
6.5 Discussion 
There is increasing data to support the conclusion that the passive transfer of 
membranes and integral membrane proteins among immune cells is a general 
phenomenon and this exchange of biological material can have important functional 
consequences 134,138-141,143,144.  Few studies have explored the mechanisms of 
membrane/protein transfer in depth, although passive acquisition of protein from dying 
cells has been previously reported 134.  The present study clearly shows that MPs shed 
from fluorescently labelled PBMCs can attach and integrate into the PMN plasma 
membrane.  It is important to note that all short-term PMN and PBMC co-cultures were 
incubated at 20-22oC prior to viewing with confocal microscopy.   This may be 
significant since membrane fluidity and fusion may be reduced at this temperature when  
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Figure 6.7. Bovine PMNs which passively acquire ovine MHC II induce cytokine expression in 
xenoreactive T-cells.  Cytokine expression was measured using qRT-PCR and the level of cytokine 
expression is expressed relative to actin (∆Ct), therefore the lower ∆Ct values are indicative of a higher 
level of gene expression. Xenoreactive T cells were stimulated with either γ-irradiated Cl2 cells (T + CL2 
B-cells; solid triangle), syngeneic PMNs (T + PMN; solid circle), or syngeneic PMNs incubated with Cl2 
B-cell membranes (T + PMN/CL2 Memb.; open triangle). T cell cultures were collected for RNA isolation 
following the indicated co-culture intervals and data presented are the mean and 1 SD for values from 
xenoreactive T cell populations derived from 3 animals. Superscripts indicate values that are significantly 
(p < 0.05) different from the T + PMN culture and data points with different superscripts differ 
significantly (p < 0.05) from each other.   
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compared to body temperature 215. Thus, passive acquisition and fusion of membranes 
and integral membrane proteins with the PMN plasma membrane may be even more 
efficient at body temperature.  It is also interesting to note that during the confocal studies 
there was no evidence of reciprocal membrane/protein transfer from PMNs to PBMCs 
even following a 24h co-culture at 37oC (Figure 6.3D). Finally, the present investigation 
also provided evidence that MPs can transfer cytoplasmic protein between cells (Figure 
6.4).  In conjunction with previous data, which confirmed oncogene transfer between 
cells 158, we must now consider the possibility of RNA and cytoplasmic proteins transfer. 
Further studies will be required to determine if the magnitude of this cytoplasmic transfer 
is sufficient to alter the biology of the recipient cell.  
Confocal microscopy provided substantial evidence that MP attachment to PMNs 
was followed by integration of passively acquired membranes and membrane proteins 
(Figures 6.2 and 6.3). A previous study demonstrated that MPs shed from leukocytes 
attached to the surface of epithelial tumour cells but the acquired proteins remained in 
segregated ‘rafts’ rather than diffusing throughout the recipient plasma membrane 148. In 
contrast, both labelled lipids and biotin-labelled proteins from donor leukocytes appeared 
to diffuse throughout the plasma membrane of bovine PMNs. These observations were 
consistent with a full integration of membranes/proteins within the plasma membrane of 
the bovine PMN with no apparent restriction in their subsequent distribution. 
Furthermore, time course studies indicated that this integration can occur relatively 
rapidly. The attachment of MPs to the surface of bovine PMNs may explain a previous 
report that goat PMNs can passively acquire MHC II but this MHC II expression is 
dependent upon the methodology used to isolate the cells 80. Centrifugation of goat PMNs 
through a density gradient was reported to remove surface MHC II molecules.  A similar 
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phenomenon with bovine PMNs following centrifugation was observed here (Chapter 5). 
It may be that certain isolation procedures can remove leukocyte-derived MPs which 
contain MHC II molecules and are loosely attached to the PMNs surface.  Thus, reports 
that surface molecules can be removed during a cell isolation procedure may need to be 
re-examined for potential passive acquisition of surface proteins from cells which are 
shedding MPs.   
The passive acquisition of integral membrane proteins by bovine PMNs was of 
sufficient amplitude to significantly alter recipient cell biology (Figures 6.5 and 6.6). This 
research has shown that the passive acquisition and integration of functional membrane 
proteins altered viral infection of PMNs and enabled PMNs to activate antigen-specific 
T-cells. Increased viral infection of bovine PMNs was observed following their exposure 
to lysed cell membranes from 293-cells which are highly permissive to BAV304 
infection (Figure 6.5). PMNs are not permissive to BAdV-3 replication (data not shown) 
and thus increased GFP-transgene expression cannot be interpreted as increased viral 
replication. This assay primarily provided a method to monitor viral uptake by PMNs 
and, therefore, provides indirect evidence for the passive transfer of a viral receptor 
protein from 293-cells to PMNs. These observations are consistent with previous reports 
that viral receptor proteins can be passively acquired and subsequently alter viral 
tropisms 145,154.   
This study provided direct evidence that PMNs could passively acquire MHC II 
molecules which conferred antigen presentation capabilities upon the PMNs.  In these 
experiments, the passive acquisition of ovine MHC II (Figure 6.6B) resulted in bovine 
PMNs inducing a significant MLR with antigen-specific T-cell populations (Figure 
6.6A). This proliferative response was by primed T-cells, but specific T-cell activation 
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should still be dependent upon a functional MHC class II protein with antigen bound in 
its groove 66.  The requirement for co-stimulation signals may be much less for activation 
of primed T-cells and in this assay, co-stimulation would be dependent upon a functional 
cross-reactivity between ovine and bovine co-stimulatory molecules. Passive acquisition 
of ovine MHC II by bovine PMNs induced significantly lower levels of T-cell 
proliferation than Cl2 B-cells and this difference in T-cell responses was observed despite 
using greater numbers of stimulator PMNs than γ-irradiated Cl2 B-cells.  Decreased T-
cell activation may reflect the 40-fold lower density of passively acquired MHC II 
molecules on bovine PMNs (MFI = 13.8) than on donor Cl2 B-cells (MFI = 617) (Figure 
6.6B). Alternatively, decreased PMN-induced T-cell responses may reflect either a lack 
of co-stimulatory molecule transfer or reduced cross-species activity of passively 
transferred ovine co-stimulatory molecules. The present assay was designed to clearly 
discriminate between potential endogenous MHC II expression and passively acquired 
MHC II molecules. This assay may not, however, be optimal for exploring the full 
potential of bovine PMNs to function as APCs following passive acquisition of MHC II 
molecules.  
It has been postulated that the transfer of membrane fragments to immune cells 
may serve to either expand and/or regulate an immune response 217.  For example, 
macrophage antigen presentation is reduced following phagocytosis of apoptotic cell 
bodies but antigen presentation is enhanced following phagocytosis of necrotic cell 
bodies 83.  Thus, we examined in more detail the antigen presentation capacity of PMNs 
following passive acquisition of ovine MHC II.  Cytokine gene expression analysis did 
not reveal a marked bias or deficiency in T-cell activation when PMNs were functioning 
as APCs (Figure 6.7).  The magnitude and duration of gene expression was markedly 
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reduced when the T-cells were stimulated using PMNs + Clone 2 cell membranes as the 
APCs rather than with Clone 2 cells.  However, the same pattern of gene expression was 
observed regardless of the stimulator population used.  That is, Th1 cytokines are 
expressed earlier than Th2 cytokines, and following the induction of IL-10, Th1 cytokine 
expression was down-regulated.  The relative levels of gene expression were compared to 
the relevant control of T-cells which had been co-cultured with purified PMNs.  This 
control showed no induction of T-cell gene expression over time, and therefore revealed 
very low level cytokine gene expression in unstimulated T cells.  Although PMNs were 
not potent APCs, one implication of the current in vitro studies may be that PMNs, at a 
site of inflammation, could further stimulate activated T-cells.  The relatively large 
number of PMNs that can infiltrate sites of inflammation may compensate for their 
relatively poor antigen presentation by providing T-cells with an increased opportunity to 
interact with antigen.  The efficiency and consequences of T-cell activation by PMNs 
may also depend upon which co-stimulatory molecules are passively acquired through 
the uptake of MPs. Further studies will be required to determine if the co-transfer of 
MHC II and co-stimulatory molecules has a significant impact on PMN antigen 
presentation.  
In summary, these studies confirmed that bovine PMNs could rapidly acquire 
membrane fragments and their associated proteins through MPs which have been shed 
from dying cells.  In vitro studies have also confirmed that these passively acquired 
membrane proteins retain their function and confer novel biological properties to 
recipient PMNs.  The observation that passively acquired MHC II can be presented to 
activated T-cells provides a novel mechanism by which PMNs may play a role in both 
innate and adaptive immune responses.  
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CHAPTER 7 
 
General Discussion and Conclusions 
 
 
The mammalian immune system is complex, dynamic and diverse.  
Immunologists have wrestled with this complexity in an attempt to understand how 
defence against a massive number of highly adaptable pathogens is mounted.  It could be 
argued that vertebrates can only exist thanks to an immune defence system whose 
repertoire matches that of invading viruses and microorganisms.  Immunologists have 
conceptually divided the mammalian immune system into innate and adaptive immune 
responses.  It seems, however, that the more that is discovered about how the immune 
system works, the less clear these functional distinctions are, and the more integrated 
immune responses become.  In addition, immunological studies are revealing many 
redundancies in immune function, such as antigen presentation which was once thought 
to be the domain of a few specialized cell types. 
PMNs are a very important component of the innate branch of the mammalian 
immune system as evidenced by the fact that no mammal can survive for more than a few 
days without them 13.  PMNs are often the first cell recruited to a site of inflammation to 
provide a rapid response to microbial invasion but evidence is emerging which suggests 
that PMNs may also play an important role in modulating adaptive immunity.  Not only 
have PMNs been shown to express several important regulatory cytokines as outlined in 
chapter 1, the research described in this thesis demonstrates that bovine PMNs have an 
impressive capacity to rapidly acquire functional proteins from dead or dying cells.   
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The passive or active transfer and acquisition of membrane fragments and their 
associated integral membrane proteins amongst leukocytes (T-cells, B-cells, dendritic 
cells, monocytes and NK cells) has been an emerging topic of interest in recent years 
(outlined in Chapter 1).  Furthermore, this transfer of membrane fragments and 
membrane proteins has been associated with a variety of interesting immunological 
phenomena, such as cross-presentation, T-cell antigen presentation and the transfer of 
viral tropism to cells which acquire viral receptor proteins.  The current evidence strongly 
argues that PMNs should be included among the list of immune cells which can passively 
acquire functional proteins.  The unique biology of PMNs has significant implications for 
the potential immunological implications of passive membrane acquisition and may also 
provide unique opportunities to exploit this phenomenon in areas such as the delivery of 
vaccine antigens. 
 
Evidence for Passive Acquisition of MHC II by Bovine PMNs 
Prior investigation that bovine PMNs could function as antigen presenting cells 
led to the observation that PMNs were preferentially targeted, when comparing all blood 
leukocytes, for infection by BAdV-3 raised a major issue concerning the efficacy of using 
BAdV-3 vaccine vectors.  If PMNs could destroy a significant portion of the viral 
vaccine, the efficiency of vaccination could be substantially reduced, and would have to 
be addressed.  However, previous studies had shown that BAdV-3 vaccine vectors could 
indeed stimulate strong immunity to the antigens they expressed 211.  It was therefore 
hypothesized that PMNs may participate in antigen presentation either directly to T-cells, 
or by an indirect pathway.   
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Initially the expression of MHC Class II, a key protein involved in antigen presentation, 
on bovine PMNs was investigated.  These experiments confirmed that purified bovine 
PMNs were MHC II- when isolated from whole blood but if purified PMNs were co-
cultured with PBMCs then MHC II+ expression was detected. Experiments were then 
conducted to determine whether the PMN isolation technique altered the level of MHC II 
expression on the surface of PMNs.  As had been previously reported using caprine 
PMNs isolated with density gradient centrifugation 80, it was observed that following 
bovine PMNs isolation with centrifugation speeds of 1400 x g there was no detectable 
MHC II expression. There are no reports that centrifugation of cells at these speeds can 
shear off integral membrane proteins. Thus, the interpretation of these observations was 
that MHC II molecules were present on the freshly isolated bovine PMNs, but as loosely 
adhered MPs. The MHC II containing MPs could be susceptible to the shearing forces 
caused by centrifugation at 1400 x g.  Following a 24 hour incubation of whole blood, 
however, PMNs isolated using the same centrifugation technique showed significant 
MHC II expression, although far less expression than PMNs isolated without using 
centrifugation (Figure 5.1).  These observations are consistent with the hypothesis that 
there is a time-dependent integration of MP derived membrane and protein into the PMN 
membrane. These integrated proteins would then be resistant to removal by the 
centrifugal forces present during PMN isolation.  
 Further evidence that MPs might be attaching to the surface of PMNs was 
provided by the observation that significant levels of MHC II acquisition occurred when 
PMNs and PBMC were co-cultured at 4oC.  MPs are unable to efficiently fuse with PMN 
membranes at such a low temperature since plasma membrane fluidity is drastically 
reduced at this temperature 179,222,223.  We observed detectable levels of MHC Class II 
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molecules on PMNs within 40 minutes of co-culture at 4oC, however, it is likely that 
significant MHC II acquisition would have occurred sooner than 40 minutes.  (Figure 
5.2B).  The minimal time for this experiment was defined by the time interval required to 
label cells for flow cytometric analysis.  That is, PMNs were combined with PBMCs and 
monoclonal antibody labelling for MHC II was initiated immediately (time = 0min).  
Over the course of labelling with primary and secondary antibodies, PMNs were exposed 
to MHC II proteins expressed by other cell populations present in the wells.  This 
experiment was carried out at 4oC since mammalian cell transcription and translation is 
markedly decreased at 4oC 215 thereby limiting endogenous gene expression.  A parallel 
experiment performed at 37 oC showed no difference in the level of MHC II acquisition 
by PMNs (data not shown) which supports passive acquisition and argues against 
endogenous expression.  These observations are also consistent with reports that 
spontaneous fusion of MPs and cells can occur at 4oC, mediated by SNARE proteins 179.   
Another experiment involved the co-incubation of PMNs with PBMCs separated 
by a 0.4µm transwell membrane such that direct cell contact between PMNs and MHC II+ 
cells was prevented (Figure 5.2B).  No acquisition of MHC II by PMNs was detected by 
flow cytometry, but this result could have several interpretations.  As MPs range in size 
from 0.05-1µm 153, perhaps some of the smaller MHC II expressing MPs were able to 
cross the transwell membrane and fuse with PMNs, but not in sufficient quantity to be 
detected by flow cytometry.  It is also possible that many of the transwell pores were 
blocked by PBMCs which settled on the transwell membrane, thereby blocking MP 
access to the bottom compartment which contained PMNs.  The adherent nature of MPs 
might also preclude them from reaching the bottom compartment as they might adhere to 
other PBMCs, MPs, or the transwell membrane itself.  Alternatively, perhaps MHC II 
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proteins are only carried by larger MPs which were unable to cross the transwell 
membrane. 
Direct evidence for bovine PMN passive acquisition versus endogenous 
expression of MHC II was provided by experiments which demonstrated the transfer of 
murine MHC II (Figure 5.3).  Although this experiment didn’t eliminate the possibility of 
endogenous MHC II expression, it conclusively supported our hypothesis that bovine 
PMNs could passively acquire protein, and demonstrated, at least using the murine 
model, that there was no species-specific limitation to this phenomenon. 
Finally, we endeavoured to determine if bovine PMNs could be stimulated to 
express MHC class II on their surface, as had been reported with PMNs from other 
species 80,88,207,208.  Throughout our experiments with bovine PMNs, we tried to duplicate 
previously reported results such as the induction of MHC II expression following co-
culture with certain cytokines (i.e. IFN-γ, GM-CSF, Figure 5.2A) or with a soluble T-cell 
factor.  To examine the potential effect of soluble T-cell factors on MHC II expression in 
bovine PMNs, we co-cultured PMNs with activated T-cells which were separated by a 
0.4µm transwell membrane (Figure 5.2B).  Here, the transwell membrane facilitates an 
exchange of secreted soluble factors but prevents direct cell contact.  None of these 
treatments induced detectable expression of MHC II on purified bovine PMNs,  
 
 
The Role of Apoptosis and Necrosis in Passive Membrane/Protein Transfer  
Following the observation that B-cells were the primary MHC II donor cell 
(Figure 5.4B) and a high percentage of B-cells underwent apoptosis within 24 hours of in 
vitro co-culture with PMNs (Figure 5.4A), the hypothesis was formulated that PMNs 
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could acquire membrane fragments and their associated integral membrane proteins from 
MPs shed from cells undergoing apoptosis.  To confirm that donor cell apoptosis was 
important for the transfer of membrane proteins to PMNs, bovine PMNs were co-cultured 
with an ovine sheep B-cell line (Clone 2 B-cells). This cell line undergoes little 
spontaneous apoptosis during culture and no detectable MHC II was detected on PMNs 
co-cultured with Clone2 B-cells.  To determine the efficiency of protein transfer using 
several different apoptosis-inducing techniques were attempted.  Clone 2 B-cells were 
cultured with two different chemicals that induce apoptosis, Anisomycin (1µg/ml) and 
Doxorubicin hydrocholoride (1mM), or rendered apoptotic by γ-irradiation.  However, it 
was difficult to determine if the induction of apoptosis in Clone 2 B-cells increased their 
capacity to be MHC II donors since  flow cytometry could not distinguish between 
bovine PMNs and apoptotic Cl2 B cells. Therefore, Cl2 B cell membranes were obtained 
by using repeated freeze/thaws followed by a short sonication step to generate lysed cell 
membranes which were then co-cultured with PMNs (Figure 5.4B).  PMNs passively 
acquired an equivalent level of MHC II from lysed Cl2 cell membranes and apoptotic 
bovine B-cells. The Cl2 cell transfer system was somewhat artificial but these 
observations raised the possibility that both apoptotic and necrotic cells could function as 
donors of integral membrane proteins.  
 
Further evidence that a variety of proteins could be transferred to PMNs from 
apoptotic cells came from the observation that T-cells, gamma-irradiated to induce 
apoptosis, also transferred CD3 protein to PMNs (Figure 5.5).  It is interesting to note, 
however, that the level of CD3 acquisition by PMNs was not equivalent to the level of 
MHC II acquisition. The reasons for this apparent difference were not critically addressed 
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but there are several possible explanations.  There are relatively more MHC II+ cells (B 
cells, monocytes, and some T-cells) than CD3+ (T-cells) within purified PBMC 
populations and these cells may release a larger number of MPs than γ-irradiated T-cells. 
Alternatively, MPs might preferentially carry more MHC II protein than CD3 protein or 
the different methods of inducing cell death (i.e. γ-irradiation versus culture induced cell 
death) may alter the physical attributes of MPs and influence either their release from 
donor cells or attachment to PMNs.   
In addition, biotin or PKH labelled bovine PBMCs were co-cultured with 
unlabeled PMNs for 24h, during which time nearly all PMNs acquired sufficient 
biotinylated proteins or PKH label on their surface to be detected with flow cytometry 
(Figure 5.6).  Thus, although it was not possible to determine if this transfer was 
selective, this was evidence that both membrane fragments as well as multiple membrane 
proteins could be transferred to PMNs. 
 
Model of Passive Acquisition  
  In Chapter 5, a theoretical model was designed which outlined a possible 
mechanism of membrane lipid and protein transfer to bovine PMNs (Figure 5.7).  After 
the induction of apoptosis or necrosis, cells are known to release MPs which may or may 
not contain integral membrane proteins 131.  Such vesicles demonstrate increased adherent 
properties 216, and it was hypothesized that MPs adhered to PMNs and eventually became 
incorporated into the PMN plasma membrane.  Based on this model, it is unlikely that 
proteins can insert into the PMN membrane in the improper orientation. This latter 
possibility was, however, included in the model.  The detection of passively acquired 
biotinylated proteins on the surface of PMNs provides evidence that at least some 
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proteins were present in the correct orientation as SA-FITC is a large molecular complex 
which is excluded from viable cells and thus detection by flow cytometry was consistent 
with binding to biotinylated extra-cellular proteins.   
 
Mechanism of Regulation of Membrane Transfer 
The lack of variation in the amount of MHC II acquisition by PMNs, whether the 
MHC II source was from apoptotic, necrotic, xenogeneic, allogeneic or syngeneic cells, 
suggests that the mechanism of acquisition is not specific to one type of syngeneic cell, 
but is rather a more general process, perhaps inherent to the nature of MPs themselves.  
Since both apoptotic and necrotic cells can form MPs, these observations were consistent 
with the hypothesis.  As described in Chapter 1, MPs have unique membrane 
characteristics which distinguish them from other cell membranes or debris. These unique 
properties may provide a specific signal which is important for the efficient acquisition of 
MP membranes and proteins by PMNs.  It is also plausible that PMNs could acquire MPs 
shed from live cells.  This investigation was limited to the use of apoptotic and necrotic 
cells since these systems provided rapid transfer of detectable levels of labelled proteins 
and membranes. Detection of this transfer by flow cytometry was clearly limited by the 
sensitivity of this methodology. All cells have an inherent level of autofluorescence and 
to detect a specific fluorescent signal it must exceed autofluorescence. Flow cytometry 
often requires 500-1000 fluorescent molecules on the surface of a cell to detect a specific 
signal 224. Thus, the possibility cannot be disregarded that viable cells participate in MP-
mediated transfer of membranes and proteins but at a level below the threshold of 
detection with flow cytometry.  
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Whatever the mechanism of passive membrane transfer, it is assumed that there 
are regulatory mechanisms to ensure both the specificity and the amplitude of this 
process. There is a growing body of literature regarding the diverse regulatory 
mechanisms which occur throughout cellular biology.  Since the passive transfer of 
membranes and proteins between cells is a relatively new area of scientific exploration, 
these regulatory systems are largely unknown.  Like all mammalian cells, PMNs possess 
numerous proteins involved in signalling pathways that control many aspects of cellular 
function, including gene transcription, cytokine-induced responses, phagocytosis, and cell 
motility. Many of these regulatory proteins are involved in the control of multiple 
intracellular signalling pathways and the functions of many proteins are not fully 
characterized.  Therefore, it is probable that some of these proteins may play a role in 
regulating the passive acquisition of MPs and their associated proteins.  For example, 
guanine exchange factors (GEF) of the Vav family are critical activators of Rho GTPases, 
which control actin cytoskeletal reorganization and gene transcription.  Integrins have 
been characterized extensively as adhesion receptors capable of transducing signals 
inside the cell. Integrin-mediated adhesive interactions are known to regulate different 
selective cell responses, such as transmigration into the inflammatory site, cytokine 
secretion, production of reactive oxygen intermediates, degranulation and phagocytosis 
225.  In fact, integrins are so involved in the regulation of neutrophil functioning that it 
would be surprising if they weren’t key regulators in the acquisition of membrane 
proteins.  They could act as primary adhesion molecules for protein-transporting 
microvesicles and subsequent membrane fusion, or they could be far more intricately 
involved in the downstream signalling processes.  Their involvement in signal 
transduction, particularly that involving tyrosine kinase activity, has drawn significant 
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attention.  Another likelihood is that newly acquired proteins only elicit their effects on 
recipient cells that have the proper cellular machinery or communication pathways to 
regulate these proteins.  If microvesicles can fuse with many different cell types, they risk 
fusing with unintended recipients.  Cells that acquire proteins which cannot access 
regulatory pathways may simply be endocytosed and degraded.  There is, however, a 
possibility that newly acquired proteins can access downstream regulators as it has been 
shown that many distinct cell surface receptors can trigger responses that converge on 
common downstream intracellular pathways, such as the activation of caspases and 
transcription factors, or the control of apoptosis in PMNs 226.  That is, each signalling 
pathways may not be activated by a single receptor protein. 
As described in Chapter 1, regulation of MP-mediated protein transfer could also 
occur at the level of the donor cell. For example, limited subsets of proteins might be 
incorporated into the MP or the generation of MPs may be regulated 153. The controlled 
expression of SNARE proteins on both MPs and the recipient cell may play an important 
role in mediating membrane fusion 179.  The state of donor cell activation or stimulation 
can alter MP formation and release 131 and therefore extrinsic factors (cytokines, 
hormones, immunologic environment, etc.) might influence this process 138. From the 
perspective of PMNs, the cytokine environment will likely affect its function and state of 
activation which may in turn impact its ability to acquire membrane proteins.  
Furthermore, because PMNs are known to be relatively short lived, there is an additional 
level of control by factors which may influence PMN lifespan (Chapter 3). Additionally, 
without the continual presence of MP shedding donor cells, any protein acquired by 
PMNs, at a site of inflammation for example, would eventually be lost by processes such 
as endocytosis or surface membrane turn-over.  Finally, it is possible passively acquired 
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proteins simply function to decorate PMNs with adhesion molecules, receptors, or 
antigen presenting proteins that can elicit effects from the surface of a cell without any 
need for downstream regulation.   
 
Direct Evidence for Passive Transfer Using Confocal Microscopy 
In Chapter 6, we confirmed the transfer of both membrane fragments as well as surface 
proteins from PBMCs to PMNs using confocal microscopy.  Confocal microscopy is a 
powerful tool used to visualize phenomena at the level of individual cells and to elucidate 
the mechanism by which cellular interactions may occur.  One of the limitations of 
confocal microscopy, however, is that the fluorescent dyes used to label the different cell 
populations can bleach when exposed for a prolonged period of time (20-30 seconds) to 
the lasers that excite fluorescence.  This means that there was limited time to view each 
individual interaction between PMNs and the microparticles (MPs) adhered to them 
before the fluorescent label was quenched.  The short viewing time, coupled with the fact 
that the cells moved during the viewing process, made following the progression of 
events with any one particular cell very difficult.  Although we were unable to capture the 
actual process of fusion between microparticle and PMN, we were able to provide direct 
evidence, from serial photographs, for MP attachment and fusion with PMN plasma 
membranes, as described in Chapter 6. A variety of membrane and membrane protein 
labelling experiments provided direct evidence for the formation and release of MPs from 
fluorescently labelled PBMCs and the subsequent attachment of MPs to the surface of 
PMNs (Figure 6.1).  These experiments also provided direct evidence that fluorescently 
labelled membrane lipids and proteins incorporated and diffused throughout the recipient 
PMN plasma membrane (Figure 6.2 and 6.3).  An alternative explanation, which is very 
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similar to the hypothesis described above, is simply that non-vesicular membrane 
fragments can adhere and fuse with PMN membranes.  Perhaps both scenarios can occur.  
It would be interesting to develop a methodology whereby a particular PMN:MP 
interaction could be viewed from start to finish, and therefore capture the details of the 
fusion event.  Perhaps the MP doesn’t fuse completely with the PMN membrane, but 
rather deposits only a small membrane fragment within the PMN membrane.  Many 
mechanistic questions remain unanswered, however the above data supports our previous 
hypotheses that the passive acquisition of membrane fragments and integral membrane 
proteins is mediated by MPs.  These MPs initially adhere to the surface of the recipient 
cell and then there is a time-dependent integration and diffusion of acquired material into 
PMNs. 
It was also curious to note that we didn’t observe reciprocal membrane transfer 
from PMNs to PBMCs, despite the death of many PMNs during co-culture.  This uni-
directional transfer might support the idea that MP transfer involves a specific signal 
from the dying cells which enables PMNs to fuse with shed MPs, but this signal may not 
invoke the same response in PBMCs.  The transfer of membrane proteins to T-cells, B-
cells and NK cells has been shown to involve interactions in the immunological synapse 
(discussed in Chapter 1), and therefore a requirement for intimate cell-cell contact might 
preclude MP-mediated transfer of membranes and proteins from PMNs to PBMCs.  If 
MP transfer is mediated by proteins involved in the phagocytic pathway, then we might 
expect at least some MP acquisition by monocytes.  It is also possible that PMNs possess 
specific receptors which facilitate MP attachment and fusion, however, as all 
membranous cells have the capacity to express SNARE proteins 178, this possibility seems 
unlikely.  Finally, our confocal photographs showed many microparticles in the media 
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that had been shed from the PBMC population, but no MPs were observed which 
contained the fluorescent stain used to label PMNs.  Thus, it is possible that PMNs do not 
efficiently generate MPs or they were prevented from forming and shedding MPs by 
some as yet unknown signal.   
 
Evidence for the Transfer of Functional Proteins to PMNs 
In Chapter 6, we reported experiments which determined that passively acquired 
proteins remained functional and could alter PMN biology.  Specifically, PMN 
acquisition of MHC class II from xenogeneic cells resulted in PMNs being able to 
stimulate proliferation and cytokine production by the xenoreactive bovine T-cells 
(Figure 6.6 and 6.7).  This observation confirmed the possibility of passive transfer of 
functional protein to PMNs.  The structural integrity of the transferred MHC II molecules 
and bound peptide must have been maintained despite Clone 2 B-cell treatment with 
freeze/thaw and sonication.  Relatively less T-cell stimulation was observed, however, 
following PMN stimulation versus Clone2 B-cell stimulation.  These diminished T-cell 
responses may be explained by some denaturation of MHC II molecules or peptide 
disassociation during Clone 2 B-cell lysis and the passive transfer of MHC II molecules 
to PMNs.  Another reason that PMNs did not function as efficient APCs may be that  
substantially lower levels of surface MHC II was achieved on PMNs following passive 
transfer as compared to the MHC II expression by other professional APCs.  A 
comparison of Clone 2 B-cells and PMNs, following passive acquisition of ovine MHC II 
revealed greater than 44-fold lower level of detectable MHC II on PMNs (Figure 6.6B).  
Therefore, the density of antigen available for T-cell stimulation may explain the 
reduction in T-cell cytokine expression and proliferative responses.  Several steps were 
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taken throughout these experiments to assure that lysed Clone 2-B-cell membrane 
fragments (or MPs) were not the cause of T-cell stimulation.  Following Clone 2 B-cell 
lysis, the lysate was centrifuged at 216 x g for 3 minutes to remove any intact cells and 
no cells were seen when the lysate was viewed using an inverted light microscope.  
Furthermore, following co-incubation of PMNs with Clone 2 B-cells lysates, the PMNs 
were washed 3 times with PBSA to remove unattached Clone 2 B-cell fragments.  An 
aliquot of the supernatant from the final PMN wash was also added to each Clone 2-
specific T-cell line but no detectable proliferative response was induced.  Therefore, it 
was concluded that the induction of an MLR by PMNs, which had passively acquired 
ovine MHC II, was due to MHC II molecules attached to the surface of PMNs.   
Neither the passive transfer to nor the endogenous expression of co-stimulatory 
molecules by PMNs was analyzed during the present investigation. The absence of co-
stimulatory molecules on PMNs may be another explanation for the reduced capacity of 
PMNs to stimulate xenoreactive T-cell responses. There is a reduced requirement for co-
stimulatory molecules during activation of primed T-cells but if PMNs lack appropriate 
co-signals this may still limit T-cell activation. A lack of cross-species recognition of co-
stimulatory molecules does not appear to have limited T-cell responses since ovine B-
cells functioned as effective inducers of xenoreactive bovine T-cells.  Thus, further 
analysis of co-stimulatory molecule expression on Clone 2 B-cells and the transfer of 
these molecules to bovine PMNs may provide further insight into the capacity of PMNs 
to function as APCs. 
 It would also be worthwhile to determine if the level of PMN antigen 
presentation would be significantly altered if membrane proteins were passively acquired 
from apoptotic versus necrotic cells.  There is evidence that an interaction between a 
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phagocyte (macrophage) and either apoptotic or necrotic cells can significantly alter the 
function of the recipient cell. Macrophages that phagocytosed apoptotic cell bodies had a 
reduced capacity to function as APCs when compared to cells that had phagocytosed 
necrotic cell bodies 83.  It would be interesting to determine if a similar modulation of 
PMN function could occur.  This may have significant implications for PMN function at 
sites of inflammation.  For example, if PMNs acquired membrane proteins from apoptotic 
cells rather than necrotic cells then there may be no T-cell stimulation but rather the 
induction of anergy or immunological quiescence. 
Finally, if bovine PMNs can acquire intact and functional MHC II proteins at sites 
of inflammation then this may have significant implications for the transport of 
immunological information to the draining lymph nodes.  There is evidence that soluble 
antigens may not be able to efficiently enter into the cortex of lymph nodes 135 where T-
cell interactions with interdigitating DCs first occur.  Thus, PMNs may provide an 
alternative antigen delivery system by carrying passively acquired MHC II proteins into 
the lymph node.  It may not be necessary for PMNs to function directly as APCs since it 
has been reported that PMNs can ‘regurgitate’ processed peptide antigens, which can 
then be presented by other APCs 74.  Potter et. al. showed that PMNs, which expressed 
MHC I and had phagocytosed and processed antigen, were able to stimulate antigen 
primed T-cells.  They were also able to regurgitate antigen into the surrounding milieu, 
which could in turn bind to MHC I molecules on the surface of the same cell or to 
neighbouring cells.  Specifically, MHC-mismatched PMNs and fixed, syngeneic 
macrophages or DCs were co-incubated together with an antigen specific T-cell line. The 
PMNs lacked expression of Kb and were therefore unable to present antigen to T-cells, 
even when they were genetically compatible.  As PMNs were only able to process and 
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not present antigen, and fixed APCs were unable to process but could present antigen, it 
was concluded that PMNs had somehow transferred antigen to the macrophages or DCs 
for presentation.  It was postulated that this transfer may have occurred through 
deposition of antigenic peptide in the groove of empty MHC molecules on the surface of 
macrophages or DCs.  The finding that MHC molecules are less stable without bound 
peptide was not addressed in this particular study. This study lacked, however, a 
comparison of T-cell stimulation by fixed APCs which had acquired regurgitated antigen 
versus fixed APCs which had processed antigen already bound to their MHC I prior to 
fixation.  This comparison would have determined the relative efficiency of passive 
versus active acquisition for antigen presentation to CD8 T-cell. Nonetheless, the above 
study along with the knowledge that DCs and B-cells can physically remove surface 
antigen or integral membrane proteins from cells 134,136,137 provide a basis for the 
conjecture that PMN passive acquisition of membrane proteins in vivo may facilitate the 
dissemination of antigenic and other protein-related information.  Furthermore, since 
PMNs can phagocytose and degrade a wide range of biological material then they may 
play an important role in the preparation of antigenic peptides for transfer to professional 
APCs as alluded to by Potter et. al. 74.   
Finally, PMNs which have acquired MHC II loaded with peptide may have the 
capacity to form cognate interactions with TCRs on CD4 T-cells.  As previously 
discussed, this protein endows them with the ability to either stimulate T-cells or render 
them tolerogenic, depending on PMN expression of appropriate co-signalling proteins 
and the state of T-cell activation.  If PMNs passively acquire co-receptor proteins, such as 
CD80 and CD86, part of their role might then be the amplification of an existing immune 
response or even the primary activation of antigen-specific T-cells.  Alternatively, if 
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either the antigen signal or co-signalling on PMNs was too weak, then this stimulation 
might result in the down-regulation of an existing T-cell response.  A capacity to down-
regulate or anergize T-cell responses might then imply that PMNs could play a role in the 
elimination of self-reactive T-cells at sites of inflammation following acquisition of MHC 
II containing self-peptides. Considering the large numbers of PMNs which can be 
recruited to sites of inflammation, their cumulative effect on an immune response may be 
very significant.  A next step in determining the biological significance of PMN passive 
acquisition of membrane proteins may be to extend this research to include in vivo 
experimentation. Ex vivo loading of PMNs with MHC II (or other proteins) and injecting 
these cells into sites of inflammation, the blood or into afferent lymphatics might provide 
a system to determine if PMNs can induce either antigen-specific T cell activation or 
tolerance.  
Further evidence that PMNs could passively acquire functional membrane 
proteins was provided by the experiments with membrane fragments and protein from a 
BAdV-3 permissive cell population (293 cells). This membrane transfer resulted in 
enhanced BAV304 infection of PMNs (Figure 6.5). The interpretation of this observation 
was limited, however, by an assumption that 293 membrane transfer resulted in PMN 
acquisition of a BAdV-3-specific receptor protein.  Direct confirmation that increased 
viral infection was due to the passive transfer of a viral receptor protein would require 
confirmation that a specific receptor protein was transferred along with antibody blocking 
experiments to demonstrate that this protein was required for increased infection by 
BAV304. Previous investigators have clearly shown that the passive transfer of known 
viral receptor proteins can alter viral tropism 145,154.  These previous observations are 
consistent with the current evidence that passive acquisition of 293 cell membranes 
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increased BAdV-3 infection of PMNs. Furthermore, these observations are important 
since they suggest that passive acquisition of functional membrane proteins may have 
biological implications beyond alteration of immune responses.  The significance of 
passive acquisition of viral receptor protein, however, may also be limited by a number of 
other cellular functions.  There are several steps involved in virus penetration and 
replication beyond the primary limiting step of viral attachment.  For a productive viral 
infection to occur, the virus must also be able to penetrate the host cell membrane and 
then effectively use the host cell machinery for replication.  Thus, no biological effect 
may be observed if passive acquisition of viral receptor proteins is not be coupled with a 
cell’s competence to support viral replication.  This issue was not addressed in the 
present investigation since bovine PMNs did not support BAdV-3 replication and viral 
infection was monitored through the expression of the GFP reporter gene.  
 
A Potential for Cytoplasmic Protein and mRNA Transfer 
An additional observation worthy of further discussion was the passive 
acquisition of cytoplasmic material by PMNs.  The ovine B cell line expressing 
cytoplasmic GFP (Cl2-GFP) enabled photography of the formation and release of GFP 
containing MPs from γ-irradiated Clone 2-GFP B-cells (Figure 6.4).  These GFP labelled 
MPs could then be visualized with confocal microscopy and these analyses revealed that 
GFP had been transferred to the cytoplasm of PMNs.  Due to rapid photo-bleaching of 
GFP fluorescence it was difficult to visualize the transfer of small amounts of GFP from 
MPs to PMNs.  Thus the initial fluorescence signal within the recipient PMN was limited 
and the signal was rapidly quenched by photo-bleaching.  However, cytoplasmic protein 
transfer was observed and this raises the possibility that mRNA was also transferred.  It is 
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logical that if MPs fuse with the plasma membrane, then the cytoplasmic contents of MPs 
may also be transferred to the recipient cell.  Endonucleases within apoptotic cells may 
degrade much of the mRNA being produced but the possibility remains that intact mRNA 
may be packaged within MPs or that MPs containing mRNA could be shed from live 
cells. Thus, MPs may also function as a transfer vehicle for mRNA which could then be 
translated into protein within the recipient cell. This passive transfer of mRNA might be 
one possible explanation for previous reports that MHC class II mRNA was detected in 
human PMNs 88. It remains to be determined, however, if sufficient mRNA could be 
transferred to alter the biology of the recipient cell.  
 
Summary and Conclusions 
The mammalian immune system, exquisitely designed to defend the host against a 
variety of pathogens, must be able to keep pace with pathogens as they evolve.  
Pathogens have an incredible ability to rapidly adapt and evolve to assure their survival 
and thus, the immune system must utilize a variety of mechanisms to control infection 
and limited disease.  Effective communication among leukocytes is of utmost importance 
to ensure a coordinated and integrated immune response. Membrane protein transfer from 
apoptotic or necrotic cells to viable cells offers another vehicle by which cells may 
communicate, even after cell death.  Further investigations may confirm that PMNs can 
present antigen directly to T-cells or perhaps PMNs merely function as a vehicle for 
antigen trafficking to other profession APCs.  Whatever the outcome of future 
investigations, the present investigation provides evidence that the passive acquisition of 
proteins by PMNs has the potential to alter important immunological functions. In 
addition, this work has substantial implications for investigators when characterizing 
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proteins present on the surface of cells. The presence of a specific protein on the surface 
of a cell cannot be interpreted as direct evidence that the protein was expressed by that 
cell. Furthermore, evidence that a protein was passively acquired by a cell does not mean 
that the protein will remain inert, but might play an important role in the biology of that 
cell. Thus, the current investigation revealed that a cell’s biological potential may not be 
limited by the repertoire of genes and proteins expressed within the cell.  
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